Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,microtubule motor activity (GO:0003777),0.9238961737220209,2.090202030893373,0.0,0.0,0.0,15/51,1.19%,KIF11;CENPE;KIF23;KIF15;KIF20B;KIF18B;KIF4A;KIF14;KIFC1;KIF22;KIF2C;DNAH8;KIF24;KIF18A;KIF20A
prerank,motor activity (GO:0003774),0.903417339682833,2.0617085821789773,0.0,0.0,0.0,15/60,1.19%,KIF11;CENPE;KIF23;KIF15;KIF20B;KIF18B;KIF4A;KIF14;KIFC1;KIF22;KIF2C;DNAH8;KIF24;KIF18A;KIF20A
prerank,DNA secondary structure binding (GO:0000217),0.8713586140988283,1.9329305019257983,0.0,0.0037281074423746365,0.01,17/31,8.41%,NEIL3;RAD51AP1;GEN1;CLSPN;HMGB2;MEN1;HMGA1;BLM;RAD51B;RAD51C;HMGB3;MSH6;RBBP8;XRCC3;LIN54;HMGB1;RAD18
prerank,four-way junction DNA binding (GO:0000400),0.8746571013900231,1.8184280882182402,0.001272264631043257,0.08108633687164835,0.254,10/17,7.33%,GEN1;HMGB2;MEN1;BLM;RAD51B;RAD51C;HMGB3;MSH6;XRCC3;HMGB1
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.6889723004232815,-1.8096465551773464,0.004,0.6971073451967953,0.383,9/12,17.39%,ACVR1;TGFBR1;BMPR2;LTBP1;BMPR1B;ENG;TGFBR3;ACVRL1;TGFBR2
prerank,damaged DNA binding (GO:0003684),0.7879913113661051,1.8091119239085731,0.0,0.08444163356978551,0.303,18/44,9.42%,NEIL3;POLQ;HMGB2;RAD1;ERCC4;RPA2;XRCC1;SMC6;POLD1;RBBP8;FEN1;PCNA;DCLRE1C;DCLRE1B;HMGB1;RAD18;RPA1;ERCC3
prerank,"DNA binding, bending (GO:0008301)",0.8907058174924067,1.7989896387826283,0.004016064257028112,0.08590180898471558,0.359,4/14,3.80%,TOP2A;HMGB2;LEF1;HMGB3
prerank,sterol transfer activity (GO:0120015),-0.6000167249384276,-1.7976574866537776,0.0,0.3948511243666858,0.426,7/17,13.34%,OSBPL2;ABCA1;PLTP;MTTP;OSBP;GRAMD1B;NPC2
prerank,microtubule binding (GO:0008017),0.746041830786173,1.783654605568919,0.0,0.099593727389151,0.445,48/222,6.10%,CENPE;NUSAP1;KIF23;TPX2;KIF15;DLGAP5;PRC1;KIF20B;KIF18B;KIF14;KIFC1;KIF22;BIRC5;KNSTRN;GTSE1;SKA1;KIF2C;FAM83D;RACGAP1;SKA2;KIF18A;CKAP5;KIF20A;SPAG5;CCSAP;PLK1;CDK5RAP2;TUBGCP6;UXT;CCDC88A;NDE1;REEP4;CCDC69;CEP44;EZR;SUN2;GAS2L3;CEP57L1;HAUS6;FBXW11;S100A9;ABRAXAS1;MAP4;CEP295;TUBGCP4;S100A8;CLASP1;CCDC88C
prerank,single-stranded DNA binding (GO:0003697),0.7381145478444375,1.7642479639104327,0.0,0.12885271347707336,0.578,39/93,14.58%,NEIL3;RAD51AP1;RAD51;MCM10;HMGB2;ERCC4;CDC45;RPA2;RADX;POLA1;BLM;BRCA2;RAD51B;DDX11;SMC6;MCM6;NUCKS1;MCM9;PMS2;RBBP8;HMGB1;TDP2;NABP2;RPA1;LONP1;PCBP2;PARK7;RAD23A;RTF1;FAM111A;DHX9;CTC1;TOP3A;TDP1;HNRNPU;REXO4;APTX;RAD52;RPA3
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.5841186515587324,-1.737503320569307,0.014705882352941176,0.4920757730800909,0.642,9/18,17.39%,ACVR1;TGFBR1;BMPR2;LTBP1;BMPR1B;ENG;TGFBR3;ACVRL1;TGFBR2
prerank,ankyrin binding (GO:0030506),0.8310152913374058,1.7128379959003142,0.00510204081632653,0.27432657263473365,0.864,2/19,0.51%,SLC4A1;RHAG
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.7460285102902261,1.7057075924049456,0.002185792349726776,0.2761595587939012,0.896,10/42,5.36%,CCNF;CCNB2;CKS2;CCNB1;CCNA2;CCNE1;CDKN2C;CCNE2;CCNYL1;CDKN2A
prerank,DNA polymerase activity (GO:0034061),0.80127030753112,1.7037691875345489,0.006053268765133172,0.2596118455326338,0.899,9/22,7.09%,POLK;POLQ;POLE2;POLA1;POLE;POLD1;POLH;POLN;PRIMPOL
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.8043332041682525,1.6982977161894062,0.007361963190184049,0.2570064068087015,0.917,9/21,7.09%,POLK;POLQ;POLE2;POLA1;POLE;POLD1;POLH;POLN;PRIMPOL
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.7106529898518634,-1.6971334155118725,0.010344827586206896,0.5446564504455037,0.775,7/10,17.58%,NSF;SQSTM1;GNAS;SHISA6;SHANK2;SHANK3;DLG4
prerank,BMP binding (GO:0036122),-0.6781383780374343,-1.6964231636461615,0.007380073800738007,0.4391643996306187,0.779,3/11,12.61%,BMPR2;ENG;GREM2
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.8009522055533669,1.6950099281139681,0.006097560975609756,0.2492813380218579,0.922,2/21,1.37%,CHRNB4;P2RX1
prerank,single-stranded DNA helicase activity (GO:0017116),0.8069920640966087,1.677490372312156,0.003875968992248062,0.29325559435107634,0.96,10/19,11.45%,RAD51;PIF1;POLQ;DSCC1;MCM6;RFC5;HELQ;DNA2;RFC2;DHX9
prerank,tubulin binding (GO:0015631),0.6983421954412005,1.6727718856747174,0.0,0.29153800199369656,0.967,52/295,6.10%,CENPE;NUSAP1;KIF23;TPX2;KIF15;DLGAP5;PRC1;KIF20B;KIF18B;KIF14;KIFC1;KIF22;BIRC5;GTSE1;SKA1;KIF2C;FAM83D;RACGAP1;SKA2;KIF18A;CKAP5;KIF20A;SPAG5;CCSAP;PLK1;CDK5RAP2;BRCA1;STMN1;TUBGCP6;AGBL1;BRCA2;UXT;CCDC88A;NDE1;FYN;REEP4;CCDC69;CEP44;EZR;SUN2;GAS2L3;CEP57L1;HAUS6;S100A9;ABRAXAS1;MAP4;CEP295;TUBGCP4;S100A8;CLASP1;AGTPBP1;CCDC88C
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.8398051000011271,1.671936447040791,0.008097165991902834,0.2760547057720844,0.968,6/13,8.71%,GEN1;EXO1;SLX4;FEN1;DNA2;DNASE1L1
prerank,kinesin binding (GO:0019894),0.7674985116392034,1.6701685081447246,0.009569377990430622,0.2663952068014464,0.97,3/27,0.62%,PRC1;KIF18B;FAM83D
prerank,lipoprotein particle binding (GO:0071813),-0.5399835956485022,-1.667741215009977,0.02127659574468085,0.4607698771224865,0.846,9/20,18.07%,TREM2;LPL;HSPD1;PLTP;CDH13;STAB1;SCARB1;CD36;THBS1
prerank,cholesterol transfer activity (GO:0120020),-0.5750901688251662,-1.6640033101938165,0.01327433628318584,0.40590582203380765,0.853,6/16,13.34%,OSBPL2;ABCA1;PLTP;MTTP;GRAMD1B;NPC2
prerank,DNA polymerase binding (GO:0070182),0.7961425658035463,1.6634907739672062,0.01164294954721863,0.27577639219565714,0.981,9/18,9.55%,RAD51;FANCD2;SMG6;PCNA;RTEL1;HMGB1;SMARCA4;NABP2;LONP1
prerank,WW domain binding (GO:0050699),0.7529560206978501,1.6503603941919387,0.015476190476190477,0.3057048102747202,0.989,2/26,0.21%,KIF20B;CDC25C
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.784248284984225,1.6362351477980948,0.022900763358778626,0.3456887625941882,0.994,4/16,7.57%,NEIL3;CD38;SMUG1;NEIL1
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.851209698187931,1.6239414713881082,0.01692524682651622,0.37414221118116886,0.997,1/11,0.81%,CHRNB4
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.5450444810908018,-1.619219232090113,0.02185792349726776,0.4897609004916764,0.925,10/20,22.63%,SLC39A11;SLC30A4;SLC39A7;SLC39A14;SLC39A8;SLC39A6;SLC39A12;SLC39A3;SLC39A1;SLC30A1
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.7987854020308948,1.6162398533944486,0.015056461731493099,0.38628276885877194,0.998,2/18,1.35%,HSD17B3;SRD5A2
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.5803055924605793,-1.5918459476020006,0.02727272727272727,0.5302895427935985,0.96,9/15,28.12%,HS6ST3;NDST3;HS3ST4;HS3ST1;HS6ST2;HS3ST5;HS6ST1;NDST2;HS3ST3A1
prerank,ATP hydrolysis activity (GO:0140603),0.7006826259386605,1.5862353563673388,0.01545253863134658,0.501470973906371,1.0,11/41,11.45%,KIF20B;KIF14;SMCHD1;CHD1L;ABCB10;ABCD1;DNA2;RUVBL2;TOR1A;RUVBL1;DHX9
prerank,protein kinase C binding (GO:0005080),0.6995326811060044,1.5852940795586719,0.007717750826901874,0.4849646431289006,1.0,10/43,14.68%,TOP2A;CCDC88A;PICK1;NELL2;ITGAV;PRKCB;NELL1;RACK1;IRS1;PRKCSH
prerank,DNA replication origin binding (GO:0003688),0.7491013322295715,1.5846668908101214,0.03444034440344403,0.46851126228322054,1.0,8/23,5.34%,MCM10;CDC45;POLA1;DDX11;MCM6;ORC5;MCM9;ORC3
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.8276653700609106,1.5843559609737166,0.024355300859598854,0.4517820970793033,1.0,1/11,0.03%,NEIL3
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.812638197023314,1.572300574677873,0.040502793296089384,0.48731197003706245,1.0,6/11,14.22%,PPP1R11;PPP1R8;PPP1R14A;PPP1R14C;PPP1R2;PABIR1
prerank,syntaxin binding (GO:0019905),-0.3777203623185841,-1.569998825325813,0.02040816326530612,0.545383981830434,0.977,19/61,13.56%,NSF;SCFD2;STX6;PTPN2;STX16;ABCA1;VAMP1;NAPA;SNAP47;SYT1;TMED9;STXBP5L;VAMP2;VAMP8;SYT9;GOLGA2;RAB11A;UNC13A;STXBP5
prerank,lysophospholipase activity (GO:0004622),-0.5129539230597985,-1.568715761762224,0.029239766081871343,0.5010947571907963,0.977,7/20,15.44%,MGLL;ABHD12;ENPP2;GDE1;ABHD16A;PLA2G6;PNPLA7
prerank,acylglycerol lipase activity (GO:0047372),-0.6161665194561414,-1.5683513628733872,0.046263345195729534,0.46099034117852594,0.977,6/11,19.31%,MGLL;ABHD12;ABHD16A;ABHD6;ABHD3;ABHD15
prerank,single-stranded telomeric DNA binding (GO:0043047),0.8117956561807232,1.567869274308859,0.0221606648199446,0.49107829551208043,1.0,9/11,18.52%,RPA2;TERF2;HNRNPA2B1;NABP2;TERF1;RPA1;CTC1;RAD50;HNRNPA1
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.7849570204563193,1.5671160384808716,0.02119205298013245,0.4772298914812153,1.0,1/15,0.36%,SLC4A1
prerank,nucleosomal DNA binding (GO:0031492),0.7381581781518135,1.558283818894107,0.03385731559854897,0.4991625189719441,1.0,11/21,11.77%,SMARCC2;MBD3;RCC1;SMARCD2;HNRNPC;MBD2;RBBP4;H3-3A;SMARCA4;SMARCC1;MTA2
prerank,diacylglycerol kinase activity (GO:0004143),-0.6119655820271346,-1.5564048226205993,0.04946996466431095,0.4616517333466444,0.981,7/11,13.70%,DGKH;DGKA;DGKI;DGKZ;AGK;DGKQ;DGKB
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.8252122739465273,1.5530548216333786,0.02717391304347826,0.50563960456336,1.0,1/10,0.70%,SLC6A12
prerank,symporter activity (GO:0015293),0.8221366658903355,1.5511018598599402,0.036337209302325583,0.4983139861842786,1.0,1/10,1.13%,SLC5A5
prerank,protein kinase regulator activity (GO:0019887),0.6473411008066272,1.5482037247251703,0.005112474437627812,0.49581004659762684,1.0,13/95,6.07%,TPX2;CCNF;CCNB2;CCNB1;CCNA2;CCNE1;CCNE2;CCNYL1;STK11;GPRC5B;GMFG;FAF1;KIDINS220
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.6988581310622409,1.53922797768582,0.03699284009546539,0.5193856743431782,1.0,7/28,8.22%,TTK;AURKB;AURKA;MAP2K6;MAPKAPK3;MAPK14;PRKACA
prerank,palmitoyltransferase activity (GO:0016409),-0.4724053538533337,-1.5319895884131836,0.007352941176470588,0.5021856247927579,0.988,19/28,35.77%,GLUL;ZDHHC17;ZDHHC13;ZDHHC5;GOLGA7;ZDHHC8;YKT6;ZDHHC24;ZDHHC16;ZDHHC20;ZDHHC15;ZDHHC3;ZDHHC12;HHAT;ZDHHC4;ZDHHC23;ZDHHC22;ZDHHC1;GOLGA7B
prerank,histone deacetylase binding (GO:0042826),0.6399921523170464,1.5266987940203869,0.01017293997965412,0.5567662171797778,1.0,15/88,8.03%,TOP2A;HEY2;LEF1;IKZF3;USF1;RAD9A;SMG5;HDAC10;MTA3;RBBP4;GMNN;HDAC6;PKN2;CAMTA2;CIR1
prerank,solute:anion antiporter activity (GO:0140323),0.7653773598940811,1.521294515789881,0.04699738903394256,0.5648859464248069,1.0,1/14,0.36%,SLC4A1
prerank,low-density lipoprotein particle binding (GO:0030169),-0.5253556569867273,-1.5151619218053878,0.06639004149377593,0.515180406153027,0.992,7/16,18.07%,TREM2;PLTP;CDH13;STAB1;SCARB1;CD36;THBS1
prerank,telomeric DNA binding (GO:0042162),0.676251311206377,1.4981218031306511,0.044673539518900345,0.6535523485973646,1.0,12/32,12.36%,PIF1;BLM;SMG6;SMG5;TERF2;UPF2;XRCC6;HNRNPA2B1;TERF1;RPA1;CTC1;APEX1
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.7126817490651932,1.4966285506982544,0.06861499364675985,0.6436626553305104,1.0,5/18,11.30%,BIRC5;DPEP1;BIRC2;TNFAIP8;XIAP
prerank,phospholipase A2 activity (GO:0004623),-0.4493266713435782,-1.4925404612733992,0.07017543859649122,0.5544119849252501,0.995,15/26,44.41%,PLA2G15;PLA2G7;ABHD3;PLA2G6;PLA2G4E;PLA2G12A;PLA2G4A;PLA2G3;PLA2G4C;PNPLA3;PNPLA8;PLAAT1;PLA2G5;PLA2G4F;PLA2G2D
prerank,gamma-tubulin binding (GO:0043015),0.6945303728486935,1.4884211672612149,0.07402912621359223,0.6666859828200336,1.0,10/21,18.18%,RACGAP1;CDK5RAP2;TUBGCP6;BRCA2;TUBGCP4;OFD1;TUBGCP3;MARK4;NDRG1;ARHGEF7
prerank,telomerase RNA binding (GO:0070034),0.6854308913114564,1.4844075292914176,0.07099143206854346,0.6701739141098706,1.0,13/22,20.46%,SMG6;NOP10;SMG5;HNRNPC;EXOSC10;DCP2;TEP1;HNRNPU;DKC1;WRAP53;XRN1;SNRPB;SMG7
prerank,endodeoxyribonuclease activity (GO:0004520),0.7045335836868034,1.482730812474051,0.06140350877192982,0.6618527328337656,1.0,10/20,14.98%,ERCC4;EXO1;RBBP8;FEN1;MBD4;DCLRE1C;ZRANB3;DNA2;APEX1;RAD50
prerank,magnesium ion binding (GO:0000287),0.6181461381015447,1.4810417772080093,0.0050200803212851405,0.654194091673835,1.0,24/135,8.91%,TOP2A;GEN1;PIF1;PLK1;STK26;OXSR1;MSH6;STK11;FEN1;DUT;IMPA1;SIK2;UBA2;EPHX2;PDE2A;STK38L;MAP3K5;GNAI1;TDP2;RP2;PPA2;STK38;MARK2;MAST2
prerank,microtubule plus-end binding (GO:0051010),0.7065868880100499,1.475368072930699,0.06577344701583435,0.665727278983108,1.0,6/20,6.92%,KNSTRN;KIF2C;KIF18A;FBXW11;CLASP1;MAPRE3
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.6868061731004507,1.4738127129130922,0.05909617612977984,0.6576508622920758,1.0,2/27,1.13%,SLC4A1;SLC5A5
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.5390303346225063,-1.4724032803362603,0.04263565891472868,0.5875496778190649,0.996,6/14,10.63%,SPOCK1;TIMP2;SPOCK2;BST2;TIMP3;RECK
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.5273910275375809,-1.4646725501693578,0.05859375,0.5481200567995975,0.996,8/16,11.22%,PTPRZ1;PTPRG;PTPN6;PTPRE;PTPRD;PTPRK;PTPRO;PTPRT
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.5273910275375809,-1.4646725501693578,0.05859375,0.5481200567995975,0.996,8/16,11.22%,PTPRZ1;PTPRG;PTPN6;PTPRE;PTPRD;PTPRK;PTPRO;PTPRT
prerank,phospholipase activity (GO:0004620),-0.3642459497087268,-1.4598281225292924,0.0,0.5358599346095291,0.997,19/67,17.88%,MGLL;PLA2G15;LPL;ABHD12;PLCB2;ENPP2;GDE1;ABHD16A;ABHD6;PLCB4;PLBD2;PDIA3;ABHD3;PLA2G6;SMPDL3A;PNPLA7;LIPH;SEC23IP;GPLD1
prerank,glutamate receptor binding (GO:0035254),-0.5275283190512583,-1.4538605453116138,0.08571428571428572,0.5265941452828418,0.998,8/17,17.58%,NSF;SQSTM1;SYNDIG1;GNAS;SHISA6;SHANK2;SHANK3;DLG4
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.7660247225823938,1.4470139369648725,0.07628294036061026,0.7754670597219375,1.0,7/12,16.37%,CDK1;MAPK1;CDK6;BRD4;CDK19;CCNK;CDK8
prerank,neuropeptide binding (GO:0042923),-0.4921476621112637,-1.4445718823189877,0.08333333333333333,0.5301358860272679,0.999,8/18,40.92%,GPR149;SORL1;OPRL1;OPRK1;GPR37;OPRD1;SSTR2;NMUR2
prerank,chloride transmembrane transporter activity (GO:0015108),0.7186684522464056,1.4425791463995952,0.08010335917312661,0.7821326276660094,1.0,1/16,0.36%,SLC4A1
prerank,protein phosphatase inhibitor activity (GO:0004864),0.6621064561379696,1.442412090336701,0.07854630715123095,0.7666416687351247,1.0,8/26,14.22%,PPP1R9B;PPP1R11;PPP1R8;PPP1R14A;PPP1R14C;LMTK2;PPP1R2;PABIR1
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.5526313743819063,-1.4409161269771529,0.08461538461538462,0.5167485765690295,0.999,7/13,14.08%,PTPRJ;ERN1;ITGA5;PDGFD;PDGFC;ITGB3;VEGFA
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.6463037666963647,1.4358451547437088,0.07339449541284404,0.7854656367653061,1.0,7/31,7.56%,UBE2C;UBE2T;UBE2O;TAF1;UBE2Z;BIRC6;UBE2K
prerank,DNA binding (GO:0003677),0.5935196609652895,1.4356547116102996,0.0,0.7704818784095377,1.0,170/694,15.03%,TOP2A;NEIL3;RAD51AP1;BRIP1;RAD51;CLSPN;E2F2;POLQ;MCM10;FOXA2;HMGB2;TIPIN;MEN1;RAD1;ERCC4;CDC45;SMC1B;BRCA1;NR4A2;EXO1;RPA2;HMGA1;SOX6;MBD3;RADX;POLA1;HEY2;BLM;GTF3C5;BRCA2;MYRFL;RPL7;LEF1;POLE;E2F1;SMARCA5;RAD51B;IKZF3;DDX11;PBX4;LIN9;RAD51C;BATF;ELK4;SMC6;MCM6;LIG4;BCLAF3;USF1;HMGB3;POLR2A;TIMELESS;TFPT;NUCKS1;POLD1;ERG;MSH6;MCM9;CTCF;PMS2;RBBP8;FEN1;PCNA;SLPI;ETS2;CGAS;ATAD5;MBD4;TAF1;FOXO1;FOXJ3;DCLRE1C;MBD1;TCF7L1;TCF3;ARID4A;SETX;MND1;PHF19;XRCC6;DCLRE1B;HMGB1;AHR;CAMTA2;ILF2;MAX;TDP2;PHF1;SMARCA4;PALB2;ZBTB16;DNA2;ZNF638;RLF;RAD18;DNASE1L1;GTF2A1;NABP2;TERF1;SNAPC3;ZBTB7A;EGFR;FLI1;ZNF148;RPA1;ERCC3;RPS27;LONP1;MECP2;SRRT;EGR1;ZBTB32;SPTY2D1;NR2C2;RFX2;DNMT1;NR2F2;KAT6A;PCBP2;PMS1;TSHZ1;CUX1;NFYC;PARK7;ARID5B;NFE2;RAD23A;RTF1;RFC1;SMAD4;ATF6;TAF6;FAM111A;DHX9;JUN;ATF5;CCNT1;FOXP2;CBFB;CTC1;APEX1;TOP3A;PDS5B;TDP1;ZBTB33;KIN;NFE2L2;ING2;HNRNPU;HIVEP2;REXO4;PRKDC;DDIT3;CEBPZ;PSIP1;CREBBP;MYC;CEBPG;BCL6;APTX;POU6F1;CHTF18;RAD52;CAMTA1;RPA3;E2F3;TP53;RAD50;JUNB;LRRFIP1
prerank,acetylcholine receptor activity (GO:0015464),0.6724120731510143,1.4351895307968734,0.0730816077953715,0.7574955106788905,1.0,1/22,0.81%,CHRNB4
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.6476735927999774,1.4333553183271737,0.08265424912689173,0.7517984508059206,1.0,9/30,11.30%,BIRC5;UBE2O;DPEP1;BIRC2;UBE2Z;BIRC6;TNFAIP8;PTTG1;XIAP
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.6394910062566415,1.4307174224532568,0.07709750566893424,0.7503533171517874,1.0,8/34,7.56%,UBE2C;UBE2T;UBE2I;UBE2O;TAF1;UBE2Z;BIRC6;UBE2K
prerank,leucine zipper domain binding (GO:0043522),0.7403214443086308,1.4235220250619904,0.109375,0.7714896302095173,1.0,4/10,13.56%,PMF1;ERC1;PAWR;DDIT3
prerank,histone acetyltransferase binding (GO:0035035),0.6615563436609729,1.4225998368721118,0.0951219512195122,0.761793880481895,1.0,8/21,14.97%,KANSL1;PCNA;TAF7;KANSL1L;ZBTB7A;EGR1;TRIM68;TP53
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.48928491856946726,-1.4214244823943796,0.10407239819004525,0.5274205705443382,1.0,7/16,14.06%,ATP6V1B2;ATP6V1C1;ATP6V0D2;ATP6V0A1;ATP6V0B;TCIRG1;ATP6V1A
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.48928491856946726,-1.4214244823943796,0.10407239819004525,0.5274205705443382,1.0,7/16,14.06%,ATP6V1B2;ATP6V1C1;ATP6V0D2;ATP6V0A1;ATP6V0B;TCIRG1;ATP6V1A
prerank,kinase binding (GO:0019900),0.5827804038098627,1.4174696687120925,0.0,0.773446726749378,1.0,106/434,14.97%,KIF11;TPX2;PRC1;KIF14;CDC25C;AURKB;FOXM1;CIT;FAM83D;RACGAP1;BORA;CKS2;BARD1;CCNB1;CCNA2;KIF20A;PLK1;CDKN2C;CDK5RAP2;CNTLN;CHEK2;POLA1;CDC25A;EXOC2;ATG13;ARHGAP33;RB1;AURKA;CEP152;FBXO5;OXSR1;SGO1;TIAM1;FLNA;USF1;RAD9A;TBL2;MAP2K6;AXIN1;POLR2A;PTPN22;CEP192;RPS19;GPRC5B;TFRC;SP100;RPS7;CAV1;CDKN2A;PPP1CB;PPP2R5A;FAF1;GSN;TRADD;MYOM1;SLC12A7;RND3;KIZ;MAPRE3;CDC25B;MAP3K1;CEP250;CIR1;PRKACA;CLTC;IBTK;GRB2;PLCG2;LRRC14;JAK2;UBQLN1;EGFR;CDKN2D;CAV2;PPP1R15A;MSN;LRBA;PARK7;RAD23A;VRK1;PPP1CC;ATF5;BECN1;KAT2B;CRK;HNRNPA0;FAS;ADIPOR1;TRIM68;PRAM1;CDK5RAP3;SPRED2;RAC2;DGKD;ADD2;PRKAG2;LATS1;SKI;CASP9;TRIM5;GSK3B;PPP1R12A;CCNK;LIMS1;PDCD10;TP53
prerank,hormone receptor binding (GO:0051427),0.7038982545865261,1.4137220203544663,0.10977242302543508,0.7774269050926859,1.0,7/14,21.26%,NPPC;PTHLH;JAK2;SOCS2;ADCYAP1;NCOA6;TYK2
prerank,metallocarboxypeptidase activity (GO:0004181),0.6400803297421234,1.4119912189313273,0.0927710843373494,0.7721106729339049,1.0,7/26,16.53%,AGBL1;CPA6;CPM;AGTPBP1;VASH2;AGBL3;CPD
prerank,Wnt-activated receptor activity (GO:0042813),-0.5100044281541655,-1.4109943817514783,0.0796812749003984,0.535269769290285,1.0,13/15,47.21%,RYK;FZD3;PKD1;TSPAN12;FZD7;FZD4;FZD6;FZD2;LRP5;FZD5;FZD8;FZD1;FZD10
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.7167773126302198,1.4087545405766169,0.10857142857142857,0.7739518911512484,1.0,1/11,1.86%,AQP1
prerank,methyl-CpG binding (GO:0008327),0.6507955263405558,1.3927251776190683,0.10987654320987654,0.8416360521815079,1.0,7/22,12.71%,UHRF1;MBD3;MBD2;MBD1;LRWD1;MECP2;ZBTB33
prerank,anion:anion antiporter activity (GO:0015301),0.6838696883990287,1.3914708079455624,0.10466582597730138,0.8342106415743545,1.0,1/17,0.36%,SLC4A1
prerank,potassium ion leak channel activity (GO:0022841),-0.5066781994797951,-1.3892087602323895,0.08294930875576037,0.5735984818022405,1.0,4/15,5.71%,KCNK13;TMEM175;KCNK6;KCNK10
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.42942268047252463,-1.3887976268074602,0.04878048780487805,0.5541049099900525,1.0,15/24,35.77%,GLUL;ZDHHC17;GOLGA7;ZDHHC8;YKT6;ZDHHC24;ZDHHC20;ZDHHC15;ZDHHC3;ZDHHC12;ZDHHC4;ZDHHC23;ZDHHC22;ZDHHC1;GOLGA7B
prerank,kinase activator activity (GO:0019209),0.6384749116330416,1.388710847333863,0.11175115207373272,0.8333542464016288,1.0,6/30,13.57%,TPX2;STK11;GPRC5B;MARK2;FGF13;PRKAG2
prerank,protein kinase activator activity (GO:0030295),0.5987927095786678,1.3853188954240439,0.061027837259100645,0.8363437804698101,1.0,20/60,19.33%,TPX2;INCENP;DBF4;ERBB3;STK11;GPRC5B;MARK2;CAB39L;MLST8;FGF13;PRKAG2;FAM20A;STK4;MAP2K1;PAK2;CD24;IQGAP1;TAOK1;CDKN1A;STK3
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.6419511661833566,1.3831636838496744,0.09722222222222222,0.8337793942253656,1.0,15/29,22.51%,CIT;CDKN2C;CDKN2A;CIB1;PKIG;CDKN2D;KAT2B;SPRED2;PRKAG2;HEXIM1;CDKN1A;PRKAR2A;YWHAG;PKIA;CDKN1B
prerank,protein kinase binding (GO:0019901),0.5692094658767182,1.3810014950657898,0.0,0.8320524168752924,1.0,107/479,14.97%,TOP2A;KIF11;TPX2;PRC1;KIF14;CDC25C;FOXM1;CIT;FAM83D;RACGAP1;BORA;CKS2;CCNB1;CCNA2;KIF20A;PLK1;CDKN2C;CDK5RAP2;CNTLN;CHEK2;POLA1;CDC25A;EXOC2;ATG13;ARHGAP33;AURKA;CEP152;FBXO5;CCDC88A;OXSR1;EZR;PPM1D;USF1;RAD9A;TBL2;MAP2K6;AXIN1;NEDD9;CEP192;RPS19;GPRC5B;MAPKAPK3;TFRC;RPS7;CAV1;BANK1;CDKN2A;PPP1CB;FAF1;ATF7;TCF3;SLC12A7;RND3;KIZ;MAPRE3;CDC25B;PIN1;MAP3K1;MAP4K2;CEP250;CIR1;PRKACA;CLTC;IBTK;GRB2;PLCG2;STK38;PICK1;NELL2;JAK2;ITGAV;CDKN2D;CAV2;PRR7;PPP1R15A;MAP3K11;MSN;LRBA;VRK1;PPP1CC;BECN1;KAT2B;CRK;HNRNPA0;PRKCB;ADIPOR1;TRIM68;PRAM1;CDK5RAP3;NELL1;RACK1;SPRED2;RAC2;ADD2;PRKAG2;LATS1;SKI;CASP9;TRIM5;IRS1;GSK3B;PPP1R12A;PRKCSH;CCNK;LIMS1;PDCD10;TP53
prerank,water transmembrane transporter activity (GO:0005372),0.7322606210297868,1.380961484064248,0.12173913043478261,0.8193519825852749,1.0,1/11,1.86%,AQP1
prerank,transcription corepressor binding (GO:0001222),0.6131530136120426,1.3767604407839773,0.11682242990654206,0.8267784334420752,1.0,8/27,10.75%,EZH2;SUZ12;NR1D1;HDAC6;PHF1;ZBTB16;ZBTB7A;EHMT1
prerank,carbohydrate kinase activity (GO:0019200),-0.5459183640433746,-1.3730627473750434,0.13214285714285715,0.5768708103581673,1.0,9/11,28.75%,HK2;HK3;GALK2;NAGK;GNE;POMK;XYLB;GALK1;KHK
prerank,protein phosphatase 1 binding (GO:0008157),0.6474364851071641,1.3715080265773962,0.12702366127023662,0.8395058061189065,1.0,4/21,9.87%,PHACTR4;PPP1R9B;PPP1R11;PPP1R15A
prerank,secondary active transmembrane transporter activity (GO:0015291),0.5942387915684382,1.3705866549286514,0.08217716115261472,0.8313816659269055,1.0,12/51,14.28%,SLC4A1;SLC5A5;SLC35E1;SLC25A16;SLCO4C1;SLC35D2;SLC35A1;SLCO4A1;SLC16A10;SLCO2A1;MCU;SLC35C2
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.42994155120560107,-1.3662742375570351,0.08045977011494253,0.5750143509621384,1.0,6/22,8.63%,ATP6V1B2;ATP6V1C1;ATP6V0D2;ATP6V0A1;ATP6V0B;TCIRG1
prerank,GABA receptor activity (GO:0016917),-0.45239205017726625,-1.365049266111979,0.1044776119402985,0.55940976284079,1.0,9/21,14.68%,GABRB3;GABRG2;GABRG3;GABRA2;GABRA3;GABBR1;GABBR2;GABRG1;GABRA1
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.7279929952922937,1.3634109596871897,0.1567489114658926,0.853898695931721,1.0,7/10,22.51%,CDKN2C;CDKN2A;CDKN2D;KAT2B;HEXIM1;CDKN1A;CDKN1B
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.715739590210505,1.3582326629192816,0.13056379821958458,0.8676770632043855,1.0,6/10,12.36%,EXO1;POLD1;FEN1;DCLRE1C;DCLRE1B;APEX1
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.6047437879719648,1.357627745960968,0.11858608893956671,0.8585542642733391,1.0,14/34,19.33%,CKS2;CCNB1;INCENP;DBF4;CAB39L;MLST8;CCNT1;FAM20A;CCNK;STK4;MAP2K1;IQGAP1;TAOK1;STK3
prerank,steroid hydroxylase activity (GO:0008395),0.6589176825335957,1.3524821709344441,0.14785992217898833,0.8709143771372332,1.0,4/16,12.04%,CYP1B1;CYP2A6;CYP27A1;CYP46A1
prerank,ubiquitin-specific protease binding (GO:1990381),0.6556014906015095,1.3517262523866072,0.14949748743718594,0.8622525209615447,1.0,12/19,17.78%,CLTC;SART3;DERL2;AMFR;PARK7;SUMO1;RAD23A;PTEN;SPATA2;RHBDD2;CHMP3;SYVN1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.6326002855014808,1.3509476420122477,0.14814814814814814,0.8542907824371176,1.0,1/21,0.81%,CHRNB4
prerank,FMN binding (GO:0010181),-0.5281769086538607,-1.3497506171341207,0.14285714285714285,0.5837199253749968,1.0,5/11,26.64%,POR;DUS2;MTRR;PPCDC;NDOR1
prerank,phospholipid transfer activity (GO:0120014),-0.43712611373065935,-1.3399345353003702,0.12437810945273632,0.5933689857367697,1.0,9/21,18.07%,OSBPL2;PLTP;PRELID2;MTTP;PITPNB;PLEKHA3;C2CD2L;PITPNM2;PRELID3A
prerank,LRR domain binding (GO:0030275),0.6699319171771604,1.3385281511816534,0.1467764060356653,0.9014315255165711,1.0,6/14,17.19%,PMF1;LRRFIP2;ERC1;PAWR;DDIT3;POLR2J
prerank,ubiquitin binding (GO:0043130),0.5693794131043565,1.3370638584261605,0.09090909090909091,0.8970267992761025,1.0,7/73,8.17%,TOP2A;CKS2;IKBKG;FAF1;NPLOC4;BIRC2;FAF2
prerank,methylated histone binding (GO:0035064),0.5723490770549159,1.3369638060700593,0.10344827586206896,0.8857644364223738,1.0,24/62,18.49%,UHRF1;SPIN4;NCAPD3;MORC4;CBX5;SUZ12;MSH6;NCAPG2;TAF1;LRWD1;PHF19;TAF7;PHF1;PHF2;ZMYND8;ING3;ING2;ING5;RBBP5;ATRX;GLYR1;MBTD1;MORC3;DPF2
prerank,double-stranded DNA binding (GO:0003690),0.5522975196502095,1.330849022645327,0.0,0.9039943604019576,1.0,117/531,19.50%,NEIL3;E2F7;RAD51AP1;RAD51;E2F8;E2F2;UHRF1;GFI1;FOXA2;VAX2;HMGB2;SPIB;MEN1;DMRTA1;NR4A2;HEY2;LEF1;E2F1;RAD51B;DDX11;BATF;ELK4;USF1;HMGB3;NUCKS1;ERG;BACH2;MSH6;RBBP8;FEN1;FOXP1;ETS2;CGAS;NR1D1;FOXJ3;ATF7;TERF2;ZBTB26;MBD1;TCF7L1;ZFP41;IRF9;RUNX3;MND1;KLF10;XRCC6;HMGB1;AHR;CAMTA2;MAX;ZNF638;TERF1;ZBTB7A;EGFR;FLI1;MECP2;KLF13;EGR1;ZBTB32;NR2C2;RFX2;CUX1;PARK7;NFE2;ATF6;DHX9;JUN;APEX1;TDP1;ZBTB33;KIN;SP3;ZBTB7B;HNRNPU;REXO4;PRKDC;PSIP1;CEBPG;BCL6;GABPA;APTX;POU6F1;CAMTA1;E2F3;GMEB2;ELF1;RAD50;JUNB;IRF8;HOXB4;TCF4;HIVEP1;TFAP4;ZNF23;RFX7;RFX4;ZNF445;NFATC3;XBP1;RXRB;TDG;POU2F2;RARG;FOXE1;CREB1;ZNF740;RFX1;GMEB1;NKX2-8;PROX1;SAFB;ZBTB20;RPS3;PAX2;SOX9;NPAS2;SREBF2
prerank,neuropeptide receptor binding (GO:0071855),0.6703024754069956,1.3275729406439385,0.17079889807162535,0.9078885446851194,1.0,4/14,19.48%,AGRP;NMU;APLN;PPY
prerank,methylation-dependent protein binding (GO:0140034),0.5686443635399299,1.3257605723237378,0.11215932914046121,0.9049864313006857,1.0,21/57,17.99%,UHRF1;SPIN4;NCAPD3;MORC4;CBX5;SUZ12;MSH6;NCAPG2;LRWD1;PHF19;PHF1;PHF2;ZMYND8;ING3;ING2;ING5;RBBP5;ATRX;GLYR1;MBTD1;MORC3
prerank,C-C chemokine receptor activity (GO:0016493),0.6214628382944989,1.3205304248078338,0.17524509803921567,0.9193121731744491,1.0,4/21,10.57%,CXCR5;CCR2;GPR75;CCR6
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.6710383665544012,1.320144249606618,0.17158176943699732,0.9098287086578126,1.0,7/14,17.64%,USP27X;MINDY4;DESI2;USP15;OTUD5;YOD1;USP7
prerank,H4 histone acetyltransferase activity (GO:0010485),0.6852770717495801,1.320104477715925,0.17862165963431786,0.8990353555765004,1.0,2/10,2.18%,NAA40;BRCA2
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.561523038601595,1.319755208393274,0.11016949152542373,0.8900412696354876,1.0,21/60,20.22%,CDKN3;PHLPP2;PPM1D;PPP3CA;LRRC40;PPP1CB;CTDSPL2;CTDSPL;TAB1;PPP2CB;PPP1CC;MTMR6;PTEN;LRRK1;PPP6C;PPP1CA;LRRK2;ILKAP;PPM1B;PPP2CA;RPAP2
prerank,histone methyltransferase activity (GO:0042054),0.5915468654083043,1.3187183535729328,0.13058419243986255,0.8841645400467023,1.0,8/32,11.74%,EZH2;MEN1;SUV39H1;SUZ12;KMT2C;EHMT1;FBL;NSD3
prerank,transaminase activity (GO:0008483),-0.5215850737154136,-1.3149550499972358,0.14652014652014653,0.6457521886134842,1.0,3/11,25.22%,GOT2;AGXT;OAT
prerank,3'-5' exonuclease activity (GO:0008408),0.5695853980390371,1.3136847996670817,0.12623490669593854,0.8964797896314823,1.0,20/45,20.91%,ERI2;RAD1;RAD9A;POLD1;PDE12;EXOSC10;PNLDC1;ERI1;APEX1;REXO4;RAD50;ANGEL2;CNOT6;ERI3;DIS3L;TATDN1;CNOT8;PNPT1;CNOT7;WRN
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.6717526349189741,1.31204397147425,0.16847826086956522,0.8934923707367004,1.0,3/13,10.11%,SLC38A5;SLC7A1;SLC3A1
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),-0.513176508971191,-1.3108150824974223,0.18055555555555555,0.6392449789459798,1.0,6/11,34.44%,AKR1B1;AKR1B10;RDH13;AKR1A1;DHRS13;RDH14
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.4811954542600615,-1.3086504902740612,0.1459227467811159,0.6273672154696439,1.0,10/15,51.90%,PLA2G4E;PLA2G12A;PLA2G4A;PLA2G3;PLA2G4C;PLA2G5;PLA2G4F;PLA2G2D;PLA2G4B;PLA2G10
prerank,deoxyribonuclease activity (GO:0004536),0.660337393095126,1.3009189735814835,0.17473118279569894,0.9346005256746166,1.0,5/14,12.36%,ERCC4;MBD4;ZRANB3;DNASE1L1;APEX1
prerank,protein heterodimerization activity (GO:0046982),0.5402488968631689,1.2999294988001253,0.04604604604604605,0.9287176416279557,1.0,37/178,15.42%,TOP2A;IL12A;BARD1;NR4A2;RCC1;AURKA;LSM6;ERBB3;SAE1;USF1;PSMF1;EXT1;TAF1;IKBKG;UBA2;YWHAH;TCF3;PEF1;TAF7;AHR;BOK;GTF2A1;PAFAH1B1;TCOF1;ATF6;LSM5;VAPA;FXR1;DGKD;ADD2;DDIT3;TPM4;MICU1;TLR6;TP53;GCA;CYBB
prerank,transmitter-gated ion channel activity (GO:0022824),-0.373007758708529,-1.2967078166188304,0.09848484848484848,0.6440529680352977,1.0,10/29,14.68%,GABRB3;GABRG2;GRIA4;GABRG3;GABRA2;GABRA3;GLRA2;GRIK2;GABRG1;GABRA1
prerank,syntaxin-1 binding (GO:0017075),-0.41720990153253157,-1.2953592793238002,0.13372093023255813,0.6306896474720632,1.0,9/22,25.99%,NSF;SYT1;VAMP2;UNC13A;STXBP5;STXBP1;CPLX1;CPLX2;SNAP25
prerank,lipase activity (GO:0016298),-0.34411759071922654,-1.295308147797565,0.06578947368421052,0.6146877057851176,1.0,13/43,19.31%,LIPA;MGLL;PLA2G15;DAGLB;LPL;ABHD12;ABHD16A;ABHD6;PLBD2;ABHD3;LIPH;SEC23IP;ABHD15
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.4383252248342265,-1.2927648804129341,0.16145833333333334,0.6065627573813862,1.0,5/18,13.09%,AKR1B1;ALDH6A1;ALDH1A1;AKR1B10;ALDH18A1
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.38905297811745154,-1.2913482511678547,0.1292517006802721,0.5951884252413793,1.0,11/27,25.24%,RNF19B;ARIH1;RNF180;AUP1;UBE3D;PRKN;SIAH1;ANKIB1;DCUN1D2;SIAH3;RNF144B
prerank,protein phosphatase 2A binding (GO:0051721),0.6039724719473023,1.2901886158011553,0.18621523579201935,0.9635915036057643,1.0,6/23,8.93%,MASTL;PTPA;ANKLE2;SMG5;FOXO1;STRN
prerank,glutathione transferase activity (GO:0004364),-0.4163368905660455,-1.2895532424277745,0.13529411764705881,0.585111604728746,1.0,11/23,33.70%,HPGDS;LANCL1;ALOX5AP;GSTT2;GSTO1;GSTA3;MGST1;PTGES;GSTA4;LTC4S;GSTZ1
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.6508425392665074,1.2848437056111703,0.20233463035019456,0.9785052989823847,1.0,3/13,4.79%,GPSM2;CCDC88A;ARHGDIB
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.5896946625339805,1.2837277584315363,0.19176470588235295,0.9732994413551653,1.0,7/29,14.50%,SLC25A21;SLC25A12;SLC1A5;ABCC2;SLC19A1;SLC25A22;SLC25A13
prerank,death receptor binding (GO:0005123),0.6440692848210441,1.283708061220264,0.1937984496124031,0.9629340739062487,1.0,2/15,4.16%,NTF4;PIDD1
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.5860204234785089,1.2803050331661583,0.18309859154929578,0.9685345510267002,1.0,9/27,14.18%,PRIM1;POLR1B;POLR2I;POLR2A;PRIMPOL;POLR1A;POLR1F;POLR1D;POLR1C
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.6700175501372827,1.2797633239915271,0.20625889046941678,0.9608412067995915,1.0,4/11,15.22%,NAA40;NAA16;NAA25;NAA20
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),-0.36366612000939585,-1.2795074852208412,0.08108108108108109,0.5973447963034011,1.0,6/38,14.36%,APP;SPOCK1;SERPINE2;TFPI;SERPINI1;SERPINE1
prerank,retinoic acid receptor binding (GO:0042974),0.6270731269775135,1.2674867085549242,0.20921052631578949,1.0,1.0,10/17,22.95%,NR4A2;HMGA1;ASXL1;ACTN4;CNOT1;RARG;MED1;NCOA6;NRIP1;NSD1
prerank,mRNA 5'-UTR binding (GO:0048027),0.5736771416879711,1.26721638658604,0.22506082725060828,0.9996804804435555,1.0,7/24,11.87%,RPS7;UTP23;RPS14;RPL41;MYH10;IGF2BP3;CCT5
prerank,cGMP binding (GO:0030553),0.6418817702149132,1.2633942947954497,0.23232323232323232,1.0,1.0,2/11,12.21%,PDE2A;PDE5A
prerank,tropomyosin binding (GO:0005523),0.6094524012265233,1.2606275108710823,0.20332480818414322,1.0,1.0,1/16,0.80%,TMOD4
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.5985847410784274,1.2593491175209468,0.2119700748129676,0.9963274859859027,1.0,3/21,5.15%,CDK1;CDKL1;CDK6
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.5985847410784274,1.2593491175209468,0.2119700748129676,0.9963274859859027,1.0,3/21,5.15%,CDK1;CDKL1;CDK6
prerank,ATP binding (GO:0005524),0.5243405726163225,1.2585850779086678,0.035,0.9899221761693594,1.0,55/266,13.59%,KIF14;KIFC1;SMC4;RAD51;PIF1;EPB42;PLK1;STK26;TRIP13;BLM;SMARCA5;OXSR1;DAPK2;PTPA;MCM6;LIG4;HASPIN;RRM1;RPS6KA5;MSH6;MAP4K1;STK11;ABCD1;CDK6;TLK1;SIK2;UBA2;RUNX3;STK38L;CARS2;MAP3K5;EIF4A3;RTEL1;AKT3;MAP4K2;TAP1;STK38;MARK2;MYH10;MAST2;ABCA2;P2RY1;LONP1;PIM1;MAP4K5;ATP7A;BTK;ABCF2;DHX9;OLA1;BMPR1A;LMTK2;HNRNPU;PRKAG2;LATS1
prerank,SH3 domain binding (GO:0017124),-0.31743734346898056,-1.2580271024797778,0.0784313725490196,0.6368004047765448,1.0,20/62,16.98%,DNM2;SYNJ1;EVL;SYNJ2;ADAM15;RUFY2;VASP;ABI1;LANCL1;AFAP1;WIPF1;SOCS7;PRKN;NCF1;ADAM9;ABI2;SHANK3;SKAP1;GPX1;DAB2IP
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.5586544825604584,1.257889585766416,0.17760180995475114,0.9836955341275405,1.0,16/35,19.90%,FOXP1;TAF1;KLF10;H3-3A;SMARCA4;GTF2A1;SNAPC3;RUVBL2;PARK7;MYC;TP53;POU2F1;TAF1C;HDAC1;AGO2;MMP12
prerank,amino acid:sodium symporter activity (GO:0005283),0.6571490309017425,1.253223434658078,0.21052631578947367,0.9948669793098392,1.0,1/11,0.70%,SLC6A12
prerank,transcription coregulator binding (GO:0001221),0.538455764661246,1.2494636822388159,0.17381974248927037,1.0,1.0,13/50,11.17%,CIT;EZH2;SUZ12;UBE2I;CTCF;NR1D1;HDAC6;AHR;PHF1;ZBTB16;ZBTB7A;EHMT1;SMAD4
prerank,C2H2 zinc finger domain binding (GO:0070742),0.6445702578828909,1.2483326542579338,0.22557471264367815,0.9975940709657999,1.0,4/11,16.35%,LEF1;MBD2;SRRM2;TAF9
prerank,carboxylic ester hydrolase activity (GO:0052689),-0.28416437396042876,-1.2471274285467344,0.09523809523809523,0.652132677764744,1.0,13/85,7.86%,LIPA;MGLL;PLA2G15;DAGLB;NDST3;LPL;ABHD12;PLA2G7;ENPP2;GDE1;ABHD16A;ABHD6;CA2
prerank,transcription cis-regulatory region binding (GO:0000976),0.5129233259355338,1.2445592009673756,0.018,1.0,1.0,99/406,19.39%,E2F7;E2F8;FOXM1;E2F2;UHRF1;GFI1;FOXA2;HMGB2;MEN1;SUV39H1;CDK5RAP2;BRCA1;HMGA1;SOX6;DEAF1;LEF1;E2F1;RB1;TWIST1;CTCF;RBL1;FOXP1;DACH1;NR1D1;NFXL1;HNRNPL;E2F6;TCF3;ARID4A;SETX;ZFP41;RUNX3;TFDP1;KLF10;TAF7;XRCC6;HMGB1;AHR;MAX;PSPC1;DMTF1;GABPB2;GABPB1;ETV6;SNAPC3;FLI1;NONO;LONP1;EGR1;TFDP2;SALL2;NR2C2;CUX1;MXI1;NFYC;PARK7;ARID5B;NFE2;SMAD4;ATF6;JUN;ATF5;ZNF25;SATB2;SP3;NFE2L2;ZBTB7B;ACTN4;DDIT3;TAF2;MYC;GABPA;NFX1;RBBP5;PBX2;E2F3;TP53;RUNX1;PLAGL1;TCF7L2;TFAP4;PURG;FOXK2;TAF9;XBP1;RXRB;MLXIP;ZBED4;SNCA;POU2F2;HDAC4;PROX1;HDAC1;BRD7;ZBTB20;RPS3;PAX2;TBL1XR1;SOX9
prerank,protein phosphatase binding (GO:0019903),0.521879330548798,1.2430623546175437,0.13366834170854272,1.0,1.0,23/117,9.87%,NEK2;MASTL;RPA2;ITGA1;PHACTR4;PPP1R9B;PTPA;ANKLE2;SMG5;STX17;PPP1R11;CDC27;SNX3;KCNN4;FOXO1;ANK1;TRAF3;ANAPC7;MAP3K5;MAPK14;STRN;EGFR;PPP1R15A
prerank,histone acetyltransferase activity (GO:0004402),0.5614794367244361,1.2407249292844895,0.2186046511627907,1.0,1.0,12/30,16.57%,NAA40;BRCA2;EPC1;TAF1;KAT6A;KAT2B;HAT1;CREBBP;TADA2A;TADA3;TAF9;BAZ1A
prerank,protein phosphatase activator activity (GO:0072542),0.6185744429622683,1.2392598839915692,0.2445054945054945,1.0,1.0,5/13,9.87%,PHACTR4;PTPA;PPP2R5E;PPP2R5A;PPP1R15A
prerank,alanine transmembrane transporter activity (GO:0022858),0.6392122097354067,1.2383875495402528,0.2361111111111111,0.9973527072190524,1.0,1/12,0.87%,SLC38A5
prerank,mRNA 3'-UTR binding (GO:0003730),0.5188282726816815,1.2378753262579731,0.16598360655737704,0.9908444128318376,1.0,31/79,18.93%,RPS7;HNRNPC;BOLL;EXOSC8;ZFP36L1;PUM2;ELAVL4;UTP23;HNRNPA2B1;RPL41;AUH;RNPS1;CPEB3;RBMS2;PUM1;IGF2BP3;HNRNPA0;CCT5;FXR1;HNRNPU;DAZAP1;RNF20;TP53;RC3H1;ANGEL2;ZFP36L2;TUT1;LARP4B;CPSF1;ELAVL1;RPL5
prerank,chloride channel inhibitor activity (GO:0019869),-0.5101840257833398,-1.236876589666786,0.2197452229299363,0.6636926626162049,1.0,5/10,29.10%,VTI1B;VAMP8;STX1A;WNK2;CFTR
prerank,5'-3' exonuclease activity (GO:0008409),0.6105107226370797,1.2365143438697337,0.2289156626506024,0.9880309524824284,1.0,6/14,13.24%,EXO1;FEN1;DCLRE1C;DCLRE1B;DCP2;DXO
prerank,anion transmembrane transporter activity (GO:0008509),0.6359202826721475,1.2359385603755517,0.2453083109919571,0.9820211084228716,1.0,3/12,11.15%,SLC4A1;ABCC2;SLC19A1
prerank,aminopeptidase activity (GO:0004177),-0.3731739026596259,-1.2351623994099714,0.1836734693877551,0.6533710290582424,1.0,7/26,8.15%,XPNPEP3;XPNPEP1;LAP3;METAP1D;NPEPPS;MMP14;ANPEP
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.5168124195668642,-1.2342967458093899,0.20202020202020202,0.6416606351028694,1.0,3/10,13.41%,CACNB2;CACNA1C;CACNB4
prerank,single-stranded RNA binding (GO:0003727),0.5380768321542339,1.2339690817415634,0.20412595005428882,0.9820807552982367,1.0,16/43,22.08%,DDX11;EIF4B;DHX58;SNRPC;EXOSC10;LONP1;DHX9;RBM7;FXR1;HNRNPU;LACTB2;HNRNPA1;AGO2;ZFR;ENDOV;AGO1
prerank,disordered domain specific binding (GO:0097718),0.5723107641173735,1.233863609198892,0.2421686746987952,0.9740243123205821,1.0,14/23,23.17%,RB1;FYN;CLTC;KCNA1;NUMA1;TP53;FKBP8;FN1;PPIL1;SMAD2;MDM2;GAPDH;CALM3;NCOA3
prerank,adenyl ribonucleotide binding (GO:0032559),0.5131538515719731,1.232510089935807,0.046,0.971116226447788,1.0,58/291,13.59%,KIF14;KIFC1;SMC4;RAD51;PIF1;EPB42;PLK1;STK26;TRIP13;BLM;SMARCA5;OXSR1;DAPK2;PTPA;MCM6;LIG4;HASPIN;RRM1;RPS6KA5;MSH6;MAP4K1;STK11;ABCD1;CDK6;PDE4A;TLK1;SIK2;UBA2;RUNX3;PDE2A;STK38L;CARS2;MAP3K5;EIF4A3;RTEL1;AKT3;MAP4K2;TAP1;STK38;MARK2;MYH10;MAST2;ABCA2;P2RY1;LONP1;PIM1;MAP4K5;ATP7A;BTK;SLC19A1;ABCF2;DHX9;OLA1;BMPR1A;LMTK2;HNRNPU;PRKAG2;LATS1
prerank,endonuclease activity (GO:0004519),0.5357564884454209,1.2306656562175775,0.19052744886975242,0.9705480046539581,1.0,8/49,7.26%,ANKLE1;SLFN14;ERCC4;SMG6;FEN1;MBD4;YBEY;ZRANB3
prerank,U6 snRNA binding (GO:0017070),0.6132768558196457,1.2296902713393987,0.2789115646258503,0.9662612253638682,1.0,10/14,24.63%,SART3;LSM2;METTL16;PRPF4;LSM7;TUT1;DDX39B;PRPF8;LSM3;RBM22
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.35932747791234854,-1.22811087158639,0.1366906474820144,0.6429541742071826,1.0,13/30,22.63%,SLC39A11;TMEM165;SLC11A2;SLC30A4;SLC39A7;TTYH1;SLC39A14;SLC39A8;SLC39A6;SLC39A12;SLC39A3;SLC39A1;SLC30A1
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),-0.47865680197694044,-1.2280627965635547,0.20717131474103587,0.6302538248433873,1.0,9/12,28.41%,SLC25A25;SLC17A9;LRRC8A;SLC25A24;SLC35B2;SLC25A17;SLC25A5;SLC25A42;SLC25A23
prerank,retinoid X receptor binding (GO:0046965),0.6426287163503634,1.2236764178681079,0.2607449856733524,0.9843291012539733,1.0,2/11,1.94%,NR4A2;HMGA1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.5728777629941791,1.223432241708656,0.2536407766990291,0.9772802308910784,1.0,2/22,7.28%,CDKN3;MTMR2
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.6354764712052672,1.2210173422412862,0.2801664355062413,0.9792470083422609,1.0,6/10,22.73%,SUV39H1;EHMT1;SETDB2;ASH1L;SETDB1;SETD5
prerank,lysine-acetylated histone binding (GO:0070577),0.5852740086099455,1.2190229509135109,0.25375,0.9717808127362387,1.0,11/20,20.11%,BRD9;TAF1;BRD4;SMARCA4;YEATS4;ZMYND8;KMT2A;PSME4;DPF2;BRD7;BRD3
prerank,acetylation-dependent protein binding (GO:0140033),0.5852740086099455,1.2190229509135109,0.25375,0.9717808127362387,1.0,11/20,20.11%,BRD9;TAF1;BRD4;SMARCA4;YEATS4;ZMYND8;KMT2A;PSME4;DPF2;BRD7;BRD3
prerank,GDP binding (GO:0019003),-0.31629964805660504,-1.2189149692095098,0.1111111111111111,0.6404091773729983,1.0,20/63,15.30%,RAP1B;RAB14;RALA;RAB28;DYNC1LI1;RAP2A;RRAGD;RAP2B;GNAI3;KRAS;NRAS;RIT1;RAP1A;MIEF1;RAP2C;RERG;RAB31;RAB12;RRAGC;MRAS
prerank,cation:chloride symporter activity (GO:0015377),0.6380304598955286,1.2184007590978467,0.26907073509015256,0.9667653657417059,1.0,4/10,12.59%,SLC12A3;SLC12A7;SLC12A1;SLC12A6
prerank,GABA-A receptor activity (GO:0004890),-0.41445115572390534,-1.2166229131238182,0.20982142857142858,0.6338426405002391,1.0,7/18,14.68%,GABRB3;GABRG2;GABRG3;GABRA2;GABRA3;GABRG1;GABRA1
prerank,peptidoglycan binding (GO:0042834),0.6391285095506827,1.216509932838958,0.27982954545454547,0.9670888234445635,1.0,1/10,1.49%,PGLYRP1
prerank,active ion transmembrane transporter activity (GO:0022853),0.5435451621301951,1.2158445981761699,0.23751387347391786,0.9622626926066187,1.0,12/37,22.53%,SLC4A1;SLCO4C1;SLCO4A1;COX10;COX4I1;SLCO2A1;NDUFA4;SLC22A4;SLCO3A1;UQCRH;ATP13A3;SLCO5A1
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.6095772969518323,1.2132550275805147,0.2849462365591398,0.9653759466992761,1.0,4/13,9.81%,AGPAT1;AGPAT4;GPAT3;AGPAT3
prerank,serine-type endopeptidase activity (GO:0004252),0.510154961460298,1.2070056780178409,0.2093973442288049,0.9843070649599824,1.0,4/80,3.02%,PRTN3;TMPRSS4;TMPRSS3;FAP
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.5365182468804949,1.2054520044046177,0.24018475750577367,0.9831521186159159,1.0,14/33,20.77%,ERI2;PDE12;EXOSC10;DCP2;PNLDC1;ERI1;ANGEL2;CNOT6;ERI3;DIS3L;XRN1;CNOT8;PNPT1;CNOT7
prerank,ligand-gated anion channel activity (GO:0099095),-0.4085022887212922,-1.2047742332681406,0.1794871794871795,0.651458806499114,1.0,8/17,14.68%,GABRB3;GABRG2;GABRG3;GABRA2;GABRA3;GLRA2;GABRG1;GABRA1
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.6260894017788512,1.200164381922698,0.2811594202898551,0.9972189378731988,1.0,4/11,10.41%,PRPF19;UBE2K;UBE4B;AMFR
prerank,MHC class II protein complex binding (GO:0023026),0.600112726575039,1.19845326352698,0.2802275960170697,0.9963578964032714,1.0,2/11,3.68%,MS4A1;CD74
prerank,exonuclease activity (GO:0004527),0.518365704013125,1.198101933069825,0.24733475479744135,0.9902259814750902,1.0,15/46,15.84%,RAD1;EXO1;RAD9A;FEN1;EXOSC8;DCLRE1C;PDE12;DCLRE1B;EXOSC10;ERI1;APEX1;DXO;REXO4;RAD50;CNOT6
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.5202227658855326,1.1935875923233905,0.2467391304347826,1.0,1.0,12/44,14.94%,EZH2;MEN1;SUV39H1;NSD2;KMT2C;EHMT1;KMT5C;NSD3;SETDB2;KMT2A;RBBP5;KMT2B
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.4938115474587291,1.1924521989742962,0.021,0.998331941846559,1.0,128/597,19.56%,E2F7;E2F8;KIF2C;E2F2;MCM10;GFI1;FOXA2;VAX2;HMGB2;SPIB;MEN1;SUV39H1;CDC45;CDK5RAP2;BRCA1;DMRTA1;NR4A2;SOX6;POLA1;HEY2;LEF1;E2F1;DDX11;BATF;ELK4;MCM6;USF1;ORC5;ERG;BACH2;MCM9;CTCF;FOXP1;ETS2;ORC3;NR1D1;MBD4;MBD2;HNRNPL;FOXJ3;ATF7;ZBTB26;TCF7L1;ARID4A;ZFP41;IRF9;RUNX3;KLF10;TAF7;XRCC6;HMGB1;AHR;MAX;PSPC1;DMTF1;GABPB2;GABPB1;ZW10;ZBTB7A;FLI1;NONO;KLF13;EGR1;ZBTB32;NR2C2;RFX2;CUX1;NFYC;ARID5B;NFE2;SMAD4;ATF6;DHX9;JUN;ATF5;ZBTB33;SP3;NFE2L2;ZBTB7B;HNRNPU;DDIT3;TAF2;CEBPG;BCL6;GABPA;POU6F1;RBBP5;E2F3;GMEB2;ELF1;TP53;JUNB;RUNX1;IRF8;HOXB4;TCF7L2;TCF4;HIVEP1;TFAP4;ZNF23;RFX7;FOXK2;RFX4;MCM3;TAF9;NFATC3;XBP1;RXRB;ZBED4;SNCA;POU2F2;HDAC4;RARG;FOXE1;CREB1;ZNF740;RFX1;GMEB1;NKX2-8;PROX1;BRD7;ZBTB20;PAX2;TBL1XR1;SOX9;NPAS2;SREBF2;CENPC
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.6238424366173375,1.191972589692866,0.27692307692307694,0.9928553195247569,1.0,4/10,16.16%,USP27X;DESI2;OTUD5;YOD1
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.4933600794839881,1.1910812362314116,0.133,0.9891254112576194,1.0,51/188,19.37%,GFI1;FOXA2;HMGB2;MEN1;SUV39H1;CDK5RAP2;BRCA1;SOX6;CTCF;NR1D1;HNRNPL;LIN54;ARID4A;TAF7;XRCC6;HMGB1;AHR;PSPC1;DMTF1;GABPB2;GABPB1;FLI1;NONO;EGR1;NFYC;ARID5B;SMAD4;ATF6;DHX9;JUN;ATF5;NFE2L2;DDIT3;TAF2;GABPA;RBBP5;TP53;RUNX1;TCF7L2;TFAP4;FOXK2;TAF9;ZBED4;SNCA;POU2F2;HDAC4;PROX1;BRD7;ZBTB20;PAX2;TBL1XR1
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.5246420380312049,1.1897336650365236,0.2582106455266138,0.9868543537407556,1.0,3/34,1.50%,EZH2;MEN1;SUV39H1
prerank,pre-mRNA binding (GO:0036002),0.5345843909816965,1.1896451099031677,0.2795321637426901,0.9801704063423099,1.0,12/28,18.52%,SLBP;SNRPC;HNRNPL;U2AF1;RNPC3;U2AF1L4;ERI1;RBM7;HNRNPU;TARBP2;PRPF8;HNRNPA1
prerank,chemoattractant activity (GO:0042056),0.5486919929298794,1.1890713062067195,0.2698961937716263,0.9757056336819092,1.0,3/26,7.33%,HMGB2;PGF;HMGB1
prerank,flavin adenine dinucleotide binding (GO:0050660),-0.3099077643668897,-1.188375977045233,0.2,0.6810624611183675,1.0,30/53,35.43%,KDM1A;ACOX3;POR;SQOR;ACADL;MICAL3;DPYD;MTHFR;MTO1;MICAL2;MTRR;NOX4;ILVBL;CYB5R3;SDHA;CRY1;SQLE;NQO2;GCDH;GFER;NDOR1;AIFM2;KDM1B;DDO;AOX1;FOXRED2;NOS1;ACADVL;CRY2;GSR
prerank,calcium-release channel activity (GO:0015278),-0.4130910362336764,-1.1845764296593189,0.21739130434782608,0.6786364657380706,1.0,7/17,16.49%,ITPR2;TPCN2;MCOLN1;RYR2;MCOLN3;TPCN1;ITPR3
prerank,nuclease activity (GO:0004518),0.5163324214328804,1.1833926969346908,0.26816239316239315,0.9908238742460037,1.0,12/52,15.00%,ANKLE1;RNASE6;EXO1;STK31;FEN1;PDE12;DNA2;DNASE1L1;APEX1;RNASE12;REXO4;RNASEH2A
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.4332255379581609,-1.182484945730359,0.2397003745318352,0.6719272005105734,1.0,7/13,14.68%,GABRG2;GABRG3;GABRA2;GABRA3;GLRA2;GABRG1;GABRA1
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.609970742732131,1.1790744050569502,0.3025210084033613,1.0,1.0,6/11,21.40%,TCF3;MAP4K2;STK38;MAP3K11;TRAF6;SASH1
prerank,nuclear localization sequence binding (GO:0008139),0.5726047401916515,1.1768594434560975,0.2917197452229299,1.0,1.0,9/18,22.60%,POM121;TNPO1;KPNA3;NUP214;RANBP6;IPO5;KPNB1;TNPO2;KPNA4
prerank,nuclear import signal receptor activity (GO:0061608),0.5816813844239003,1.1763659441930667,0.2996057818659658,0.9977865335355449,1.0,8/15,22.60%,TNPO1;KPNA3;RANBP6;IPO5;KPNB1;TNPO2;TNPO3;KPNA4
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.38337259352419567,-1.1743085156327422,0.24479166666666666,0.6814660005893637,1.0,8/19,18.51%,GABRG2;GABRG3;GABRA2;GABRA3;GRIK2;GABRG1;GABRA1;GRIK4
prerank,metalloaminopeptidase activity (GO:0070006),-0.41922783902078403,-1.171560580452735,0.24878048780487805,0.6761936687083618,1.0,5/16,8.15%,XPNPEP3;XPNPEP1;NPEPPS;MMP14;ANPEP
prerank,hexose transmembrane transporter activity (GO:0015149),0.6002141677646373,1.1700796717065785,0.310948905109489,1.0,1.0,4/12,18.59%,SLC2A4;SLC2A8;SLC2A3;SLC2A1
prerank,3'-5' DNA helicase activity (GO:0043138),0.569413257274541,1.169443958583831,0.3082099596231494,1.0,1.0,6/16,14.20%,BLM;MCM6;HELQ;ERCC3;DHX9;FANCM
prerank,rRNA binding (GO:0019843),0.513686824386573,1.1685149887460227,0.27759562841530055,1.0,1.0,17/42,21.10%,FASTKD5;MRPL18;MRPL16;UTP23;RPS14;EMG1;MRPS7;RPS5;RPLP0;ERI1;RPS9;RPL12;RPL5;RPS3;PTCD3;RPL23;MDM2
prerank,metal ion transmembrane transporter activity (GO:0046873),0.5286007919965787,1.1684566888249648,0.29732868757259,1.0,1.0,4/27,3.00%,SLC12A3;AQP1;MAGT1;ITPR1
prerank,cAMP binding (GO:0030552),0.6082491863689622,1.1682917837968532,0.3146853146853147,0.9964493078235522,1.0,3/11,16.67%,PDE4A;PDE2A;CNBD2
prerank,nuclear export signal receptor activity (GO:0005049),0.597985584862967,1.1681708029367248,0.3126801152737752,0.9901542691326835,1.0,5/11,18.91%,XPO1;NUP42;NUP214;XPO4;EIF4ENIF1
prerank,protein serine/threonine kinase activity (GO:0004674),0.4796093250098608,1.1656374202934219,0.093,0.9928740181548,1.0,86/335,16.37%,TTK;CDK1;AURKB;CIT;PBK;NEK2;MASTL;PLK1;CHEK2;MAPK1;CDKL1;AURKA;OXSR1;DAPK2;SLK;PRKCE;RPS6KA5;MAP4K1;STK11;MAPKAPK3;CHEK1;CDK6;GRK6;TLK1;TAF1;SIK2;ATM;PRKD3;CSNK1A1;STK38L;BRD4;MAP3K5;PIM2;AKT3;PKN2;CSNK1G2;PIM3;MAP3K1;MAP4K2;MAPK14;PRKCA;PRKACA;STK38;MARK2;CLK4;MAST2;STK24;EGFR;PIM1;PDPK1;MAP4K5;CDK19;RIOK3;HIPK2;TESK2;MAP3K11;MELK;DYRK1A;VRK1;PRKCB;RPS6KA6;BMPR1A;LMTK2;PDIK1L;GRK2;ROCK2;PRKDC;LATS1;CDK16;STK39;FAM20A;NRBP1;HTATIP2;CDC7;GSK3B;SGK3;CCNK;STK4;MAP3K20;BCR;PAK5;MAP2K1;MARK4;LIMK2;PAK2;CDK8
prerank,chemokine receptor activity (GO:0004950),0.540117394390412,1.164632094091133,0.2921083627797409,0.9901313772448797,1.0,6/24,17.65%,CXCR5;CCR2;GPR75;CCR6;GPR35;CXCR4
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.5770883545636187,1.1643576841958294,0.3151595744680851,0.98465287398365,1.0,4/15,9.81%,AGPAT1;AGPAT4;GPAT3;AGPAT3
prerank,C-C chemokine binding (GO:0019957),0.5476512635335185,1.1637461577458494,0.3006134969325153,0.9805285700793576,1.0,3/22,10.57%,CXCR5;CCR2;CCR6
prerank,transforming growth factor beta binding (GO:0050431),-0.3687701220738222,-1.1636667639959921,0.2545454545454545,0.6848211449212401,1.0,9/23,18.07%,ACVR1;TGFBR1;LTBP1;ENG;TGFBR3;ACVRL1;CD36;TGFBR2;THBS1
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.5445652605557683,1.1629972786330198,0.3039906103286385,0.9770527775751127,1.0,3/26,7.49%,SLC6A12;SLC16A12;SLC16A1
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.5026319119079197,1.162150939676128,0.281615302869288,0.9738485786972209,1.0,7/55,11.15%,SLC6A12;SLC38A5;SLC7A1;SLC16A12;SLC16A1;SLC3A1;SLC19A1
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.5925495691054488,1.1617309231144934,0.32331902718168815,0.9690645394678237,1.0,6/12,18.96%,TAF1;H3-3A;GTF2A1;RUVBL2;POU2F1;HDAC1
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),-0.46304334270030156,-1.1609151905275215,0.2545454545454545,0.68026389131538,1.0,8/11,28.41%,SLC25A25;SLC17A9;LRRC8A;SLC25A24;SLC35B2;SLC25A17;SLC25A42;SLC25A23
prerank,cyclic nucleotide binding (GO:0030551),0.5412286665620142,1.1602512104502665,0.2959309494451295,0.9682225366481065,1.0,5/21,16.67%,PDE4A;PDE2A;SLC19A1;PDE5A;CNBD2
prerank,O-acyltransferase activity (GO:0008374),0.5320456455018698,1.159107385439308,0.30778032036613273,0.9662129024237359,1.0,4/30,7.36%,LRAT;GPAT3;MBOAT2;MOGAT2
prerank,RNA polymerase binding (GO:0070063),0.5571983191064857,1.1583978721540824,0.3197452229299363,0.962941026525975,1.0,7/18,17.07%,BRCA1;ANP32B;PKN2;DHX9;CCNT1;TCERG1;SCAF8
prerank,nucleotidyltransferase activity (GO:0016779),0.548722950691765,1.1576088440722667,0.31835205992509363,0.9598429417436748,1.0,8/19,22.19%,DNTT;CGAS;TUT4;PAPSS2;TUT1;TENT2;PNPT1;TENT4A
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.5085260909150643,1.1573918792084288,0.291044776119403,0.9547291938770083,1.0,6/48,7.84%,RHAG;P2RX1;AQP1;RHD;SLC12A7;TRPM7
prerank,RNA stem-loop binding (GO:0035613),0.5793233160337835,1.1561769862983322,0.30264993026499304,0.9533148115261142,1.0,7/12,17.66%,CSDE1;MYH10;CPEB3;DHX9;METTL16;RC3H1;EPRS1
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.4487599817826116,-1.1560572180489908,0.29225352112676056,0.6815808929878518,1.0,7/12,14.68%,GABRB3;GABRG2;GABRG3;GABRA2;GABRA3;GABRG1;GABRA1
prerank,triglyceride lipase activity (GO:0004806),-0.37932903876855406,-1.152581033042915,0.2568306010928962,0.6789510634203837,1.0,3/20,2.77%,PLA2G15;DAGLB;LPL
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.4031043690502044,-1.151582889785823,0.22660098522167488,0.6704626892811683,1.0,7/17,20.19%,ABCA1;ATP8B1;PLTP;MTTP;PITPNB;PITPNM2;ATP10B
prerank,carboxypeptidase activity (GO:0004180),0.5078905740877189,1.1512461288604658,0.3147942157953281,0.9657844188371124,1.0,8/35,17.21%,AGBL1;CPA6;CPM;AGTPBP1;VASH2;AGBL3;CPD;NAALAD2
prerank,chloride channel activity (GO:0005254),-0.29129429865846007,-1.150788763627263,0.19298245614035087,0.6617848697182219,1.0,13/59,14.68%,TTYH2;GABRB3;PACC1;CLCN7;GABRG2;GABRG3;GABRA2;GABRA3;CLCN4;GLRA2;GABRG1;TTYH1;GABRA1
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.46645286628902016,-1.149786816436349,0.28888888888888886,0.6541066790049743,1.0,6/10,14.68%,GABRG2;GABRG3;GABRA2;GABRA3;GABRG1;GABRA1
prerank,cytokine receptor activity (GO:0004896),0.4858776367738848,1.14901932949997,0.26816786079836236,0.9679635568790945,1.0,17/83,14.33%,IL2RG;IL7R;IL2RA;IL18RAP;CD74;CD44;CCR2;GFRA2;IL21R;IL20RA;IL17RA;CCR6;IL1R1;IL10RA;FLT3;F3;GFRA1
prerank,1-phosphatidylinositol binding (GO:0005545),-0.41314129981812586,-1.147141157653941,0.26436781609195403,0.6508299356154199,1.0,6/15,10.92%,WDFY3;SNAP91;EEA1;ZFYVE9;ZFYVE1;SCARB1
prerank,TBP-class protein binding (GO:0017025),0.5300437639417432,1.1451061756433236,0.3226600985221675,0.9761914586986574,1.0,9/21,21.60%,TAF1;PSMC1;AHR;GTF2A1;RUVBL2;RUVBL1;YEATS2;GTF2A2;TAF11
prerank,sodium channel regulator activity (GO:0017080),0.512485799350266,1.1430636652706117,0.30616740088105726,0.9777798917502268,1.0,7/37,14.70%,TMPRSS3;GPD1L;YWHAH;FXYD5;NEDD4L;FGF13;SGK3
prerank,chemokine binding (GO:0019956),0.5190677869167115,1.1401817992795507,0.3291428571428571,0.9821676865820252,1.0,5/30,10.57%,CXCR5;CCR2;HMGB1;ITGAV;CCR6
prerank,glucose transmembrane transporter activity (GO:0005355),0.5585140087233135,1.1389976108397835,0.33070866141732286,0.9806301311404751,1.0,4/17,18.59%,SLC2A4;SLC2A8;SLC2A3;SLC2A1
prerank,aspartic-type endopeptidase activity (GO:0004190),0.5854267706741924,1.1380730128109418,0.3659863945578231,0.9781841202368239,1.0,4/12,17.63%,NAPSA;CTSE;PSEN1;SPPL3
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.47283327589020313,1.1378568185331486,0.112,0.9731505018988003,1.0,113/431,19.44%,KIF14;KIFC1;SMC4;RAD51;PIF1;EPB42;PLK1;RRAD;ARHGEF5;STK26;TRIP13;BLM;SMARCA5;GBP4;OXSR1;DAPK2;TUBA1C;PTPA;MCM6;LIG4;HASPIN;NOA1;ATL2;RRM1;RPS6KA5;ARL5C;MSH6;MAP4K1;STK11;ABCD1;CDK6;REM1;TLK1;TUBB4B;SIK2;ARL11;RAB1B;UBA2;RAB22A;TUBA1B;ARF4;RUNX3;RND3;GBP2;STK38L;CARS2;MAP3K5;EIF4A3;RTEL1;AKT3;GNAI1;MAP4K2;RAB8A;TAP1;STK38;MARK2;MYH10;MTG2;MAST2;ABCA2;P2RY1;LONP1;PIM1;SEPHS1;MAP4K5;RABL6;RIT2;RHOU;ATP7A;BTK;ABCF2;TUBB;DHX9;ARF3;OLA1;RAB11B;BMPR1A;LMTK2;RAC2;HNRNPU;PRKAG2;LATS1;RAB35;RAB2A;TUBD1;STK4;ATP5F1D;MAP3K20;ARL4C;MARK4;PDXK;RAB5A;MMAA;RAC1;SRPK1;AK6;TRNT1;PGK1;CLP1;TDG;DRG1;STK17B;TAOK1;LRRK2;RAB6A;YARS2;ABCD4;N4BP2;NIM1K;MTHFD1L;KSR1;STK3;TUBB3
prerank,acetyltransferase activity (GO:0016407),0.5130537885988179,1.1362122374043453,0.3384615384615385,0.9733611681088244,1.0,8/31,19.51%,ESCO2;PAFAH2;KAT6A;KAT2B;NAA16;CREBBP;NAT10;ELP3
prerank,CoA hydrolase activity (GO:0016289),0.5579382043194975,1.135680446498522,0.35771276595744683,0.9696958305894444,1.0,4/16,8.69%,ABCD1;ACOT11;ACOT13;ACOT2
prerank,fibroblast growth factor binding (GO:0017134),0.5373485665387451,1.1332441204358406,0.34278668310727495,0.9734752735090253,1.0,7/21,16.13%,FGFBP3;RPS19;ITGAV;GLG1;CEP57;FGFR1;FIBP
prerank,protein tyrosine phosphatase activity (GO:0004725),0.4824116157980363,1.131219893671414,0.3216494845360825,0.9749000961809672,1.0,16/71,16.22%,CDC25C;CDKN3;CDC25A;PTPRA;PTPN22;CDC25B;EYA3;PTPDC1;PTPN7;PTPN14;MTMR6;PTEN;EYA1;PTPN5;PTPRU;DUSP22
prerank,5'-3' RNA polymerase activity (GO:0034062),0.5130905166197702,1.1302369888965098,0.34583821805392734,0.9729301303165309,1.0,11/27,22.39%,POLR1B;POLR2I;POLR2A;POLR1A;POLR1F;POLR1D;POLR1C;POLR2J;TENT2;POLR3B;POLR2B
prerank,protein homodimerization activity (GO:0042803),0.46718187367276526,1.1290733434742903,0.089,0.971677494832474,1.0,116/589,17.66%,TOP2A;CENPF;KIF20B;GEN1;SLC4A1;KNSTRN;ECT2;CIP2A;MAD2L1;BARD1;STK26;SOX6;CHEK2;BLM;SMCHD1;PECAM1;GBP4;CCDC88A;IKZF3;FAP;FLNA;SLK;S100A11;PTPA;RBM44;USF1;PML;AXIN1;MSH6;PSMF1;ABCB10;ABCD1;TFRC;EXT1;SNRPC;IMPA1;IKBKG;TERF2;MYOM1;TCF3;CDADC1;EPHX2;PDE2A;DPY30;GBP2;MAP3K5;DCLRE1B;MGAT2;AHR;BOK;SNX9;TPST1;ST3GAL2;TAP1;ZBTB16;PEX11B;NRF1;TERF1;CAV2;TIMM9;NADK2;TXN;NR2F2;MAP3K11;UXS1;CARD9;PARK7;B2M;SMAD4;RNF8;DPP4;TRIM68;FOXP2;EFEMP2;BMPR1A;KMT2A;FXR1;GALM;SMIM1;RACK1;ZBTB7B;PON3;DGKD;ADD2;ACTN4;DDIT3;TPM4;NRBP1;NECTIN1;TYROBP;TRIM5;STK4;PDCD10;LRRFIP1;CEP57;GCA;APPL1;RPE;TARBP2;STARD3NL;PDXK;FGFR1;TFAP4;GSTM1;RDH5;TGFB2;MMAA;SYNE1;TARS2;PIP4K2A;ADCY8;CANT1;TRIM37;CRYL1;SPPL3;EPRS1
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.4211844323955829,-1.1287856197070643,0.29961089494163423,0.6850443417723074,1.0,5/14,29.24%,SLC26A11;SLC25A11;SLC26A8;SLC26A6;SLC25A10
prerank,calcium channel regulator activity (GO:0005246),0.4975979944938606,1.127059631915154,0.32395950506186727,0.9731617090027814,1.0,13/37,23.89%,RRAD;ITPR1;REM1;INAFM2;SGK3;NRXN2;STIMATE;YWHAE;CACNG8;NRXN1;CACNG4;FKBP1A;INAFM1
prerank,sequence-specific DNA binding (GO:0043565),0.4665407852461881,1.1257882957092538,0.096,0.9723591514437064,1.0,123/590,20.75%,E2F7;PIF1;E2F8;E2F2;UHRF1;GFI1;FOXA2;VAX2;SPIB;DMRTA1;NR4A2;MBD3;HEY2;MYRFL;LEF1;E2F1;SMG6;IKZF3;PBX4;BATF;ELK4;USF1;SMG5;ERG;BACH2;CTCF;FOXP1;ETS2;NR1D1;TAF1;MBD2;FOXO1;FOXJ3;ATF7;TERF2;ZBTB26;UPF2;MBD1;TCF7L1;ZFP41;IRF9;RUNX3;LRWD1;KLF10;XRCC6;AHR;MAX;TERF1;ZBTB7A;FLI1;ZNF148;LONP1;MECP2;KLF13;EGR1;ZBTB32;NR2C2;RFX2;NR2F2;CUX1;NFE2;SMAD4;ATF6;JUN;ATF5;FOXP2;CBFB;CTC1;ZBTB33;KMT2A;SP3;NFE2L2;ZBTB7B;HNRNPU;CEBPG;BCL6;GABPA;POU6F1;E2F3;GMEB2;ELF1;KMT2B;JUNB;IRF8;HOXB4;POU2F1;TCF7L2;TCF4;HIVEP1;TFAP4;ZNF23;RFX7;FOXK2;RFX4;NFATC3;XBP1;RXRB;POU2F2;HDAC4;RARG;KDM2B;FOXE1;CREB1;ZNF740;RFX1;GMEB1;NKX2-8;PROX1;SAFB;ZBTB20;PAX2;SOX9;NPAS2;SREBF2;ZBTB18;MMP12;SLTM;ZCWPW1;KDM2A;SMG7;RBPJ;PRDM4;PPARD
prerank,calcium ion transmembrane transporter activity (GO:0015085),-0.286896072839394,-1.1245348901150254,0.22641509433962265,0.6853773605681072,1.0,26/55,30.17%,ITPR2;SLC24A3;CACNB2;TRPC5;CUL5;ATP2B2;TRPC1;TMEM165;RYR2;PKD1;SEC61A1;ATP2B3;TRPV4;TRPC3;ORAI1;ANXA2;PKD2L1;PKD1L2;PKD2L2;ANXA6;ANXA9;CHRNA7;ATP2C1;SLC24A5;TRPM2;SLC8A2
prerank,aspartic-type peptidase activity (GO:0070001),0.5860032069027294,1.1231677491613985,0.36426592797783935,0.9762049337857986,1.0,3/10,14.04%,NAPSA;CTSE;PSEN1
prerank,RNA binding (GO:0003723),0.46024293087096446,1.1215303669148868,0.033,0.9766457155497036,1.0,405/1321,20.21%,TOP2A;MKI67;NUSAP1;RAD51AP1;MBNL3;ADAD1;HMGB2;BARD1;LBR;BRCA1;PTCD2;RADX;RBM15;ZC3H4;SUGP2;RPL7;RPL18A;FASTKD5;SMG6;NOL7;LSM6;CTNNA1;DDX11;RPS20;DHX38;KRI1;PRPF38B;FLNA;EIF4B;EZR;EIF2S1;EIF2A;DHX58;RBM3;RCAN3;NOP10;DEK;UTP3;NPM3;HMGB3;TBL2;NOA1;DDX18;SMG5;RPL36;RPL14;POLR2A;MKRN1;PA2G4;NUCKS1;UBE2I;SCAF11;SLBP;UBE2O;COA6;RPS19;MAP4;DDX49;DUT;ANKHD1;SLPI;TFRC;ZC3H7A;TNPO1;SNRPF;PPP1R8;RPS7;EIF3E;CDKN2A;HNRNPC;SNRPC;NKAP;RBM27;ZC3H18;RANGAP1;CRKL;TUBB4B;EDF1;HNRNPM;NUP42;R3HDM1;MRPL40;RPS4X;MRPL16;HEATR6;HNRNPL;RPS18;MRPL10;LRRC47;NAP1L4;HNRNPA3;CPSF2;SETX;CRNKL1;PEF1;TUBA1B;U2AF1;ZFP36L1;RPL23A;HMGN2;JAKMIP1;CSDE1;PSMC1;MTHFSD;SNRNP200;TNRC6B;PUM2;MRPL22;TAF15;TCP1;XRCC6;EIF4A3;DCP1B;CCDC137;HMGB1;METAP2;NOL10;SRSF3;RPL28;PKN2;EXOSC10;ZNF326;DYNC1H1;KMT2C;SPEN;UTP23;SAP18;ILF2;EWSR1;DCP2;HNRNPA2B1;PSPC1;DCN;NOVA2;MRPL37;TFB1M;CLTC;RPS14;GRB2;DNA2;ZNF638;RPL41;URB1;NOL11;TFB2M;MYEF2;MARK2;MYH10;SART3;NUDT4;SRSF4;NCBP1;NCOA5;PRPF38A;LSM2;SNRNP35;CSRP1;CCDC9;HNRNPUL2;RBM47;LLPH;RALY;DHX40;EDC3;NONO;CASC3;RNPS1;RPS27;EMG1;LONP1;RPS19BP1;MECP2;SRRT;MRPS7;CSTF3;BTF3;MRPL43;RBM19;RPS5;TXN;CPEB3;NIFK;SLC4A1AP;PUM3;RBMS2;UTP6;PCBP2;RBM38;RBFOX3;PNLDC1;MSN;SPATS2L;PARK7;TCOF1;SUMO1;LTA4H;RPLP0;RPS11;TUT4;RTF1;PUM1;PRPF31;PPP1CC;UBAP2;CCAR2;DHX9;JUN;RDX;IGF2BP3;MSI2;FBL;HNRNPA0;RPL27A;CNOT4;FASN;ERI1;LSM5;PELP1;TEP1;DHX29;DCP1A;NUP98;TEFM;APEX1;U2SURP;METTL16;CANX;UPF3B;RBM7;UCHL5;SRFBP1;KIN;FXR1;RTCA;VIRMA;HNRNPR;PPIG;ROCK2;RACK1;RPS9;RPS15A;THOC5;CWC15;DXO;HNRNPU;SF3B5;REXO4;DAZAP1;ACTN4;HELZ2;PRKDC;CEBPZ;LSM14A;PSIP1;DNAJC21;NAP1L1;NOL8;NFX1;SUMO2;CLNS1A;APTX;PPIA;HNRNPAB;PRRC2C;DIAPH1;NSA2;RPL12;RSRC2;PCBP3;TPT1;ANXA11;FDPS;KYAT3;CNOT1;CS;LARP1B;LUC7L2;DNAJC2;SRRM2;LRRFIP1;RPL22L1;LSM7;DDX43;METTL14;RC3H1;NOP58;MAP3K20;NTPCR;DIMT1;STAU1;THOC2;DHX57;SRSF10;IPO5;SART1;AHNAK;TARBP2;ASS1;NOSIP;PYM1;SAMD4A;ZFP36L2;ZC3H15;EEF2;PURG;UBAP2L;DARS1;TASOR;TRIM28;SNRNP40;VIM;TRUB2;SYNE1;SRSF7;ZGRF1;CDC40;POP4;TUT1;SRPK1;TCERG1;KPNB1;PSMD4;NAT10;LARP4B;SCAF8;TRNT1;RPL3;SCG3;ZCCHC24;DDX39B;TDRD7;POLDIP3;PNO1;SNRPG;PCF11;SEC63;HSP90B1;GSPT1;PRPF8;EPRS1;YWHAE;MEX3C;ERI3;HEXIM1;RPL18;ZBED4;MDH2;LACTB2;FLNB;DKC1;PTCD1;RBM25;FAM32A;REPIN1;PPIE;POLR1G;CAST;ALKBH5;HNRNPA1;RBBP6;CKAP4;PES1;YARS2;GNL3L;HADHB;ELAVL1;RTCB;EIF4ENIF1;RPL5;HNRNPLL;WRAP53;GPATCH8;RPS6;RPS17;NCBP2;SAFB;RPS3;TES;DDX54;CCT6A;THRAP3;ZCCHC8;NCBP3;RPL21;HELB;XRN1;AGO2;SRSF2;PTCD3;HELZ;SF3A2;SRBD1;CDK11B;AFF2;G3BP1;FAM120A;ZYX;SLTM;RPL17;RPL23;ZFR;SNRPB;CPSF7;PNPT1;TPR
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.4791778142539787,1.118654610054661,0.3188854489164087,0.9817776350478754,1.0,21/75,19.45%,H6PD;DHDH;DCXR;CBR4;GFUS;HPGD;IMPDH2;ME3;BDH1;ABCC4;DHRS4;RDH10;NSDHL;HADHA;RDH5;PHGDH;CRYL1;GLYR1;MDH2;HADHB;PGD
prerank,calcium:sodium antiporter activity (GO:0005432),-0.4694989318209746,-1.1182407846054525,0.2947019867549669,0.6904167403656845,1.0,5/10,16.40%,SLC24A3;SLC8A3;SLC8B1;SLC3A2;SLC8A1
prerank,microtubule minus-end binding (GO:0051011),0.5674137722054707,1.1156202158255761,0.3463687150837989,0.9869298636384658,1.0,6/13,13.42%,TUBGCP6;TUBGCP4;HAUS4;HAUS7;TUBGCP3;NUMA1
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.4001114239809176,-1.1114575184047255,0.3178294573643411,0.6960680146468949,1.0,6/14,16.72%,ACO2;SDHB;NFU1;ACO1;ISCU;RSAD1
prerank,peptide hormone receptor binding (GO:0051428),0.5767952442328582,1.1100046092437565,0.38095238095238093,1.0,1.0,2/11,13.65%,PTHLH;ADCYAP1
prerank,CoA-ligase activity (GO:0016405),0.560453053252477,1.1072348724190122,0.3684895833333333,1.0,1.0,2/14,10.20%,ACSS3;SLC27A2
prerank,MAP kinase kinase kinase activity (GO:0004709),0.5718562042469779,1.1053018262581775,0.3907380607814761,1.0,1.0,5/11,17.72%,MAP3K5;MAP3K1;EGFR;MAP3K20;MAP3K7
prerank,serine-type peptidase activity (GO:0008236),0.46397014430769734,1.1051372529134935,0.3303030303030303,1.0,1.0,4/96,3.02%,PRTN3;TMPRSS4;TMPRSS3;FAP
prerank,vitamin D receptor binding (GO:0042809),0.5542875895324942,1.1050279982755586,0.3829787234042553,0.9974422564741555,1.0,12/14,29.48%,MED30;TAF7;MED14;MED1;THRAP3;MED13;TAF11;MED16;RXRA;MED12;MED4;SNW1
prerank,antiporter activity (GO:0015297),0.5250779374062691,1.1049846969702086,0.35862913096695226,0.9923077936301505,1.0,5/20,14.28%,SLC35E1;SLC25A16;SLC35D2;SLC35A1;SLC35C2
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.5884379253691854,1.1048917509502165,0.38186813186813184,0.9873107696404513,1.0,3/12,6.74%,PDE7B;PDE4A;PDE2A
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.5847016185524954,1.1037097657260138,0.36962750716332377,0.9864308787546993,1.0,6/10,25.16%,SLCO4C1;SLCO4A1;SLCO2A1;SLCO3A1;SLCO5A1;SLCO1C1
prerank,copper ion binding (GO:0005507),0.490986992767194,1.1036859541786672,0.3435448577680525,0.9813757411394671,1.0,10/42,17.91%,CUTA;CUTC;HEPH;COA6;ATP7A;PARK7;SUMF1;TP53;ATOX1;SNCA
prerank,nucleoside-triphosphatase activity (GO:0017111),0.45863060471785594,1.103487475277273,0.238,0.9769041953889797,1.0,35/248,12.50%,KIF15;KIF20B;KIF18B;KIF14;RAB33B;SMCHD1;CHD1L;GBP4;ATL2;ARHGDIB;ABCB10;ABCD1;RAB1B;RAB22A;RND3;GBP2;PIN1;GNAI1;RAB8A;DNA2;MTG2;GNAO1;KIF2A;RIT2;RHOU;RUVBL2;TOR1A;RUVBL1;DHX9;GPN2;RAB8B;DHX29;GFM2;RAB11B;RAB43
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.49825143831758045,1.1016629160364488,0.3653631284916201,0.9778114790547806,1.0,2/32,2.20%,SLC38A5;SLC1A5
prerank,cation transmembrane transporter activity (GO:0008324),0.48079521183549967,1.1005817010303707,0.35456475583864117,0.9763387632837299,1.0,3/48,2.84%,SLC38A5;SLC1A5;SLC7A1
prerank,MHC protein binding (GO:0042287),0.5197485701541953,1.0998075075087792,0.3682266009852217,0.9738634540605111,1.0,5/20,11.28%,CD74;TUBB4B;TAP1;PILRA;TUBB
prerank,manganese ion binding (GO:0030145),-0.2809976196924454,-1.0995668990103091,0.23529411764705882,0.7156076951388115,1.0,16/48,13.35%,XPNPEP3;XPNPEP1;FAM20C;GALNT3;ADCY2;EXD2;LARGE1;GYG1;GALNT1;ADPRM;MGAT1;MPPE1;HMGCL;XYLT2;ME1;B4GALT7
prerank,I-SMAD binding (GO:0070411),-0.39897293928058397,-1.0977546046019473,0.3471698113207547,0.7104086765778432,1.0,6/13,12.52%,TGFBR1;SMAD1;CTNNB1;SMAD3;SMAD6;SMAD7
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.5615937661693066,1.0974800894684085,0.4002659574468085,0.976844578616013,1.0,7/12,21.92%,DCPS;CYFIP2;NCBP1;NCBP2;NCBP3;AGO2;EIF4E2
prerank,PDZ domain binding (GO:0030165),0.47201117015680877,1.096069090715353,0.3682008368200837,0.9764864247265232,1.0,6/61,8.39%,KIF14;CIT;PLEKHA2;KIDINS220;CCDC88C;ERC1
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.5219670836599212,1.0958623799594713,0.37484885126964934,0.9722257879528317,1.0,7/21,21.36%,PDE7B;PDE4A;PDE2A;PDE5A;PDE8A;PDE7A;PDE1C
prerank,solute:proton symporter activity (GO:0015295),-0.38221643515151815,-1.0935933597721965,0.3474178403755869,0.7107700765601179,1.0,6/16,22.78%,CTNS;SLC25A3;SLC11A2;SLC2A9;SLC39A8;SLC36A1
prerank,growth factor activity (GO:0008083),0.4665601596192861,1.0935157228540633,0.35677352637021714,0.9752076650449634,1.0,4/74,6.89%,IL12A;NTF4;PGF;TGFA
prerank,RNA methyltransferase activity (GO:0008173),0.5333308169233806,1.0922434168142474,0.3877038895859473,0.9744503120741138,1.0,6/19,11.69%,TRDMT1;METTL4;TRMT5;METTL8;TYW3;FBL
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.42417836778018136,-1.0899440843514245,0.35231316725978645,0.7097452982470578,1.0,5/12,6.81%,KDM1A;KDM7A;KDM4A;PHF8;KDM4B
prerank,N-methyltransferase activity (GO:0008170),0.5130964676323416,1.08753498087184,0.37605804111245467,0.9850001298336383,1.0,6/20,15.24%,ZCCHC4;TRMO;TFB1M;TFB2M;METTL15;DIMT1
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.5364469350622434,1.0874671616371816,0.3862433862433862,0.9804187970993593,1.0,4/16,14.50%,SLC25A12;SLC1A5;SLC25A22;SLC25A13
prerank,phosphatase inhibitor activity (GO:0019212),0.5108738101919139,1.0864023386451702,0.3639705882352941,0.9788886228932139,1.0,5/20,16.13%,PPP1R9B;LMTK2;ANP32E;PPP1R2;STYX
prerank,chloride channel regulator activity (GO:0017081),-0.4000780483904384,-1.0861999185882447,0.3230769230769231,0.7089418557249939,1.0,7/14,29.10%,VTI1B;VAMP8;STX1A;WNK2;CHRNA7;SGK1;CFTR
prerank,organic anion transmembrane transporter activity (GO:0008514),0.45634682082961986,1.0853586329323344,0.3410230692076229,0.9776552585103322,1.0,20/134,12.39%,SLC4A1;SLC38A5;SLC25A21;SLC25A12;SLC1A5;SLC7A1;SLC16A12;SLC2A8;SLC16A1;SLCO4C1;SLC35D2;SLC35A1;SLCO4A1;ABCC2;SLC3A1;SLC52A1;SLC19A1;ABCC4;SLC25A22;SLCO2A1
prerank,beta-tubulin binding (GO:0048487),0.49733444958424533,1.0851005865501713,0.36507936507936506,0.9737870932309379,1.0,10/31,18.22%,RACGAP1;UXT;EMD;CCT5;FGF13;BBS4;APPL1;PEX14;TAOK1;TBCD
prerank,NADPH binding (GO:0070402),0.54921000691805,1.081034467490078,0.39030955585464333,0.9822212347091088,1.0,2/13,7.13%,LBR;CBR4
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.46389201113825884,1.0769151137235196,0.3987341772151899,0.9912105662413565,1.0,9/53,15.61%,SLC38A5;SLC25A12;SLC1A5;SLC7A1;SLC43A2;SLC3A1;SLC25A22;SLC25A13;SFXN1
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.32882757836456167,-1.0766836956025907,0.3167701863354037,0.7225013234411308,1.0,14/24,30.85%,EEF2K;CAMK1;PHKG2;CAMK4;CAMK2G;MAPKAPK2;CAMK2B;MKNK2;PHKA1;PTK2B;CAMK2D;CAMKK1;MAPKAPK5;MKNK1
prerank,acyl-CoA hydrolase activity (GO:0047617),0.5247898836614325,1.0763331201059119,0.4005235602094241,0.9883275262156445,1.0,4/17,8.69%,ABCD1;ACOT11;ACOT13;ACOT2
prerank,MHC class I protein binding (GO:0042288),0.5438323831778389,1.076272259667118,0.4008207934336525,0.9837676660260443,1.0,5/13,17.92%,TUBB4B;TAP1;PILRA;TUBB;ATP5F1B
prerank,nuclear receptor binding (GO:0016922),0.447832740831453,1.0753338531080552,0.37322515212981744,0.9822856360431123,1.0,43/111,23.17%,NR4A2;HMGA1;LEF1;BRD8;FOXP1;MED30;TAF1;YWHAH;TAF7;SMARCA4;NCOA7;TACC2;STRN;ZBTB7A;ASXL1;PARK7;PRKCB;TRIM68;STAT5B;ACTN4;LATS1;MED14;CNOT1;KDM4C;TADA3;TCF7L2;SIRT1;TMF1;MED1;PROX1;DDX54;THRAP3;NCOA6;NCOA2;MED13;MMS19;TAF11;NRIP1;RNF6;PHB2;BCAS3;NSD1;NCOA3
prerank,phosphatase binding (GO:0019902),0.4547778985520724,1.075223025814481,0.37373737373737376,0.9779907324215209,1.0,20/105,13.08%,NEK2;RPA2;ITGA1;MAPK1;RCAN3;STX17;CEP192;CDC27;SNX3;KCNN4;ANK1;TRAF3;ANAPC7;MAP3K5;MAPK14;MAST2;EGFR;CNST;PPP6R3;RACK1
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.42443496151588034,-1.0720093908322355,0.3771626297577855,0.7237348220950687,1.0,6/12,15.11%,FRS2;PIK3R1;SH2B2;BLNK;SH2B3;GAB2
prerank,signal sequence binding (GO:0005048),0.4764499583370755,1.0708025433229689,0.4165733482642777,0.9877253108682914,1.0,11/35,16.87%,POM121;TNPO1;KPNA3;NUP214;PEX5L;RANBP6;TOMM70;AP2B1;KDELR2;IPO5;KPNB1
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.5332942164650606,1.0693839060731398,0.4105263157894737,0.9876740904899449,1.0,6/14,15.29%,MTMR12;MTMR2;MTMR14;MTMR6;PTEN;MTM1
prerank,histone methyltransferase binding (GO:1990226),0.5607947229071653,1.068008880449877,0.4314574314574315,0.987527976389848,1.0,2/11,7.94%,LCORL;PHF1
prerank,lipid phosphatase activity (GO:0042577),0.5336737610821719,1.0662896561670132,0.3945578231292517,0.9884490051729308,1.0,2/14,6.72%,PLPPR3;EPHX2
prerank,ribosomal small subunit binding (GO:0043024),0.5143508066412875,1.0605433605674979,0.41106719367588934,1.0,1.0,7/17,25.23%,EIF4B;PIM1;DHX29;PTCD3;ABCE1;NPM1;MTIF2
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.5231404504187238,1.0600388226905098,0.4207723035952064,0.9991969248449755,1.0,3/15,14.66%,SNX3;PHLDA3;RUBCNL
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.4752676668959065,1.059611869354387,0.4134078212290503,0.996085619980215,1.0,6/31,12.59%,SLC12A3;AQP1;SLC12A7;SLC12A1;KCNA1;SLC12A6
prerank,amino acid transmembrane transporter activity (GO:0015171),0.4615619922284123,1.0577909752642354,0.41239316239316237,0.9972179030064556,1.0,5/47,10.11%,SLC38A5;SLC1A5;SLC7A1;SLC43A2;SLC3A1
prerank,mRNA binding (GO:0003729),0.433154420601159,1.0548148212619308,0.362,1.0,1.0,89/249,20.71%,RBM15;RPL7;EIF2A;SLBP;SLPI;PPP1R8;RPS7;HNRNPC;HNRNPM;BOLL;HNRNPL;ZFP36L1;PUM2;EIF4A3;DCP1B;ELAVL4;UTP23;HNRNPA2B1;NOVA2;RPS14;RPL41;AUH;MYEF2;MYH10;SRSF4;NCBP1;SNRNP35;RBM47;EDC3;RNPS1;MRPS7;CSTF3;RPS5;CPEB3;SLC4A1AP;PUM3;RBMS2;PCBP2;RBFOX3;PARK7;PUM1;TYMS;DHX9;IGF2BP3;HNRNPA0;CCT5;DCP1A;NUP98;UPF3B;FXR1;HNRNPR;THOC5;DXO;HNRNPU;DAZAP1;LSM14A;HNRNPAB;RNF20;PCBP3;LUC7L2;SRRM2;TP53;METTL14;RC3H1;THOC2;ANGEL2;SAMD4A;TUT1;LARP4B;SCAF8;TDRD7;PCF11;RBM25;PPIE;ELAVL1;EIF4ENIF1;RPL5;HNRNPLL;NCBP2;RPS3;NCBP3;AGO2;SRBD1;G3BP1;TPR;FYTTD1;RBM4B;SYNCRIP;PTBP2
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.3642566883566215,-1.0545201916558198,0.3788546255506608,0.7568361456099495,1.0,7/18,24.22%,PIK3R5;WDR91;PIK3R1;SOCS7;AGAP2;PIK3R2;SOCS5
prerank,double-stranded RNA binding (GO:0003725),0.4442434528543603,1.0544268708455609,0.41995841995842,0.9990698197685246,1.0,17/70,16.42%,ADAD1;EIF4B;DHX58;TFRC;TUBB4B;TUBA1B;ILF2;CLTC;MSN;DHX9;FXR1;HNRNPU;APTX;LRRFIP1;RC3H1;TARBP2;VIM
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.5497824234919164,1.053700147995011,0.43175487465181056,0.9967546632394617,1.0,3/11,8.81%,DCPS;DCP2;NUDT4
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.4634271140146843,1.050705745687117,0.4250559284116331,1.0,1.0,5/35,11.00%,BLK;FYN;MELK;DYRK1A;BTK
prerank,pyrophosphatase activity (GO:0016462),0.4534179466994328,1.0498523222423704,0.42398286937901497,0.9999239818025065,1.0,11/50,13.24%,ALPL;DCPS;DCP2;ENTPD3;PPA2;ENTPD5;NUDT4;NUDT9;DHX9;DHX29;DXO
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.5034848120643439,1.0493604396772542,0.42997542997543,0.9969346958099582,1.0,5/20,9.81%,AGPAT1;AGPAT4;GPAT3;MOGAT2;AGPAT3
prerank,ubiquitin-protein transferase activity (GO:0004842),0.43338463885365597,1.048929744850431,0.357,0.9939430062225242,1.0,90/346,19.66%,UBE2C;UBE2T;UHRF1;TRIM58;BARD1;NEURL1B;RFWD3;RNF26;BRCA1;MEFV;DTL;TRIM59;PML;PRPF19;PPP1R11;CDC23;FBXW11;MKRN1;FBXO3;UBE2O;TAF1;TRAIP;FBXO44;MSL2;TRAF3;BIRC2;UBE2Z;BIRC6;UBE2K;UBE3B;NEDD4L;TRIM11;RNF157;FBXO17;KLHL9;RNF141;KCMF1;TNFAIP1;ASB1;CUL3;TRIM47;CBLL1;IRF2BPL;AMFR;UBE3C;TRIM44;UBR2;RNF168;XIAP;MIB1;RNF8;TRIM3;CNOT4;TRIM68;RNF2;RNF152;FBXO11;NFX1;ARIH2;FANCL;RNF20;TRIM5;RNF111;RBCK1;RC3H1;MYLIP;TRIM28;RNF115;TRAF3IP2;UBE2R2;RNF103-CHMP3;SH3RF1;RNF4;RNF19A;TRIM37;UBE2M;DDB2;MEX3C;SYVN1;UBE2G1;MALT1;FBXW8;RNF214;RBBP6;RNF43;BSPRY;TRAF6;AKTIP;RNFT2;DTX3
prerank,actin binding (GO:0003779),0.4302951674216934,1.0476184217640707,0.417,0.9937940792935283,1.0,43/170,18.13%,KIF18A;ANLN;MEFV;ALKBH4;PHACTR4;CCDC88A;SYNE2;SLC6A2;EZR;GAS2L3;PRKCE;PHACTR2;GSN;SORBS1;SYNPO2;FXYD5;SHROOM2;DBNL;MYH10;PDLIM7;FLII;LIMA1;PAWR;EMD;VPS16;MTSS1;VASH2;RDX;HNRNPU;ADD2;ACTN4;DAG1;PARVB;SYNE1;PARVA;ADCY8;CALD1;UTRN;CXCR4;PDLIM5;SNCA;FLNB;LRRK2
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.42793769632903195,-1.0461600495548673,0.41254125412541254,0.7691907194689402,1.0,5/10,32.37%,B4GALT5;B4GALT7;B3GALT5;B3GALT2;B3GALT6
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.4639729805903964,1.0459460334617237,0.4255079006772009,0.9947982591566984,1.0,13/34,20.77%,ERI2;PDE12;EXOSC10;PNLDC1;ERI1;CNOT1;ANGEL2;CNOT6;ERI3;DIS3L;CNOT8;PNPT1;CNOT7
prerank,sulfuric ester hydrolase activity (GO:0008484),0.5376364876242439,1.0451640212799405,0.42162162162162165,0.9929125283346144,1.0,3/12,13.73%,SULF2;GALNS;ARSB
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.4315630787095702,1.0430785013857562,0.317,0.9949205173163168,1.0,141/732,19.62%,E2F7;PAX5;E2F8;E2F2;UHRF1;GFI1;FOXA2;NKX6-1;VAX2;MYB;HMGB2;SPIB;MYBL1;DMRTA1;NR4A2;HMGA1;SOX6;HEY2;LEF1;E2F1;TEAD4;IKZF3;PBX4;BATF;ELK4;USF1;PBX3;ERG;BACH2;CTCF;FOXP1;ETS2;DACH1;NR1D1;FOXO1;FOXJ3;ATF7;E2F6;ZBTB26;BCL11A;EBF1;TCF7L1;TCF3;IRF9;RUNX3;HDAC6;EBF3;KLF10;H3-3A;AHR;DMTF1;ZBTB16;E2F5;PLAG1;NFE2L1;NRF1;SNAPC3;ZBTB7A;ZNF148;KLF13;EGR1;SALL2;ZBTB32;MYNN;NR2C2;RFX2;NR2F2;ZEB1;MXI1;NFYC;RUVBL2;NFE2;SMAD4;ATF6;MED8;DHX9;JUN;FOXP2;SATB2;ZBTB33;STAT5B;SP3;NFE2L2;ZBTB7B;HNRNPU;HIVEP2;CC2D1A;DDIT3;SKI;MYC;CEBPG;BCL6;GABPA;POU6F1;ZNF112;PBX2;E2F3;GMEB2;ELF1;TP53;JUNB;LRRFIP1;RUNX1;IRF8;HOXB4;POU2F1;PLAGL1;TCF7L2;TCF4;HIVEP1;TFAP4;ZNF23;RFX7;FOXK2;RFX4;ZNF445;NFATC3;XBP1;RXRB;MLXIP;ZNF467;POU2F2;HDAC4;RARG;FOXE1;ZBTB34;CREB1;ZNF740;RFX1;GMEB1;NKX2-8;PROX1;HDAC1;SAFB;ZBTB20;PAX2;SOX9;THRAP3;NPAS2;SREBF2;PRRX1
prerank,protein kinase inhibitor activity (GO:0004860),0.4545663358222119,1.0413987986939992,0.45861297539149887,0.9955332425430753,1.0,10/42,19.04%,CIT;GMFG;CIB1;IBTK;RACK1;SPRED2;PARVA;HEXIM1;SNCA;CDKN1A
prerank,cytokine receptor binding (GO:0005126),0.4399657758851053,1.041347715783889,0.43782117163412126,0.9913605705644134,1.0,22/83,23.12%,IL12A;INHBC;PGF;JAK2;SOCS2;IL22;SPRED2;TLR5;PIBF1;IL27;USP15;TGFB2;CCL25;KITLG;ERAP1;TRAF6;SMAD2;TYK2;SYK;PXDN;FKBP1A;ADAM17
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.49867691917804435,1.041339447130064,0.42893725992317544,0.987135935991838,1.0,5/18,18.86%,STXBP6;S100A11;PDLIM5;PPP1CA;CDC42EP1
prerank,SUMO transferase activity (GO:0019789),0.5071595735074264,1.0407326230109006,0.4529032258064516,0.9849461559166429,1.0,8/16,21.10%,UBE2I;PIAS3;NSMCE2;RANBP2;PIAS1;TRIM28;HDAC4;MDM2
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.40939093883583366,-1.0384509002141973,0.3843537414965986,0.7795829485611601,1.0,6/11,17.08%,ITPR2;TRPC5;TRPC4;TRPC1;ITPR3;TRPC3
prerank,protein tyrosine kinase activity (GO:0004713),0.4321741902948859,1.0378000304321686,0.43724696356275305,0.990112670193708,1.0,15/108,12.67%,TTK;BLK;WEE1;ERBB3;FYN;BAZ1B;JAK2;EGFR;EPHA3;HIPK2;MELK;DYRK1A;BTK;FLT3;LMTK2
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.5112573563412728,1.03777420742082,0.4512040557667934,0.9860057664523451,1.0,4/15,14.50%,SLC25A12;SLC1A5;SLC25A22;SLC25A13
prerank,neurexin family protein binding (GO:0042043),0.5446849782270508,1.0373254001978116,0.44541484716157204,0.9831747716281708,1.0,1/10,3.01%,CEL
prerank,snRNA binding (GO:0017069),0.4552608779072912,1.0368016159288374,0.46061269146608314,0.9806482451036245,1.0,16/42,19.12%,SNRPC;RNPC3;SART3;LSM2;SNRNP35;PRPF31;CCNT1;RBM7;HNRNPU;PRPF4;LSM7;TUT1;DDX39B;PRPF8;HEXIM1;NCBP2
prerank,sequence-specific mRNA binding (GO:1990825),0.5402084178869808,1.0333443370581337,0.45821325648414984,0.9867873220987892,1.0,2/10,11.45%,TYMS;DHX9
prerank,mRNA methyltransferase activity (GO:0008174),0.5331383563616334,1.0326205406214364,0.44201909959072305,0.9847424545220913,1.0,6/12,22.24%,CMTR2;METTL8;METTL16;METTL14;RNMT;TRMT10C
prerank,acid-thiol ligase activity (GO:0016878),0.530826444489884,1.0324011387817753,0.4601063829787234,0.9812702301785786,1.0,2/13,10.20%,ACSS3;SLC27A2
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.42637029768826046,1.0307626860452845,0.421,0.9819152283950653,1.0,48/254,17.40%,E2F2;MYB;SPIB;MYBL1;NR4A2;LEF1;SMARCD2;ELK4;ERG;FOXO1;FOXJ3;MDM4;TCF3;TFDP1;KLF10;ZBTB16;RLF;PLAG1;NRF1;EGR1;TFDP2;SALL2;NR2C2;NFYC;SMAD4;ATF6;JUN;ATF5;SATB2;DDIT3;MYC;CEBPG;GABPA;ZNF112;PBX2;E2F3;ELF1;TP53;RUNX1;PLAGL1;TCF4;TFAP4;FOXK2;RFX4;ZNF445;NFATC3;RXRB;MLXIP
prerank,store-operated calcium channel activity (GO:0015279),-0.42240448912200323,-1.0295730716549063,0.41118421052631576,0.7929847135677369,1.0,8/10,30.68%,TRPC5;TRPC4;TRPC1;TRPC3;ORAI1;STIM2;TRPC7;ORAI3
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.4205757102147905,1.0258226194858362,0.418,0.9922724656972788,1.0,82/269,21.10%,UBE2C;UBE2T;CCNB1;BRCA1;RPA2;CHEK2;RB1;ERBB3;GLMN;SMC6;PML;AXIN1;SMG5;POLR2A;PA2G4;TANK;PTPN22;IKBKG;FOXO1;FAF1;NPLOC4;TUBA1B;HDAC6;TRAF3;CCT2;TCP1;DDRGK1;UBE2K;SNX9;FAF2;PRKACA;RAD18;BLZF1;EGFR;CASC3;CUL3;PRR7;PCBP2;SUMO1;TUBB;RNF8;JUN;BECN1;AMBRA1;ARRB2;CDK5RAP3;SPOP;SKI;SUMO2;BAG1;FANCL;RNF20;GSK3B;TP53;CCDC50;HGS;TRIOBP;YOD1;TRIM28;USP25;UBXN1;CAMLG;TRIM37;UBA52;USP7;CXCR4;YWHAE;UBE2G1;STAM;RPL5;WRAP53;CDKN1A;SLF1;TRAF6;CASP8;PRKAR2A;RPL23;PRR5L;UBE2N;SMAD2;RIPK1;MDM2
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.5244341068570014,1.0255735576262444,0.4668470906630582,0.9889185410025496,1.0,3/12,12.97%,DCXR;CBR4;DHRS4
prerank,gated channel activity (GO:0022836),-0.379279290970495,-1.0244584745801406,0.390625,0.7966226692241715,1.0,4/14,10.17%,PACC1;TMEM63A;TMEM63B;TMEM266
prerank,leak channel activity (GO:0022840),0.4937789346946631,1.0236725016317993,0.4681647940074906,0.9905323840948268,1.0,1/18,0.51%,RHAG
prerank,carboxy-lyase activity (GO:0016831),0.4771817513417299,1.0233327361311624,0.4667472793228537,0.9875258527621268,1.0,4/23,11.99%,PISD;AZIN1;UXS1;CSAD
prerank,R-SMAD binding (GO:0070412),0.49667817682245813,1.021499552257406,0.45671267252195735,0.9888804990898723,1.0,5/18,11.47%,MEN1;PMEPA1;TRIM33;SMAD4;JUN
prerank,tau-protein kinase activity (GO:0050321),0.49220866212947373,1.0214878156047726,0.46064516129032257,0.9849352930213353,1.0,10/20,21.66%,FYN;MARK2;DYRK1A;ROCK2;GSK3B;MARK4;TAOK1;MARK1;ROCK1;BRSK1
prerank,clathrin adaptor activity (GO:0035615),0.5110074154629287,1.0198193581330128,0.4697986577181208,0.9856519580447758,1.0,5/15,17.61%,AP1G2;STON1;AP2B1;STON2;LDLRAP1
prerank,phospholipase inhibitor activity (GO:0004859),-0.4236966694694493,-1.0191005833001834,0.4524590163934426,0.8007945125649477,1.0,8/10,39.47%,ANXA4;APOC1;ANXA2;ANXA9;ANXA1;ANGPTL3;ANXA5;SNCB
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.4213448630004147,1.0185090698855916,0.416,0.9854940110545678,1.0,156/831,19.50%,E2F7;PAX5;E2F8;FOXM1;E2F2;GFI1;FOXA2;NKX6-1;VAX2;MYB;SPIB;MYBL1;DMRTA1;NR4A2;SOX6;HEY2;DEAF1;LEF1;E2F1;RB1;TEAD4;IKZF3;PBX4;BATF;ELK4;TWIST1;USF1;PBX3;ERG;BACH2;CTCF;RBL1;FOXP1;ETS2;DACH1;NR1D1;TAF1;NFXL1;FOXO1;FOXJ3;ATF7;E2F6;ZBTB26;BCL11A;EBF1;TCF7L1;TCF3;ZFP41;IRF9;RUNX3;HDAC6;TFDP1;EBF3;KLF10;H3-3A;MAX;DMTF1;ZBTB16;E2F5;GTF2A1;ETV6;PLAG1;NFE2L1;NRF1;SNAPC3;ZBTB7A;ZNF148;KLF13;EGR1;TFDP2;SALL2;ZBTB32;MYNN;NR2C2;RFX2;NR2F2;ZEB1;CUX1;MXI1;NFYC;RUVBL2;NFE2;SMAD4;ATF6;MED8;DHX9;JUN;ATF5;FOXP2;ZNF25;SATB2;ZBTB33;STAT5B;SP3;NFE2L2;ZBTB7B;HNRNPU;HIVEP2;CC2D1A;ACTN4;DDIT3;SKI;MYC;CEBPG;BCL6;GABPA;NFX1;POU6F1;ZNF112;PBX2;E2F3;GMEB2;ELF1;TP53;JUNB;LRRFIP1;RUNX1;IRF8;HOXB4;POU2F1;PLAGL1;TCF7L2;TCF4;HIVEP1;TFAP4;ZNF23;PURG;RFX7;FOXK2;RFX4;ZNF445;NFATC3;XBP1;RXRB;MLXIP;ZNF467;POU2F2;HDAC4;RARG;FOXE1;ZBTB34;CREB1;ZNF740;RFX1;GMEB1;NKX2-8;PROX1;HDAC1;SAFB;ZBTB20;RPS3;PAX2;SOX9;THRAP3;NPAS2;SREBF2
prerank,nuclear receptor coactivator activity (GO:0030374),0.4335793021430303,1.015694017491732,0.474025974025974,0.9897274600068403,1.0,23/52,23.76%,PSMC3IP;HMGA1;BRD8;MED30;NCOA7;CCAR2;PRKCB;ACTN4;HELZ2;MED14;SS18;CNOT6;TMF1;RNF4;MED1;THRAP3;NCOA6;NCOA2;MED13;CALCOCO1;ACTN1;NCOA3;WDR77
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",-0.24849629707149953,-1.0136809877289867,0.40540540540540543,0.8048985211675207,1.0,21/74,13.70%,DGKH;HK2;HK3;FAM20C;PIK3CD;GALK2;DGKA;PI4KA;ETNK1;DGKI;PIK3C2B;DGKZ;AGK;PKM;PANK4;DGKQ;PANK3;NMRK1;PIK3CB;GNE;DGKB
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.47588565754758283,1.0121073024635314,0.4762484774665043,0.9963367139746215,1.0,10/20,21.36%,SENP1;DESI2;OTUD5;USP50;YOD1;USP21;USP25;USP7;USP47;COPS2
prerank,RNA cap binding (GO:0000339),0.49844885114941934,1.0112535079531215,0.4949238578680203,0.9951441599207124,1.0,7/16,21.92%,DCPS;CYFIP2;NCBP1;NCBP2;NCBP3;AGO2;EIF4E2
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.3686400009573927,-1.0102149805400593,0.4122137404580153,0.8040350060707139,1.0,8/13,25.94%,TRMT1;WDR4;METTL1;FTSJ1;TRMT10B;TRMT10A;TRMT11;THUMPD2
prerank,purinergic nucleotide receptor activity (GO:0001614),0.4959461660018635,1.0087855518424267,0.47643979057591623,0.9984310331554849,1.0,2/15,9.48%,P2RX1;P2RY1
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.4207444928837403,1.0074230116130807,0.5115115115115115,0.998371882002246,1.0,35/173,16.67%,E2F8;GFI1;HEY2;DEAF1;CTCF;FOXP1;ETS2;DACH1;NR1D1;E2F6;ZBTB26;BCL11A;TCF3;MAX;ZBTB16;ETV6;ZNF148;ZBTB32;ZEB1;MXI1;JUN;FOXP2;ZNF25;ZBTB33;CC2D1A;SKI;MYC;BCL6;NFX1;POU6F1;LRRFIP1;IRF8;PLAGL1;FOXK2;NFATC3
prerank,E-box binding (GO:0070888),0.44031840716247594,1.0073181548834251,0.47085201793721976,0.9947990509828251,1.0,8/34,16.05%,TWIST1;TCF3;AHR;MAX;ZEB1;MYC;TCF4;TFAP4
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.41654856316208566,1.0067789155273215,0.469,0.9925146813447452,1.0,140/731,19.62%,E2F7;PAX5;E2F8;E2F2;GFI1;FOXA2;NKX6-1;VAX2;MYB;SPIB;MYBL1;DMRTA1;NR4A2;SOX6;HEY2;LEF1;E2F1;TEAD4;IKZF3;PBX4;BATF;ELK4;TWIST1;USF1;PBX3;ERG;BACH2;CTCF;FOXP1;ETS2;DACH1;NR1D1;FOXO1;FOXJ3;ATF7;E2F6;ZBTB26;BCL11A;EBF1;TCF7L1;TCF3;IRF9;RUNX3;HDAC6;EBF3;KLF10;H3-3A;AHR;MAX;DMTF1;ZBTB16;E2F5;PLAG1;NFE2L1;NRF1;SNAPC3;ZBTB7A;ZNF148;KLF13;EGR1;SALL2;ZBTB32;MYNN;NR2C2;RFX2;NR2F2;ZEB1;MXI1;NFYC;RUVBL2;NFE2;SMAD4;ATF6;MED8;DHX9;JUN;FOXP2;SATB2;ZBTB33;STAT5B;SP3;NFE2L2;ZBTB7B;HNRNPU;HIVEP2;CC2D1A;DDIT3;SKI;MYC;CEBPG;BCL6;GABPA;POU6F1;ZNF112;PBX2;E2F3;GMEB2;ELF1;TP53;JUNB;LRRFIP1;RUNX1;IRF8;HOXB4;POU2F1;PLAGL1;TCF7L2;TCF4;HIVEP1;TFAP4;ZNF23;RFX7;FOXK2;RFX4;ZNF445;NFATC3;XBP1;RXRB;MLXIP;ZNF467;POU2F2;HDAC4;RARG;FOXE1;ZBTB34;CREB1;ZNF740;RFX1;GMEB1;NKX2-8;PROX1;HDAC1;SAFB;ZBTB20;PAX2;SOX9;THRAP3;NPAS2;SREBF2;PRRX1
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.5266648266547268,1.0065779878232968,0.4653179190751445,0.9892871362915984,1.0,7/10,31.50%,PML;ANKRD13A;DNAJB2;LAPTM5;ANKRD13B;FAAP20;ANKRD13D
prerank,filamin binding (GO:0031005),0.5205359005088159,1.0044655551108048,0.46771879483500717,0.9911209482739918,1.0,2/11,6.71%,RFLNB;SYNPO2
prerank,receptor antagonist activity (GO:0048019),-0.34996297128730713,-1.0019457571299013,0.42358078602620086,0.8159887421127751,1.0,9/17,49.39%,DKK2;IL18BP;CCL5;DKK3;ESR2;FST;IGSF1;WFIKKN1;AGTR2
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.4723000065512415,1.0012259178144736,0.4932349323493235,0.996083174100667,1.0,8/22,18.78%,EXOSC8;ZFP36L1;ELAVL4;CPEB3;HNRNPA0;ZFP36L2;CPSF1;ELAVL1
prerank,tRNA binding (GO:0000049),-0.2686275364414118,-0.9996313828386314,0.4,0.8124024442966078,1.0,15/43,21.46%,NEMF;CARS1;SARS1;TRNAU1AP;AIMP1;NSUN2;ELP5;TYW5;ALKBH1;TRMT10B;IGHMBP2;RPUSD4;YRDC;DARS2;TRMT10A
prerank,calcium channel activity (GO:0005262),-0.226958931395106,-0.9971545237414932,0.43478260869565216,0.8087774001275136,1.0,37/84,29.80%,SLC24A3;CACNB2;CACNA1C;TRPC5;TPCN2;CUL5;MCOLN1;TRPC4;TRPC1;CACNA2D3;CACNG7;CACNG2;RYR2;PKD1;SEC61A1;CACNB4;CACNA2D2;TRPV4;TRPC3;NCS1;ORAI1;P2RX4;ANXA2;PKD2L1;CACNA1E;PKD1L2;PKD2L2;ANXA6;ANXA9;CACNB1;CHRNA7;STIM2;CACNA2D4;CATSPER3;SLC24A5;TRPC7;TRPM2
prerank,phosphatase activator activity (GO:0019211),0.49421567366824815,0.9953015867723322,0.48707482993197276,1.0,1.0,4/14,9.87%,PHACTR4;PPP2R5E;PPP2R5A;PPP1R15A
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.48266025588842854,0.9904809595086609,0.5019255455712451,1.0,1.0,7/16,19.72%,MTMR12;MTMR2;MTMR14;MTMR6;PTEN;MTM1;INPP5F
prerank,cadherin binding (GO:0045296),0.40974910634476386,0.990460715775911,0.536,1.0,1.0,86/315,19.55%,DIAPH3;CIP2A;CCNB2;TMPO;CKAP5;ANLN;CTNNA1;STXBP6;FLNA;SLK;EZR;S100A11;EIF2A;VASN;RPL14;SWAP70;EIF3E;CNN2;RANGAP1;CRKL;STX5;RPL23A;FXYD5;PKN2;SNX9;DBNL;ERC1;STK38;MARK2;CDH18;CDH24;UNC45A;STK24;EGFR;CLIC1;LIMA1;CEMIP2;PARK7;EMD;RUVBL1;AHSA1;UBAP2;BSG;RDX;FASN;VAPA;DHX29;OLA1;PACSIN2;RAB11B;HCFC1;PLCB3;RACK1;CC2D1A;TXNDC9;PSEN1;BAG3;PPL;LRRFIP1;SPTAN1;AHNAK;PPFIBP1;CTNND2;CDH4;ZC3H15;EEF2;PAK2;PARVA;LASP1;SEPTIN9;DNAJB1;CHMP2B;CALD1;YWHAE;PDLIM5;NDRG1;PPP1CA;IQGAP1;FLNB;CAST;NUDC;CDC42EP1;CLINT1;TES;TAGLN2;ARHGAP1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.5149795031164986,0.989330846703106,0.48760330578512395,1.0,1.0,1/11,2.63%,DDAH2
prerank,heme binding (GO:0020037),0.4213051091897749,0.9884546201191672,0.5261506276150628,1.0,1.0,9/65,12.98%,CYP1B1;SDHD;NR1D1;CYP2A6;JAK2;PGRMC2;CYP27A1;CYP46A1;HEBP1
prerank,metal ion binding (GO:0046872),0.4086663049510142,0.9884445047406186,0.541,1.0,1.0,82/477,17.93%,TOP2A;EFCAB11;GEN1;PIF1;PLK1;STK26;SLC25A12;C2CD5;OXSR1;ITPR1;S100A11;PPP3CA;RCN3;S100A9;MSH6;STK11;FEN1;DUT;SYT8;RASGRP1;IMPA1;SIK2;S100A8;UBA2;GSN;EPHX2;PDE2A;STK38L;MAP3K5;GNAI1;CIB1;TDP2;RP2;PPA2;STK38;MARK2;CDH18;CDH24;MAST2;SMOC2;CAPN1;CEMIP2;MELK;DNER;MICU3;SYT3;SLIT3;SLIT1;CRACR2A;APEX1;CANX;NT5C3A;DXO;BAIAP3;LATS1;TPM4;MICU1;ADGRL3;SLC25A13;TPT1;ANXA11;ADGRV1;STK4;IDH2;MAP3K20;GCA;RPE;NDUFAB1;CDH4;PDXK;FOXK2;PIR;ACER3;SRPK1;TRPM4;ADPRH;CANT1;HSP90B1;MCTP1;TDG;SNCA;IQGAP1
prerank,tumor necrosis factor receptor binding (GO:0005164),0.5013763919250824,0.9869785567398395,0.4899135446685879,1.0,1.0,5/12,26.48%,TRAF3;TRIM37;TRAF6;BABAM2;TRAP1
prerank,androgen receptor binding (GO:0050681),0.4525677427823677,0.9867610326296158,0.5018050541516246,1.0,1.0,8/25,17.13%,FOXP1;SMARCA4;ZBTB7A;PARK7;PRKCB;TRIM68;KDM4C;TMF1
prerank,protein phosphatase regulator activity (GO:0019888),0.4256633015475242,0.9864213679790053,0.5117021276595745,1.0,1.0,11/53,13.71%,PHACTR4;PPP1R9B;PTPA;RCAN3;ANKLE2;PPP2R5E;PPP2R5A;PPP1R15A;LMTK2;PPP6R3;PPP1R2
prerank,ribosome binding (GO:0043022),0.4290397265719502,0.9857597393880285,0.4978494623655914,1.0,1.0,14/46,22.90%,SLFN14;EIF2S1;EIF2A;CPEB3;ERI1;NAA16;RACK1;PYM1;EEF2;NCLN;CCDC47;EIF6;EFL1;SRP68
prerank,glutamate receptor activity (GO:0008066),-0.3278879294478835,-0.9852601239010286,0.43283582089552236,0.8299505631438128,1.0,6/19,18.51%,GRIA1;GRIA4;GRM5;GRIK2;GRM8;GRIK4
prerank,ubiquitin protein ligase activity (GO:0061630),0.4085870989518491,0.9845715816533437,0.561,0.9998283881325074,1.0,56/228,19.66%,UHRF1;TRIM58;NEURL1B;RFWD3;RNF26;MEFV;TRIM59;PRPF19;PPP1R11;MKRN1;UBE2O;FBXO44;MSL2;BIRC2;UBE2K;UBE4B;UBE3B;NEDD4L;TRIM11;RNF157;FBXO17;KCMF1;ASB1;CUL3;CBLL1;IRF2BPL;AMFR;UBE3C;TRIM44;UBR2;XIAP;RNF8;TRIM3;TRIM68;RNF2;RNF152;NFX1;ARIH2;FANCL;TRIM5;RNF111;RC3H1;MYLIP;RNF115;TRAF3IP2;SH3RF1;RNF19A;TRIM37;MEX3C;SYVN1;RBBP6;RNF43;BSPRY;TRAF6;RNFT2;DTX3
prerank,phosphatidate phosphatase activity (GO:0008195),0.4953288120703424,0.9826435178385293,0.5160839160839161,1.0,1.0,1/13,1.23%,PLPPR3
prerank,Toll-like receptor binding (GO:0035325),0.5127469371467932,0.9824184433821871,0.5027932960893855,0.9983742471479631,1.0,4/11,14.19%,S100A9;S100A8;MYD88;TLR6
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.42575850809859733,0.9810122715884383,0.5032608695652174,0.9983193892962481,1.0,20/49,23.06%,ABRAXAS1;IKBKG;HDAC6;ZRANB3;RAD18;UBQLN1;TAB3;RNF169;RAD23A;RNF168;ZFAND2B;PSMD4;UBXN1;PRPF8;ATRIP;OTUD7A;UBQLN2;MINDY2;ZBTB1;UIMC1
prerank,growth factor receptor binding (GO:0070851),0.40404023751833595,0.976786934391529,0.5287588294651867,1.0,1.0,15/95,15.38%,IL12A;CCDC88A;GLMN;FYN;PGF;ARF4;TGFA;GRB2;JAK2;IL1R1;FGF9;TLR5;PIBF1;PSEN1;EGF
prerank,proton transmembrane transporter activity (GO:0015078),-0.27620444131307953,-0.975521317353974,0.45348837209302323,0.8447888675357665,1.0,11/39,19.29%,ATP6V1B2;CTNS;SLC9A1;COX6B1;CLCN4;SLC11A2;COX5A;ATP6V1F;UQCRQ;UQCRFS1;NNT
prerank,phosphatidylinositol binding (GO:0035091),-0.23100582567938346,-0.9746882234637566,0.48,0.8378167119525345,1.0,26/91,17.91%,SNX24;ITPR2;WDFY3;APPL2;SNAP91;SNX5;EEA1;ZFYVE9;TULP3;PHF12;SNX16;SNX11;ZFYVE1;SNX27;SCARB1;FES;PITPNB;MPPE1;NCF1;GAP43;MCF2L;ITPR3;SH3YL1;C2CD2L;PITPNM2;THY1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.5022557738422408,0.972992575367201,0.5104602510460251,1.0,1.0,6/10,26.06%,NSD2;NSD3;ASH1L;SETD5;NSD1;SETD2
prerank,protein kinase C activity (GO:0004697),0.48346361378873426,0.9699540010762121,0.5059920106524634,1.0,1.0,4/14,11.86%,PRKCE;PRKD3;PRKCA;PRKCB
prerank,MAP kinase phosphatase activity (GO:0033549),-0.390469493214048,-0.9697004334784453,0.4908424908424908,0.842254169917562,1.0,3/12,12.83%,DUSP3;DUSP10;DUSP7
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.24919314145059276,-0.9691831164114597,0.49056603773584906,0.8345204578030724,1.0,6/60,4.03%,MERTK;ACVR1;IGF1R;CSF1R;ERBB4;FLT1
prerank,hexosaminidase activity (GO:0015929),-0.36695517553229606,-0.9681241749520797,0.48314606741573035,0.8285273762193008,1.0,2/12,10.95%,HEXB;HEXD
prerank,neuropeptide hormone activity (GO:0005184),0.45263282095163526,0.9678899227132832,0.5323565323565324,1.0,1.0,4/22,19.87%,AGRP;ADCYAP1;PPY;HCRT
prerank,ATPase regulator activity (GO:0060590),-0.2700748632139809,-0.9663161249084727,0.5675675675675675,0.824011097201661,1.0,12/38,15.45%,PFN1;DNAJC19;DNAJB6;HSPH1;DNAJA2;ATP1B2;FNIP1;TSC1;ATP1B1;HSPBP1;SIL1;DNAJC1
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.44000606064533565,0.9654886700185651,0.5195266272189349,1.0,1.0,10/28,26.48%,PIDD1;TRAF3;MYD88;TRIM37;TRAF6;RIPK1;MADD;BABAM2;CASP8AP2;TRAP1
prerank,voltage-gated ion channel activity (GO:0005244),0.4809116474536032,0.9653436412425628,0.5067024128686327,1.0,1.0,4/14,19.98%,VDAC2;HVCN1;ANO6;PKD2
prerank,transcription coactivator binding (GO:0001223),0.46180547434860214,0.9647544945493653,0.5236318407960199,1.0,1.0,3/20,11.17%,CIT;AHR;SMAD4
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.39992416871274095,0.9645011803220495,0.6,1.0,1.0,57/232,19.66%,UHRF1;TRIM58;NEURL1B;RFWD3;RNF26;MEFV;TRIM59;PRPF19;PPP1R11;MKRN1;UBE2O;FBXO44;MSL2;BIRC2;UBE3B;NEDD4L;TRIM11;RNF157;FBXO17;KCMF1;ASB1;CUL3;PIAS3;CBLL1;IRF2BPL;AMFR;UBE3C;TRIM44;NSMCE2;UBR2;XIAP;RNF8;TRIM3;TRIM68;RNF2;RNF152;NFX1;ARIH2;FANCL;TRIM5;RNF111;RC3H1;PIAS1;MYLIP;RNF115;TRAF3IP2;SH3RF1;RNF19A;TRIM37;MEX3C;SYVN1;RBBP6;RNF43;BSPRY;TRAF6;RNFT2;DTX3
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.4925588575230545,0.9643422062109254,0.5214285714285715,1.0,1.0,3/11,13.84%,SGMS2;PIGF;SGMS1
prerank,protein tyrosine kinase binding (GO:1990782),-0.2283222759492087,-0.9617228321231056,0.631578947368421,0.8263957350604405,1.0,13/71,9.99%,ACVR1;SIRPA;TREM2;PTPN2;SQSTM1;HSP90AA1;BMPR2;GRM5;ANGPT1;TJP2;DUSP3;BLNK;SH2B3
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.45165903301699517,0.9614412280434037,0.5518867924528302,1.0,1.0,7/23,21.36%,PDE7B;PDE4A;PDE2A;PDE5A;PDE8A;PDE7A;PDE1C
prerank,glycine binding (GO:0016594),-0.3881095596049505,-0.9595132172684904,0.5086505190311419,0.8234809786391301,1.0,9/11,44.24%,GRIN3A;GLRA2;GRIN2B;GLRA3;GRIN1;SRR;GNMT;GRIN3B;GLDC
prerank,cAMP response element binding (GO:0035497),0.5060175228111287,0.9594956591815222,0.5358166189111748,1.0,1.0,4/10,23.92%,ATF7;JUN;CREB1;HMGA2
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.4388015243260516,0.9587330989212431,0.5550510783200908,1.0,1.0,10/28,22.79%,EXO1;FEN1;EDC3;APEX1;PRORP;RNASEH2A;POP4;AGO2;ENDOV;RPP30
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.4361884344165685,0.9582376299446356,0.5420023014959724,1.0,1.0,3/28,10.27%,CHRNB4;GABRA4;GABRA5
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.2749371132373044,-0.954932486006409,0.5225225225225225,0.8266322277532072,1.0,10/35,14.96%,GPCPD1;PLCB2;ENPP2;GDE1;APEX2;PLCB4;PDIA3;MPPE1;PLCXD2;SMPDL3A
prerank,hyaluronic acid binding (GO:0005540),0.4972534173283717,0.9536105079253986,0.5252525252525253,1.0,1.0,1/10,3.89%,CD44
prerank,death domain binding (GO:0070513),0.4897425294607854,0.9511763110529409,0.5398601398601398,1.0,1.0,3/11,13.08%,DAP;TRADD;RACK1
prerank,pyridoxal phosphate binding (GO:0030170),-0.3015414527318227,-0.9497371275608807,0.4973821989528796,0.830868900652014,1.0,15/20,47.47%,PYGB;PYGL;PLPBP;AGXT;OAT;SHMT2;SHMT1;SRR;CBS;PYGM;THNSL2;CTH;GLDC;ACCS;SDS
prerank,chemokine receptor binding (GO:0042379),-0.26733425433435026,-0.9495487819910291,0.5294117647058824,0.8230893253799886,1.0,16/35,47.33%,CX3CR1;CCL15;CCL4;CCL3;CCL14;PF4;CCL13;CCL2;CCL5;CCRL2;CCL28;CXCL12;CCL7;CXCL10;CKLF;CCL24
prerank,ubiquitin-dependent protein binding (GO:0140036),0.5023514807911397,0.9471352462309397,0.5358208955223881,1.0,1.0,8/10,31.50%,USP15;DNAJC2;ANKRD13A;DNAJB2;LAPTM5;ANKRD13B;FAAP20;ANKRD13D
prerank,epidermal growth factor receptor binding (GO:0005154),0.43684301356711575,0.9449905099125119,0.553921568627451,1.0,1.0,4/25,8.31%,CCDC88A;ARF4;TGFA;GRB2
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.4153490352364805,0.94390596945548,0.557628979143798,1.0,1.0,14/40,21.23%,SUV39H1;ARMT1;LCMT1;METTL4;DNMT1;METTL8;METTL9;FBL;LRTOMT;ICMT;DNMT3B;THUMPD3;PRMT7;PCMTD1
prerank,ribonuclease activity (GO:0004540),0.40906175649268484,0.9432567008361786,0.5738575982996812,1.0,1.0,7/56,7.55%,SLFN14;RNASE6;SMG6;PPP1R8;EXOSC8;YBEY;EXOSC10
prerank,endopeptidase activity (GO:0004175),0.3891996169676592,0.9399154209877466,0.6456456456456456,1.0,1.0,35/257,14.89%,PRTN3;TMPRSS4;TMPRSS3;ADAMTS7;KEL;ESPL1;NAPSA;USP1;SENP1;NRDC;FAP;PSMB7;PIDD1;MBTPS2;CASP2;USP38;CTSE;PITRM1;PREP;USP48;ATG4B;PSMA4;DPP4;CTSK;CTSO;F3;USP14;MMP19;PSEN1;USP24;CASP9;USP15;PSMB1;PCSK1;ADAMTS1
prerank,galactosyltransferase activity (GO:0008378),-0.3822842315484091,-0.9396941084768244,0.5212765957446809,0.839391791027257,1.0,7/11,40.81%,B4GALT5;B4GALT7;B3GALT6;B4GALT4;B4GALT2;A4GALT;B3GNT6
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.4846339380952776,0.9389070904633531,0.5406896551724137,1.0,1.0,2/12,4.65%,CCDC88A;PGF
prerank,phosphotyrosine residue binding (GO:0001784),-0.2629969100659311,-0.9386405459684942,0.5851063829787234,0.8338469338368037,1.0,6/37,4.52%,BCAR3;YES1;PTPN6;PFN1;PIK3R1;VAV2
prerank,ubiquitin protein ligase binding (GO:0031625),0.38441212446466255,0.938530189035693,0.665,1.0,1.0,75/254,21.10%,UBE2T;BRCA1;RPA2;CHEK2;RB1;ERBB3;GLMN;SMC6;PML;AXIN1;SMG5;POLR2A;PA2G4;TANK;PTPN22;IKBKG;FOXO1;FAF1;NPLOC4;TUBA1B;HDAC6;TRAF3;CCT2;TCP1;UBE2K;SNX9;FAF2;PRKACA;RAD18;BLZF1;EGFR;CASC3;CUL3;PCBP2;SUMO1;TUBB;RNF8;JUN;BECN1;AMBRA1;ARRB2;SPOP;SKI;SUMO2;BAG1;FANCL;RNF20;GSK3B;TP53;CCDC50;TRIOBP;YOD1;TRIM28;USP25;UBXN1;CAMLG;TRIM37;UBA52;USP7;CXCR4;YWHAE;UBE2G1;RPL5;WRAP53;CDKN1A;SLF1;TRAF6;CASP8;PRKAR2A;RPL23;PRR5L;UBE2N;SMAD2;RIPK1;MDM2
prerank,SUMO binding (GO:0032183),0.4801191781656045,0.9383693477141462,0.5555555555555556,1.0,1.0,6/13,17.81%,PML;UBA2;RNF111;USP25;RNF4;TDG
prerank,general transcription initiation factor binding (GO:0140296),0.4257411115966576,0.9371854393163108,0.56062424969988,1.0,1.0,7/25,14.84%,TAF1;PSMC1;AHR;GTF2A1;RUVBL2;RUVBL1;YEATS2
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.48597092212427134,0.9349858668218904,0.5466101694915254,1.0,1.0,1/11,3.00%,ITPR1
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.4832471782533846,0.9349118124468702,0.5710306406685237,1.0,1.0,5/11,20.50%,NDUFAF7;FBXO11;PRMT9;PRMT3;PRMT7
prerank,peptide N-acetyltransferase activity (GO:0034212),0.49847584073783824,0.9339515046360662,0.5495495495495496,1.0,1.0,3/10,15.22%,NAA16;NAA25;NAA20
prerank,chemokine activity (GO:0008009),-0.2733566740035054,-0.9334027465887251,0.5611510791366906,0.8383113624484813,1.0,17/31,52.17%,CCL15;CCL4;CCL3;CCL14;PF4;CCL13;CCL2;CCL5;CCL28;CXCL12;CCL7;CXCL10;CKLF;CCL24;CCL19;CCL8;CXCL9
prerank,aminoacyl-tRNA ligase activity (GO:0004812),-0.25670198018901585,-0.9319581571219486,0.5238095238095238,0.8342826246805831,1.0,13/37,16.55%,IARS2;CARS1;WARS2;SARS1;NARS1;FARSA;IARS1;HARS2;HARS1;NARS2;TARS1;QARS1;TARS3
prerank,methyltransferase activity (GO:0008168),0.40889788573713853,0.9316787860182421,0.5899122807017544,1.0,1.0,14/46,20.50%,SUV39H1;ARMT1;LCMT1;METTL4;DNMT1;EHMT1;NDUFAF7;NSUN3;COQ5;LRTOMT;PRMT3;GCSH;DNMT3B;PRMT7
prerank,metalloexopeptidase activity (GO:0008235),0.3942979539430914,0.9272281786058882,0.6059637912673056,1.0,1.0,12/51,18.45%,AGBL1;CPA6;CPM;AGTPBP1;DPEP1;METAP2;LTA4H;VASH2;AGBL3;CPD;ERAP1;RNPEP
prerank,alpha-tubulin binding (GO:0043014),0.41744247415291946,0.9263915550735287,0.5646794150731158,1.0,1.0,8/31,18.06%,RACGAP1;FYN;HDAC6;OFD1;BBS4;ARL4C;SNCA;TAOK1
prerank,calcium channel inhibitor activity (GO:0019855),0.47879320567670897,0.9261551682998785,0.5769230769230769,1.0,1.0,1/11,3.00%,ITPR1
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.43776699406307906,0.9225981916408039,0.5722964763061968,1.0,1.0,11/22,23.06%,IKBKG;ZRANB3;TAB3;RNF169;RNF168;PRPF8;ATRIP;OTUD7A;MINDY2;ZBTB1;UIMC1
prerank,AMP binding (GO:0016208),-0.36555798264659556,-0.9215348463720958,0.5362318840579711,0.8502983692790765,1.0,5/11,20.88%,PFKL;PYGL;APRT;PFKP;PFKM
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.47224348614723877,0.9191047185020462,0.5822102425876011,1.0,1.0,3/12,13.08%,APAF1;BCL2L13;RACK1
prerank,mitogen-activated protein kinase binding (GO:0051019),0.41367557473626176,0.9176986887480523,0.570446735395189,1.0,1.0,9/29,21.35%,PPM1D;MAPKAPK3;ATF7;MAPK14;CDK5RAP3;SIRT1;TPR;DUSP16;NBR1
prerank,miRNA binding (GO:0035198),0.413369229158661,0.9152593801366123,0.5855646100116414,1.0,1.0,13/30,24.92%,ZC3H7A;PUM2;HNRNPA2B1;TUT4;PUM1;RC3H1;HNRNPA1;ELAVL1;AGO2;PNPT1;AGO1;YBX1;ZNF346
prerank,hormone activity (GO:0005179),0.39396409097592905,0.9123750230294773,0.6060279870828849,1.0,1.0,9/54,19.87%,AGRP;NPPC;PTHLH;ADCYAP1;CCL25;INSL6;APLN;PPY;HCRT
prerank,protease binding (GO:0002020),0.3904072371290075,0.912180278955301,0.6538071065989848,1.0,1.0,27/99,17.78%,CD177;BRCA2;FAP;COL1A2;CLTC;INSL3;SART3;ITGAV;RIOK3;DERL2;AMFR;PARK7;SUMO1;RAD23A;DPP4;PTEN;F3;SPATA2;FLOT1;CFLAR;RHBDD2;GSK3B;CCBE1;TP53;CHMP3;FN1;SYVN1
prerank,metalloendopeptidase activity (GO:0004222),0.3874161948939983,0.9120832861580339,0.6377870563674322,1.0,1.0,18/76,24.41%,ADAMTS7;KEL;NRDC;MBTPS2;PITRM1;MMP19;ADAMTS1;ADAMTSL3;ADAMTS5;ADAM10;MMP12;MME;ADAMTS3;ADAMTS2;ADAM17;ADAMTS10;ADAMTS9;ZMPSTE24
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),-0.23011497219585728,-0.9097027660118507,0.7,0.870529363316445,1.0,6/60,4.03%,MERTK;IGF1R;CSF1R;ERBB4;NRP2;FLT1
prerank,thioesterase binding (GO:0031996),0.473904377802003,0.9087030241696514,0.5589887640449438,1.0,1.0,4/11,19.36%,TRAF3;HAUS7;RAC1;TRAF6
prerank,ADP binding (GO:0043531),0.42237747124288494,0.9085941172194438,0.5940119760479042,1.0,1.0,11/25,23.65%,MSH6;ABCD1;TAP1;MYH10;LONP1;PRKAG2;ATP5F1D;PGK1;PRKAG1;GCLC;MYH9
prerank,sulfotransferase activity (GO:0008146),0.4104955737058832,0.9060734226563845,0.5997745208568207,1.0,1.0,4/33,13.19%,CHST3;TPST1;CHST12;SULT6B1
prerank,transforming growth factor beta receptor binding (GO:0005160),0.4348925421010239,0.9046512393033769,0.5816326530612245,1.0,1.0,1/18,0.90%,INHBC
prerank,zinc ion binding (GO:0008270),0.3751653699881408,0.9039928074438012,0.757,1.0,1.0,67/293,18.45%,UHRF1;RNF26;TK1;MEFV;BLM;ZCCHC4;DHX58;HDAC10;S100A9;TNFSF10;CTCF;RASGRP1;SNRPC;S100A8;MDM4;DPEP1;MBD1;CDADC1;PDE2A;BIRC2;GDA;PRIMPOL;BAZ1B;PHF2;SEC24B;SEC24A;PITRM1;TAB3;CSRP1;RPS27;TIMM9;EGR1;ZBTB32;TMEM163;KAT6A;ZEB1;NAPEPLD;ZMYND8;RPS29;LTA4H;RNF8;RNF2;KMT2A;HHIP;GLO1;SKI;ARIH2;KDM4C;LIMS1;KMT2B;TP53;RC3H1;PDXK;TRIM28;CRIP1;ACER3;KPNB1;DUSP12;SLC30A5;EPRS1;LACTB2;SNCA;HDAC4;RASSF1;KDM2B;ERAP1;RNPEP
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.4766759621196089,0.9028602807948761,0.5872093023255814,1.0,1.0,5/10,24.80%,GFUS;GALM;RPE;GALE;GLCE
prerank,lipase activator activity (GO:0060229),0.47115867035447057,0.8996087293295549,0.5842857142857143,1.0,1.0,3/10,11.00%,FYN;PDPK1;BTK
prerank,semaphorin receptor binding (GO:0030215),-0.3010861717488087,-0.8982324163563984,0.6208791208791209,0.8893313979458239,1.0,14/23,36.86%,SEMA3D;SEMA3E;SEMA4C;SH3BP1;SEMA4G;SEMA3A;SEMA7A;SEMA4D;SEMA4F;PLXNB1;SEMA6C;SEMA6B;SEMA3B;SEMA3F
prerank,ephrin receptor binding (GO:0046875),0.4229307578679335,0.8973208784470194,0.6049382716049383,1.0,1.0,5/21,15.71%,FYN;GRB2;ANKS1A;CRK;ANKS1B
prerank,tau protein binding (GO:0048156),0.3917211011854452,0.8965617419706603,0.6061269146608315,1.0,1.0,17/40,22.05%,FYN;HDAC6;PIN1;MARK2;PPP2CB;DYRK1A;ROCK2;GSK3B;MARK4;SNCA;TAOK1;PPP2CA;MARK1;SMAD2;ROCK1;BRSK1;DCTN1
prerank,ligand-gated ion channel activity (GO:0015276),0.40813334356281294,0.895708660914666,0.6127167630057804,1.0,1.0,1/30,0.81%,CHRNB4
prerank,hydro-lyase activity (GO:0016836),-0.2495417394706079,-0.8955850873619173,0.5925925925925926,0.8871106174934762,1.0,10/41,12.66%,TBXAS1;HACD3;ACO2;ECHS1;ENO1;ECHDC1;NAXD;CA2;ACO1;TGDS
prerank,dipeptidyl-peptidase activity (GO:0008239),0.475650153505063,0.8951245572289185,0.6031294452347084,1.0,1.0,5/10,20.61%,FAP;DPP4;NAALAD2;DPP9;PRCP
prerank,endopeptidase activator activity (GO:0061133),-0.3744049946952608,-0.8940310522318988,0.5797546012269938,0.8824063729949583,1.0,2/10,2.22%,PSMD14;VSIR
prerank,ligand-gated channel activity (GO:0022834),0.40813384907675365,0.8935392315117943,0.6104651162790697,1.0,1.0,1/29,0.81%,CHRNB4
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.3438572801677149,-0.8917476408415951,0.5874125874125874,0.8796996848460646,1.0,4/12,5.63%,PIK3R1;IGF1;ARRB1;GNAS
prerank,regulatory RNA binding (GO:0061980),0.39517883115762237,0.8905228675341372,0.6210762331838565,1.0,1.0,14/38,23.22%,ZC3H7A;PUM2;HNRNPA2B1;TUT4;PUM1;DHX9;RC3H1;TARBP2;HNRNPA1;ELAVL1;AGO2;PNPT1;AGO1;YBX1
prerank,DNA-binding transcription factor binding (GO:0140297),0.3673070264349389,0.8890683190682771,0.757,1.0,1.0,63/189,23.97%,HEY2;RB1;CBX5;TWIST1;ZFPM1;USF1;MTA3;RBL1;RBBP8;TAF1;PTMA;TCF3;DDRGK1;HMGB1;SPEN;TLE4;ZBTB7A;PIAS3;HIRA;HIPK2;ZMYND8;PARK7;DHX9;JUN;MTA2;HCFC1;NFE2L2;BBS4;BEX1;DDIT3;CREBBP;SKI;MYC;GABPA;RERE;GSK3B;TP53;PIAS1;SIN3A;TCF7L2;TAF9;TCERG1;SIRT1;HCLS1;HDAC4;CREB1;TLE3;HDAC1;PRRX1;FIZ1;RBPJ;PPARD;SMAD2;MEF2D;CIITA;PURB;HDAC9;ATN1;BBS7;BHLHE40;NPM1;MIER1;DAPK3
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.4390763379181396,0.8876870563736232,0.6426701570680629,1.0,1.0,1/17,1.17%,LBR
prerank,alkali metal ion binding (GO:0031420),0.45875453218956824,0.8873621985152244,0.6294820717131474,1.0,1.0,6/13,17.98%,IMPA1;PDXK;ADPRH;TDG;DRG1;HDAC4
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.4292168990216235,0.8853927141748515,0.6089743589743589,1.0,1.0,6/17,18.99%,AK9;NME4;AK5;AK3;CLP1;CMPK2
prerank,cytokine activity (GO:0005125),0.368744432688894,0.8849119494688893,0.700502512562814,1.0,1.0,4/131,7.33%,IL12A;INHBC;IL16;HMGB1
prerank,signaling receptor complex adaptor activity (GO:0030159),0.39277107498232244,0.8821883682115129,0.6339285714285714,1.0,1.0,9/38,18.13%,CARD10;AXIN1;TRADD;SORBS1;SPATA2;IRS1;SPAG9;LDLRAP1;LRRK2
prerank,MAP kinase activity (GO:0004707),0.44210336469384615,0.8788434263135321,0.6346911957950065,1.0,1.0,2/14,8.10%,MAPK1;MAPK14
prerank,vinculin binding (GO:0017166),0.4548840734740585,0.8760702343962644,0.6215827338129496,1.0,1.0,6/11,22.53%,CTNNA1;DAG1;UTRN;RTCB;ACTN1;PXN
prerank,deubiquitinase activity (GO:0101005),0.36461398139426765,0.8738080660205074,0.7012195121951219,1.0,1.0,21/88,17.64%,USP27X;MINDY4;USP1;TANK;USP38;DESI2;USP48;USP31;BAP1;UCHL5;USP14;USP24;USP15;VCPIP1;OTUD5;USP50;YOD1;USP21;USP25;USP40;USP7
prerank,phospholipase binding (GO:0043274),0.44294134198435753,0.8721175586762843,0.6208791208791209,1.0,1.0,4/13,11.00%,FYN;PDPK1;PAFAH1B1;BTK
prerank,receptor ligand activity (GO:0048018),0.3626877230266091,0.8704639269617012,0.7887887887887888,1.0,1.0,11/245,7.33%,IL12A;INHBC;NTF4;HMGB2;TNFSF13B;NPPC;IL16;PGF;PTHLH;TGFA;HMGB1
prerank,endoribonuclease activity (GO:0004521),0.3892248004368851,0.8702397226158367,0.6440677966101694,1.0,1.0,3/32,6.66%,SLFN14;SMG6;YBEY
prerank,exopeptidase activity (GO:0008238),0.37754969778745384,0.8702252286576282,0.6609442060085837,1.0,1.0,14/50,20.61%,DPEP3;FAP;DPEP2;CPM;DPEP1;METAP2;LTA4H;DPP4;NAALAD2;ERAP1;RNPEP;MME;DPP9;PRCP
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.43106032605154365,0.8650966503672354,0.6275862068965518,1.0,1.0,2/14,13.00%,KCNJ3;KCNJ2
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.35276830607456866,-0.8638020476963614,0.6230031948881789,0.9354111143114564,1.0,4/10,6.81%,KDM7A;KDM4A;PHF8;KDM4B
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.3240506607447873,-0.8597922537708729,0.6536964980544747,0.9357518121432316,1.0,4/13,12.78%,PIK3CD;PIP4K2B;PIK3C2B;PIK3CB
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.4482406316153984,0.8551498597968091,0.639943741209564,1.0,1.0,2/10,6.99%,CDADC1;GDA
prerank,CCR chemokine receptor binding (GO:0048020),-0.2605404230163597,-0.8536895755048203,0.7248322147651006,0.9415180899427089,1.0,11/28,33.52%,CNIH4;NARS1;CCL15;CCL4;CCL3;CCL14;NES;CCL13;CCL2;CCL5;DEFB130A
prerank,ligand-gated cation channel activity (GO:0099094),0.3597989510787922,0.852026820165092,0.737874097007224,1.0,1.0,13/75,22.20%,CHRNB4;P2RX1;SHROOM2;KCNJ3;GRIA3;KCNJ2;GRIA2;TRPM4;KCNJ10;GRIK5;GRIK3;GRIN2D;KCNN3
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.39829714585185383,0.8505890388206117,0.6658739595719382,1.0,1.0,4/25,12.04%,KMO;FMO5;CYP27A1;CYP46A1
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.4227215770919263,0.8499205676205357,0.6347381864623244,1.0,1.0,5/14,23.81%,KMO;CYBB;CYBA;NCF4;AIFM1
prerank,calcium-activated potassium channel activity (GO:0015269),-0.33754337875779256,-0.8488852690328482,0.6394557823129252,0.9438298306477003,1.0,2/11,2.11%,KCNMA1;KCNN2
prerank,MAP kinase kinase activity (GO:0004708),0.4206763465241708,0.8478206076739638,0.6644474034620506,1.0,1.0,5/15,18.13%,MAP2K6;MAPKAPK3;MAPK14;MAP2K1;LRRK2
prerank,ribosomal large subunit binding (GO:0043023),-0.33613251932909627,-0.8469431093170009,0.6550632911392406,0.9399245394399165,1.0,4/11,9.60%,NEMF;DHX33;MRRF;NMD3
prerank,cell-cell adhesion mediator activity (GO:0098632),0.36591986347906735,0.8462687622766271,0.6851851851851852,1.0,1.0,12/42,23.28%,CD47;STXBP6;S100A11;BSG;PALLD;EMB;PDLIM5;PPP1CA;CDC42EP1;CNTN4;RAB10;DSCAM
prerank,glycerophospholipid flippase activity (GO:0140333),0.43431050059389126,0.844607002674623,0.6427586206896552,1.0,1.0,4/11,20.69%,ATP11C;ATP8A1;ATP11A;ATP8B2
prerank,thiol-dependent deubiquitinase (GO:0004843),0.35335480773270406,0.8433954762793044,0.7275510204081632,1.0,1.0,20/83,17.64%,USP27X;USP1;TANK;USP38;DESI2;USP48;USP31;BAP1;UCHL5;USP14;USP24;USP15;VCPIP1;OTUD5;USP50;YOD1;USP21;USP25;USP40;USP7
prerank,insulin-like growth factor I binding (GO:0031994),-0.3108632124232979,-0.8408850054694257,0.6585365853658537,0.9451864248074131,1.0,7/13,31.64%,IGF1R;ITGB3;IGFBP4;INSR;ITGB4;IGFBP6;IGFBP3
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.2952031973976777,-0.8392402586182534,0.6807511737089202,0.9403866045740906,1.0,4/17,10.82%,GRIA1;GRIA4;GRIN3A;GRIK2
prerank,guanyl ribonucleotide binding (GO:0032561),0.34808229108854344,0.8384058474741822,0.8278278278278278,1.0,1.0,38/196,16.74%,RRAD;ARHGEF5;GBP4;TUBA1C;NOA1;ATL2;ARL5C;REM1;TUBB4B;ARL11;RAB1B;RAB22A;TUBA1B;ARF4;RND3;PDE2A;GBP2;GNAI1;RAB8A;MTG2;SEPHS1;RABL6;RIT2;RHOU;SLC19A1;TUBB;RAB8B;ARF3;PDE5A;RAB11B;RAC2;RAB35;RAB2A;TUBD1;ARL4C;RAB5A;MMAA;RAC1
prerank,GTP binding (GO:0005525),0.3492385336149018,0.8372848227531215,0.8178178178178178,1.0,1.0,37/172,18.44%,RRAD;ARHGEF5;GBP4;TUBA1C;NOA1;ATL2;ARL5C;REM1;TUBB4B;ARL11;RAB1B;RAB22A;TUBA1B;ARF4;RND3;GBP2;GNAI1;RAB8A;MTG2;SEPHS1;RABL6;RIT2;RHOU;TUBB;ARF3;RAB11B;RAC2;RAB35;RAB2A;TUBD1;ARL4C;RAB5A;MMAA;RAC1;DRG1;LRRK2;RAB6A
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.24463354016110544,-0.8370379795033731,0.725,0.9370918118930452,1.0,10/33,19.73%,RNF19B;ARIH1;RNF180;RNF185;AUP1;UBE3D;PRKN;SIAH1;ANKIB1;DCUN1D2
prerank,Hsp70 protein binding (GO:0030544),0.3751340883384169,0.83692416582768,0.6708715596330275,1.0,1.0,12/31,25.77%,SPN;DNAJC18;DNAJC2;DNAJC8;DNAJB1;SNCA;RPS3;HDAC8;DNAJB12;DNAJB14;DNAJC10;DNAJB2
prerank,phospholipase activator activity (GO:0016004),0.4387409983729023,0.8355071412211968,0.6575539568345323,1.0,1.0,3/10,11.00%,FYN;PDPK1;BTK
prerank,cytochrome-c oxidase activity (GO:0004129),0.41779954599993363,0.8342595443381976,0.6851119894598156,1.0,1.0,3/15,13.44%,COX10;COX4I1;NDUFA4
prerank,translation elongation factor activity (GO:0003746),0.4165849154667057,0.8320164363485331,0.6701434159061278,1.0,1.0,4/14,16.01%,EEF1B2;GFM2;EIF5A2;EEF2
prerank,actinin binding (GO:0042805),0.39845488562644243,0.8307756010232357,0.7123287671232876,1.0,1.0,7/21,19.98%,CSRP3;SYNPO2;CSRP1;MAGI1;DAG1;PDLIM5;PKD2
prerank,frizzled binding (GO:0005109),-0.23672996593559967,-0.8291682219981106,0.7521367521367521,0.9448793019591345,1.0,23/34,47.26%,RYK;DVL3;DVL2;WNT5B;DVL1;FZD7;WNT4;WNT5A;WNT2B;LRP6;BAMBI;MYOC;WNT7B;WNT7A;NDP;WNT3;WNT9A;SFRP1;ZNRF3;SDCBP;FZD1;WNT6;WNT8B
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.38783425916314096,0.8279056360295275,0.7019464720194647,1.0,1.0,6/23,16.54%,PLCG2;PLCB1;PLCB3;CHRM3;PLCD1;PLCG1
prerank,sialyltransferase activity (GO:0008373),-0.26817644484076336,-0.8272557103042051,0.7122641509433962,0.9408193359456243,1.0,9/20,20.65%,ST8SIA1;ST3GAL6;ST6GALNAC4;ST6GAL2;ST6GALNAC6;ST3GAL4;ST8SIA5;ST6GALNAC3;ST8SIA3
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.4140020706857254,0.8262427027044268,0.6524547803617571,1.0,1.0,1/14,2.57%,PYCR3
prerank,transition metal ion binding (GO:0046914),0.3425108184362142,0.8242963725917348,0.934,1.0,1.0,82/397,18.45%,UHRF1;RNF26;TK1;MEFV;BLM;CUTA;CUTC;ZCCHC4;RIOX1;HEPH;DHX58;HDAC10;S100A9;TNFSF10;COA6;CTCF;FEN1;RASGRP1;SNRPC;IMPA1;S100A8;MDM4;DPEP1;MBD1;CDADC1;PDE2A;BIRC2;GDA;PRIMPOL;MGAT2;BAZ1B;TDP2;PHF2;SEC24B;SEC24A;PITRM1;TAB3;CSRP1;RPS27;PIM1;TIMM9;EGR1;ZBTB32;TMEM163;KAT6A;ZEB1;NAPEPLD;ZMYND8;ATP7A;RPS29;PARK7;LTA4H;RNF8;ISCA2;RNF2;KMT2A;HHIP;GLO1;SKI;ARIH2;KDM4C;LIMS1;KMT2B;TP53;RC3H1;PDXK;TRIM28;CRIP1;ACER3;KPNB1;DUSP12;ATOX1;SLC30A5;EPRS1;LACTB2;SNCA;CYP2R1;HDAC4;RASSF1;KDM2B;ERAP1;RNPEP
prerank,pentosyltransferase activity (GO:0016763),-0.23862830802772794,-0.8230182438358331,0.7920792079207921,0.9410134718561285,1.0,11/36,18.93%,LACC1;UPP2;PARP6;LARGE1;QTRT1;SIRT3;PPAT;PARP16;UMPS;PARP2;SIRT5
prerank,potassium:proton antiporter activity (GO:0015386),0.43074669931552445,0.8226000917502777,0.6803394625176803,1.0,1.0,4/10,19.26%,SLC9A8;SLC9A9;SLC9A7;SLC9A6
prerank,endopeptidase regulator activity (GO:0061135),0.36113172442970853,0.8217915047309085,0.7249154453213078,1.0,1.0,7/40,13.47%,PSMF1;SLPI;ABCA2;PCSK1N;UCHL5;USP14;PSME1
prerank,RNA polymerase II complex binding (GO:0000993),0.37238190255672543,0.8190503011668174,0.7071759259259259,1.0,1.0,14/32,23.17%,BRD4;ZNF326;CCAR2;DHX9;RPRD1B;HNRNPU;ELOF1;SCAF8;PCF11;AGO2;RPRD2;AGO1;ELP4;NCOA3
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.3396814386417351,0.8188843641858216,0.821285140562249,1.0,1.0,23/147,15.38%,ECT2;ARHGEF5;PSD;RCC1;CCDC88A;TIAM1;ARHGEF18;RASGRP1;RIN3;CCDC88C;DENND4C;EEF1B2;SOS1;FGD6;ARHGEF28;FGD3;DENND1B;DENND1A;LAMTOR4;DENND6A;LAMTOR3;BCR;EGF
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.33914775547823844,0.8187232051612453,0.8316633266533067,1.0,1.0,50/181,20.75%,HEY2;RB1;ZFPM1;MTA3;RBL1;RBBP8;CDKN2A;TAF1;FAF1;TCF3;DDRGK1;SPEN;SMARCA4;MAPK14;NCOA7;TACC2;PIAS3;HIRA;HIPK2;TAF6;DHX9;JUN;MTA2;CDK5RAP3;NFE2L2;BBS4;BEX1;ACTN4;CREBBP;RERE;GSK3B;TADA3;TP53;PIAS1;SIN3A;TCF7L2;COMMD6;TCERG1;SIRT1;HCLS1;HDAC4;MED1;CREB1;PROX1;HDAC1;PRRX1;NCOA2;FIZ1;RBPJ;PPARD
prerank,NADP binding (GO:0050661),0.37052599952449583,0.818096145166567,0.7079152731326644,1.0,1.0,7/32,19.45%,LBR;CBR4;ME3;DHCR7;GMDS;DECR1;PGD
prerank,small GTPase binding (GO:0031267),0.3414394462646229,0.8179023947930187,0.832,1.0,1.0,41/170,19.88%,BIRC5;RCC1;EXOC2;FLNA;ARHGDIB;EXOC4;CAV1;RANGAP1;RIN3;EVI5;CIB1;RAB8A;ERC1;CYRIB;FGD6;LSM2;TNFAIP1;PEX5L;PDE6D;WHAMM;GGA1;FGD3;RANBP2;RNF152;EXOC5;BRK1;CHML;TRIOBP;PAK2;FMNL1;ATP6AP1;NDRG1;GGA2;IQGAP1;LRRK2;AP3M1;SGSM3;MAPKAP1;ARHGAP1;OCRL;HPS4
prerank,exoribonuclease activity (GO:0004532),0.41992851585662627,0.8168333924306903,0.6795580110497238,1.0,1.0,4/12,20.77%,EXOSC8;EXOSC10;CNOT6;CNOT7
prerank,muscle alpha-actinin binding (GO:0051371),0.39847733311024547,0.816039315492655,0.6702702702702703,1.0,1.0,5/15,19.98%,SYNPO2;PDLIM7;PALLD;PDLIM5;PKD2
prerank,MAP-kinase scaffold activity (GO:0005078),0.41997999990272306,0.811026348380417,0.6931659693165969,1.0,1.0,7/11,27.69%,SPAG9;MAP2K1;SH3RF1;IQGAP1;KSR1;AKAP13;MAPK8IP1
prerank,actin monomer binding (GO:0003785),0.3759182317515559,0.8096794311395613,0.7066167290886392,1.0,1.0,3/22,11.23%,PRKCE;LIMA1;MTSS1
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.4230750027972348,0.8083603686932506,0.6728571428571428,1.0,1.0,1/10,2.56%,CD47
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.31410269475390895,-0.8078450288771806,0.7360594795539034,0.9642338836547144,1.0,6/12,31.80%,SDHB;ISCA1;ISCU;CIAPIN1;FDX1;AOX1
prerank,inward rectifier potassium channel activity (GO:0005242),-0.25241656612254343,-0.8078275638344998,0.7777777777777778,0.9564698641969821,1.0,3/24,5.26%,KCNN2;KCNK6;KCNJ6
prerank,insulin-like growth factor binding (GO:0005520),-0.28356155220123413,-0.8019558789235739,0.7604562737642585,0.9593173370088971,1.0,11/15,42.19%,IGF1R;ITGB3;IGFBP4;INSR;ITGB4;IGFBP6;IGFBP3;IGF2R;LRP2;IGFBP5;IGFALS
prerank,omega peptidase activity (GO:0008242),0.33650381105751764,0.8018788809704155,0.7983706720977597,1.0,1.0,20/89,17.64%,USP27X;USP1;TANK;USP38;DESI2;USP48;USP31;BAP1;UCHL5;USP14;USP24;USP15;VCPIP1;OTUD5;USP50;YOD1;USP21;USP25;USP40;USP7
prerank,voltage-gated sodium channel activity (GO:0005248),0.37859359114175706,0.8001271741016186,0.7191943127962085,1.0,1.0,2/22,3.75%,CACNA1I;HCN3
prerank,carboxylic acid binding (GO:0031406),-0.23241462203755406,-0.7994116733932317,0.8461538461538461,0.9569445179324632,1.0,22/38,42.33%,PSAP;GRIN3A;MAG;GLRA2;GLUD1;SESN3;SESN2;GRIN2B;SHMT2;SHMT1;GLRA3;NOS1;CAD;GRIN1;CASTOR1;CASTOR2;SRR;GNMT;UBR1;RTN4R;THNSL2;GRIN3B
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.3793925621342939,0.7991519899572952,0.726010101010101,1.0,1.0,3/21,8.22%,EZR;AKAP7;PRKACA
prerank,voltage-gated anion channel activity (GO:0008308),0.3976433179492103,0.7990328050468829,0.7088274044795784,1.0,1.0,1/15,3.03%,VDAC2
prerank,chemorepellent activity (GO:0045499),-0.2440316705550854,-0.7982994467789031,0.76,0.951312900098684,1.0,13/25,36.86%,SEMA3D;SEMA3E;SEMA4C;SEMA4G;SEMA3A;SEMA7A;SEMA4D;NRG3;SEMA4F;SEMA6C;SEMA6B;SEMA3B;SEMA3F
prerank,adrenergic receptor binding (GO:0031690),-0.28247430521775807,-0.7975074366469728,0.7422222222222222,0.9452700191745755,1.0,6/16,25.62%,GNAS;ARRDC3;ADRB1;DLG4;AKAP5;C1QBP
prerank,myosin II binding (GO:0045159),0.4165105712164431,0.7957090341862135,0.686046511627907,1.0,1.0,4/10,22.12%,GSN;SHROOM4;TRIOBP;SHROOM1
prerank,thyroid hormone receptor binding (GO:0046966),0.3608806322367241,0.793314443227864,0.7226697353279632,1.0,1.0,10/28,23.17%,BRD8;MED30;TAF7;MED1;THRAP3;NCOA6;MED13;TAF11;NSD1;NCOA3
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.4251553430904611,0.7896066941956164,0.6963276836158192,1.0,1.0,5/10,22.45%,PKIG;PRKAG2;PRKAR2A;PRKAG1;PKIA
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.35298565815620125,0.7894564569544944,0.7457817772778402,1.0,1.0,7/35,12.86%,DUS1L;GATC;TRDMT1;FTO;TRMT5;TYW3;NT5C3A
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.3473894612081218,0.7884767121873519,0.7334083239595051,1.0,1.0,7/34,19.51%,RACGAP1;PHLDA3;BTK;ARHGAP9;IQGAP1;KIF16B;MAPKAP1
prerank,CARD domain binding (GO:0050700),0.4003259876715147,0.7877613296272271,0.703125,1.0,1.0,2/14,10.74%,CARD10;CARD9
prerank,RNA polymerase core enzyme binding (GO:0043175),0.3555591363164958,0.7838563625787769,0.7514384349827388,1.0,1.0,14/33,23.17%,ZNF326;SPTY2D1;CCAR2;DHX9;RPRD1B;HNRNPU;ELOF1;SCAF8;PCF11;AGO2;RPRD2;AGO1;ELP4;NCOA3
prerank,ferrous iron binding (GO:0008198),0.37151044426443913,0.7800573017996848,0.7361809045226131,1.0,1.0,3/21,6.55%,HAAO;HEPH;FTO
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.36373016419206505,0.779869468201979,0.7546948356807511,1.0,1.0,1/27,1.12%,SLC12A3
prerank,channel activity (GO:0015267),0.33769359040860575,0.7771427131177685,0.7537960954446855,1.0,1.0,1/41,1.86%,AQP1
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.3906264241485027,0.7767086180961055,0.7356770833333334,1.0,1.0,3/14,13.08%,APAF1;BCL2L13;RACK1
prerank,outward rectifier potassium channel activity (GO:0015271),-0.3141577354772248,-0.7750346962459076,0.7439446366782007,0.9786227210048168,1.0,3/11,16.60%,KCND2;KCND1;KCND3
prerank,G protein-coupled receptor activity (GO:0004930),0.31874687951236813,0.7734752138633908,0.916,1.0,1.0,22/239,16.26%,ADGRD1;S1PR4;CXCR5;VIPR2;MRGPRE;GPR141;LPAR4;GPR75;P2RY1;CALCRL;GPR63;TAPT1;S1PR2;GPR22;TM2D1;ADGRL3;ADGRV1;F2R;LPAR1;GPR35;LGR4;ELOVL4
prerank,mannosyltransferase activity (GO:0000030),0.3693876882879429,0.7734699379972383,0.7340025094102886,1.0,1.0,10/21,28.45%,ALG8;TMTC2;POMT1;PIGM;TMTC4;POMT2;PIGV;DPY19L1;TMTC1;TMTC3
prerank,sodium:proton antiporter activity (GO:0015385),0.3947217906354725,0.7728003588933758,0.7262723521320495,1.0,1.0,4/11,19.26%,SLC9A8;SLC9A9;SLC9A7;SLC9A6
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.3837392442625423,0.771968648768091,0.7337748344370861,1.0,1.0,4/14,18.99%,AK9;NME4;AK5;CMPK2
prerank,calcium-dependent phospholipid binding (GO:0005544),-0.19821308867115134,-0.7684246012335643,0.9295774647887324,0.9825929165546934,1.0,28/49,37.13%,PCLO;ANXA3;SYT1;SYT4;ANXA4;SYT7;SYT9;SYT6;CPNE4;CPNE2;ANXA2;PLA2G4E;ANXA6;ANXA9;DYSF;PLA2G4A;ANXA1;SYT12;SYT11;CPNE9;CPNE5;SYT13;PLA2G4C;ESYT3;SYT5;ESYT1;ANXA5;SYT17
prerank,semaphorin receptor activity (GO:0017154),-0.30284692875427877,-0.7681184039259318,0.714765100671141,0.9755330974463927,1.0,2/11,2.38%,NRP2;PLXNA4
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.38160284332798944,0.7676470805058903,0.7278645833333334,1.0,1.0,3/14,14.50%,SLC25A12;SLC25A22;SLC25A13
prerank,GTPase regulator activity (GO:0030695),0.32343973954755295,0.7675782523004644,0.9209209209209209,1.0,1.0,42/212,15.61%,ECT2;RACGAP1;GPSM2;ARHGAP15;ARHGAP11A;TBC1D1;RGS12;ARHGAP33;CCDC88A;SEC23B;TBC1D8B;TBC1D22B;RANGAP1;EVI5;ARHGAP35;ARFGAP3;ARFGAP1;RP2;RAP1GAP2;SOS1;ARHGAP19;LARS1;GMIP;PDE6D;IPO7;STARD8;ARHGAP39;ASAP2;ARHGAP30;JUN;PLCB1;RANBP2;ARHGAP9;NRP1;ARHGAP45;ADAP1;ARHGAP26;TBC1D25;ARHGAP31;BCR;IPO5;NPRL3
prerank,transferrin receptor binding (GO:1990459),0.4003874386045728,0.767037606693395,0.7334293948126801,1.0,1.0,1/10,5.73%,IKBKG
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.3749708505894608,0.7648401280487909,0.7363636363636363,1.0,1.0,4/16,22.01%,HAAO;PIR;ETHE1;IDO2
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.27612435870605967,-0.763970470326584,0.8040816326530612,0.9748314702644063,1.0,3/15,11.87%,PIK3R5;PIK3R1;SOCS7
prerank,metallopeptidase activity (GO:0008237),0.31869507988936313,0.7638619660025512,0.8635437881873728,1.0,1.0,17/113,19.90%,ADAMTS7;KEL;NRDC;MBTPS2;DPEP1;METAP2;PITRM1;MMP19;ADAMTS1;ADAMTSL3;ADAMTS5;PRPF8;ADAM10;ERAP1;RNPEP;MMP12;MME
prerank,GTPase binding (GO:0051020),0.3182765211858132,0.7629858830618798,0.909,1.0,1.0,62/195,24.87%,BIRC5;RCC1;EXOC2;FLNA;ARHGDIB;EXOC4;CAV1;RANGAP1;RIN3;EVI5;CIB1;RAB8A;ERC1;CYRIB;FGD6;LSM2;TNFAIP1;PEX5L;PDE6D;WHAMM;GGA1;BECN1;AMBRA1;FGD3;RANBP2;RNF152;EXOC5;BRK1;CHML;TRIOBP;PAK2;FMNL1;ATP6AP1;EPRS1;NDRG1;GGA2;IQGAP1;LRRK2;GNB2;AP3M1;SGSM3;MAPKAP1;ARHGAP1;OCRL;HPS4;RRAGB;BNIP3;TNPO3;RAB34;EVI5L;FGD4;GNB1;CHM;YBX1;EHD1;CDC42EP4;DAPK3;AKAP13;RNF41;RADIL;SRGAP2;TBC1D20
prerank,myosin V binding (GO:0031489),-0.27208323007200735,-0.7604350970227541,0.8223140495867769,0.9730381535171012,1.0,6/15,21.45%,RAB14;RAB6B;RAB11A;RAB3C;RAB3A;RAB3B
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.3430286755940145,0.7597729742442911,0.7782909930715936,1.0,1.0,14/33,23.17%,ZNF326;LLPH;CCAR2;DHX9;RPRD1B;HNRNPU;ELOF1;SCAF8;PCF11;AGO2;RPRD2;AGO1;ELP4;NCOA3
prerank,bHLH transcription factor binding (GO:0043425),0.363911851427808,0.7583510407401873,0.758576874205845,1.0,1.0,5/19,16.94%,TWIST1;USF1;TCF3;CREBBP;SIRT1
prerank,poly-pyrimidine tract binding (GO:0008187),0.3532637601558428,0.7582355065952954,0.7437425506555423,1.0,1.0,4/23,13.49%,HNRNPC;RBMS2;HNRNPU;DAZAP1
prerank,phosphatase activity (GO:0016791),0.3206941430183227,0.7549957040901168,0.8076525336091003,1.0,1.0,12/73,17.86%,PLPPR3;ALPL;PTPN22;PPP1CB;ARMT1;EPHX2;PPP1CC;BPNT2;APTX;PLPPR4;DUSP12;PPP1CA
prerank,ATPase binding (GO:0051117),0.3224016660581111,0.7549273005202809,0.8350730688935282,1.0,1.0,18/71,20.09%,PEX26;EZR;PPP3CA;CAV1;ANK1;EGFR;RDX;FBL;ZNHIT6;PSEN1;NOP58;TAF9;USP25;DNAJB1;UBXN1;SYVN1;PKD2;SVIP
prerank,cholesterol binding (GO:0015485),0.3265869006967749,0.7545630059715366,0.8062770562770563,1.0,1.0,7/47,11.42%,VDAC2;OSBP2;CAV1;OSBPL5;TSPO;OSBPL3;STARD5
prerank,peptidase inhibitor activity (GO:0030414),0.3355284252189625,0.7518432833146315,0.7885714285714286,1.0,1.0,5/33,12.89%,PSMF1;SLPI;PCSK1N;UCHL5;USP14
prerank,peptidase activator activity (GO:0016504),0.3493481951943584,0.7489348812891014,0.7662976629766297,1.0,1.0,10/22,25.74%,TANK;CAV1;PSME1;PCOLCE2;PSME4;PSME2;PSME3;CASP8AP2;NLRC4;VCP
prerank,poly(U) RNA binding (GO:0008266),0.35291588455092254,0.7447063498175751,0.7527272727272727,1.0,1.0,3/20,13.49%,HNRNPC;RBMS2;DAZAP1
prerank,histone deacetylase activity (GO:0004407),0.3533153438658553,0.7442539687232446,0.7726708074534161,1.0,1.0,10/19,25.68%,HDAC10;HDAC6;SIRT7;SIRT1;HDAC4;HDAC1;HDAC8;HDAC9;MIER1;HDAC11
prerank,GTPase activator activity (GO:0005096),0.3106225421373291,0.7441984185402578,0.965,1.0,1.0,56/313,15.61%,ECT2;RACGAP1;ARHGEF5;PSD;ARHGAP15;ARHGAP11A;RCC1;TBC1D1;ARHGAP33;CCDC88A;SEC23B;TIAM1;TBC1D8B;TBC1D22B;ARHGEF18;RASGRP1;RANGAP1;RIN3;EVI5;CCDC88C;DENND4C;EEF1B2;ARHGAP35;ARFGAP3;ARFGAP1;RP2;RAP1GAP2;SOS1;ARHGAP19;LARS1;FGD6;GMIP;STARD8;ARHGAP39;ASAP2;ARHGAP30;JUN;PLCB1;ARHGEF28;FGD3;RANBP2;DENND1B;ARHGAP9;NRP1;DENND1A;ARHGAP45;ADAP1;LAMTOR4;DENND6A;LAMTOR3;ARHGAP26;TBC1D25;ARHGAP31;BCR;EGF;NPRL3
prerank,kinase activity (GO:0016301),0.31356560515556503,0.7423154548972605,0.8721047331319235,1.0,1.0,26/109,21.31%,MASTL;FN3KRP;PANK2;CHKB;TAF1;PRKD3;PKN2;RFK;SEPHS1;NADK2;PAPSS2;DCAKD;DGKD;STK39;CDC7;GSK3B;PDXK;PIK3CA;PGK1;TAOK1;LRRK2;PANK1;NADK;PKMYT1;CHKA;DGKE
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.39353473997213995,0.7415915898400796,0.7442857142857143,1.0,1.0,2/11,18.18%,SLC25A47;SLC22A4
prerank,nucleotide diphosphatase activity (GO:0004551),0.36942272400500076,0.7357714888548186,0.7878378378378378,1.0,1.0,2/14,8.81%,NUDT13;NUDT4
prerank,ATPase activator activity (GO:0001671),-0.25054965706266835,-0.7328533418266464,0.8317757009345794,1.0,1.0,6/20,15.45%,DNAJC19;DNAJB6;DNAJA2;ATP1B2;ATP1B1;DNAJC1
prerank,phospholipase C activity (GO:0004629),0.3371808360127066,0.7285334157963271,0.7992831541218638,1.0,1.0,6/25,16.54%,PLCG2;PLCB1;PLCB3;CHRM3;PLCD1;PLCG1
prerank,mannose binding (GO:0005537),-0.2858212000332778,-0.7281269976808473,0.8062283737024222,1.0,1.0,4/12,31.73%,CLN5;CLEC4D;LMAN2;CLEC6A
prerank,potassium ion antiporter activity (GO:0022821),0.3615203835912616,0.7260522783515888,0.7755644090305445,1.0,1.0,6/15,19.26%,SLC9A8;SLC24A4;SLC24A2;SLC9A9;SLC9A7;SLC9A6
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.32380818592116195,0.724299975408735,0.804147465437788,1.0,1.0,4/32,6.55%,ALKBH4;RIOX1;JMJD4;FTO
prerank,nucleoside-diphosphatase activity (GO:0017110),0.36595994029829426,0.7233328480096816,0.7780821917808219,1.0,1.0,3/12,17.33%,ENTPD3;ENTPD5;CANT1
prerank,ion channel activity (GO:0005216),0.3039118083778365,0.7187888785733492,0.8680981595092024,1.0,1.0,4/80,7.84%,CHRNB4;P2RX1;TMC4;TRPM7
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.3706835712432837,0.7177881137627233,0.7629310344827587,1.0,1.0,1/11,9.21%,KCNJ3
prerank,NAD+ binding (GO:0070403),0.3647236526939367,0.7170710884198211,0.7941988950276243,1.0,1.0,4/12,17.54%,HPGD;UXS1;SIRT1;CRYL1
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.37703905157960815,0.7104500938045522,0.797979797979798,1.0,1.0,4/10,19.40%,CASP2;CFLAR;CASP9;CASP8
prerank,sodium channel activity (GO:0005272),0.3193743256038784,0.7100751827912644,0.8257993384785005,1.0,1.0,3/37,7.34%,CACNA1I;HCN3;SHROOM2
prerank,tRNA methyltransferase activity (GO:0008175),0.34917033808843945,0.7095059384412498,0.7955439056356488,1.0,1.0,3/16,11.37%,TRDMT1;TRMT5;TYW3
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.3006732099398149,0.7061254361989917,0.881619937694704,1.0,1.0,15/69,23.31%,ESCO2;MOGAT2;KAT6A;KAT2B;NAA16;CERS4;ZDHHC7;CREBBP;CERS6;CERS2;ELP3;ZDHHC6;SOAT1;LPCAT3;ZDHHC21
prerank,endopeptidase inhibitor activity (GO:0004866),0.29260411780432827,0.6996822288083345,0.8909465020576132,1.0,1.0,10/82,12.89%,UBE2O;PSMF1;LXN;SLPI;UBE2Z;BIRC6;PCSK1N;PTTG1;UCHL5;USP14
prerank,cysteine-type endopeptidase activity (GO:0004197),0.293649758383825,0.6972482136521381,0.8884339815762539,1.0,1.0,23/78,21.33%,ESPL1;USP1;CASP2;USP38;CAPN1;USP48;CTSK;CTSO;USP14;CFLAR;USP24;CASP9;USP15;CAPN10;USP25;USP40;USP7;MALT1;CASP8;USP34;CAPN15;USP47;USP46
prerank,adenyl nucleotide binding (GO:0030554),-0.2785878656182166,-0.6969065403023643,0.8408304498269896,1.0,1.0,4/11,15.43%,PFN1;HSPH1;HSPBP1;SIL1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.2785878656182166,-0.6969065403023643,0.8408304498269896,1.0,1.0,4/11,15.43%,PFN1;HSPH1;HSPBP1;SIL1
prerank,fatty acid synthase activity (GO:0004312),0.37282640412945656,0.6968585116576481,0.826530612244898,1.0,1.0,3/10,16.26%,CBR4;ELOVL5;ELOVL4
prerank,GABA receptor binding (GO:0050811),-0.2951594298098906,-0.696256130631728,0.8272058823529411,1.0,1.0,5/11,25.17%,ARFGEF2;PLCL2;LHFPL4;AKAP5;SHISA7
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.2931493290687708,0.6949842554373643,0.8881987577639752,1.0,1.0,7/73,15.96%,VIPR2;NPSR1;SORCS2;CALCRL;S1PR2;F2R;LGR4
prerank,cardiolipin binding (GO:1901612),0.36595178403855944,0.6946131869784823,0.8118518518518518,1.0,1.0,2/10,19.90%,NME4;MME
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.3426678288800894,0.6908385959392862,0.8067567567567567,1.0,1.0,2/14,16.21%,RDH10;RDH5
prerank,solute:sodium symporter activity (GO:0015370),-0.20653471567703427,-0.6901333379631592,0.9104477611940298,1.0,1.0,27/27,79.39%,SLC5A7;SLC4A8;SLC5A11;SLC5A6;SLC28A2;SLC4A9;SLC13A5;SLC4A10;SLC28A1;SLC4A5;SLC5A1;SLC5A10;SLC20A1;SLC28A3;SLC34A1;SLC17A2;SLC17A1;SLC34A3;SLC5A8;SLC5A9;SLC5A2;SLC17A7;SLC34A2;SLC4A4;SLC4A7;SLC5A3;SLC20A2
prerank,platelet-derived growth factor binding (GO:0048407),0.3614038504047612,0.689936934602201,0.8072463768115942,1.0,1.0,2/11,17.16%,COL1A2;COL4A1
prerank,pseudouridine synthase activity (GO:0009982),-0.25944855415482115,-0.6890594948227311,0.84375,1.0,1.0,2/13,3.31%,PUS10;PUS7
prerank,alpha-actinin binding (GO:0051393),0.31456392893204566,0.6888119087239708,0.8303030303030303,1.0,1.0,7/24,19.98%,SYNPO2;PDLIM7;MAGI1;PALLD;DAG1;PDLIM5;PKD2
prerank,poly(A) binding (GO:0008143),0.3236815139636082,0.6873046035691337,0.8275862068965517,1.0,1.0,5/21,18.40%,EIF4A3;ELAVL4;RBMS2;HNRNPU;PPIE
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.2933795772641964,-0.6862006612712025,0.84,1.0,1.0,2/10,12.83%,DUSP10;DUSP7
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.2933795772641964,-0.6862006612712025,0.84,1.0,1.0,2/10,12.83%,DUSP10;DUSP7
prerank,ligand-gated calcium channel activity (GO:0099604),0.3287792114693272,0.6837674338439693,0.82625,1.0,1.0,1/19,3.00%,ITPR1
prerank,cysteine-type peptidase activity (GO:0008234),0.28863312727149,0.6821065999504841,0.8896907216494845,1.0,1.0,22/73,21.33%,ESPL1;USP1;CASP2;USP38;USP48;ATG4B;CTSK;CTSO;USP14;USP24;CASP9;USP15;USP50;USP21;USP25;USP40;USP7;MALT1;CASP8;USP34;USP47;USP46
prerank,adenylate cyclase binding (GO:0008179),0.3536223669224444,0.6784193514472991,0.8253968253968254,1.0,1.0,1/10,3.34%,AKAP12
prerank,GTPase inhibitor activity (GO:0005095),-0.2589552732877906,-0.6774876852352596,0.8938775510204081,1.0,1.0,5/13,17.57%,TNK2;GPS2;RHOH;CDC42SE1;ARL2
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.2211625999669139,-0.6770637231544762,0.8871794871794871,1.0,1.0,1/21,1.61%,FRS2
prerank,retinoid binding (GO:0005501),-0.20824220321335113,-0.6749373569732038,0.9473684210526315,0.9974528775412295,1.0,15/22,49.74%,PTGDS;RARA;RBP4;ALDH1A2;CYP26B1;RBP1;ABCA4;CYP26C1;CRABP2;CRABP1;UGT1A6;UGT1A7;UGT1A8;UGT1A4;UGT1A1
prerank,neuropeptide receptor activity (GO:0008188),0.30607285978834053,0.6740895298890343,0.8438228438228438,1.0,1.0,2/29,8.66%,NPSR1;SORCS2
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.31775608527298715,0.6728452645462892,0.8469135802469135,1.0,1.0,4/22,17.61%,HSPG2;CLTC;HSP90B1;LDLRAP1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.3485378661670857,0.6718949975840461,0.8183098591549296,1.0,1.0,1/10,6.22%,DPEP1
prerank,glucuronosyltransferase activity (GO:0015020),0.3272948275699272,0.6708372776703929,0.8430884184308842,1.0,1.0,4/19,20.56%,EXT1;CHSY1;B3GAT2;B3GAT1
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.329733138734393,0.670687147205003,0.8363636363636363,1.0,1.0,2/15,10.57%,CCR2;CCR6
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.32751142597830857,0.6703087098885293,0.825065274151436,1.0,1.0,3/16,17.46%,ANO10;ANO3;ANO6
prerank,intracellular chloride channel activity (GO:0061778),0.32751142597830857,0.6703087098885293,0.825065274151436,1.0,1.0,3/16,17.46%,ANO10;ANO3;ANO6
prerank,5'-nucleotidase activity (GO:0008253),-0.25713800030954137,-0.6689336656042484,0.8837209302325582,0.9965401056678339,1.0,5/13,25.03%,NT5M;NT5DC1;NT5DC3;NT5C;NT5E
prerank,Tat protein binding (GO:0030957),-0.27988378604968667,-0.6688042474231662,0.8711864406779661,0.9898503910060238,1.0,3/10,20.45%,MDFIC;ACTB;TRIM32
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.33714989805863765,0.6687752506168497,0.8399452804377565,1.0,1.0,5/12,22.19%,TUT1;TENT2;TENT5D;PAPOLA;TENT4A
prerank,titin binding (GO:0031432),0.33767987236235153,0.6685906627081849,0.8461538461538461,1.0,1.0,2/13,10.21%,MYBPC1;ACTN2
prerank,lipoprotein particle receptor binding (GO:0070325),0.3064583477630685,0.6678175525063594,0.8554778554778555,1.0,1.0,5/27,17.61%,HSPG2;CLTC;RELN;HSP90B1;LDLRAP1
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.33873195229127434,0.6649794643744616,0.8575380359612724,1.0,1.0,12/12,66.15%,ELOVL4;RHO;OPN1SW;GNAT2;OPN4;OPN5;OPN1MW;OPN1MW3;GPR52;RRH;GPR88;OPN3
prerank,nucleotidase activity (GO:0008252),0.31808245598703283,0.6636544598255518,0.825974025974026,1.0,1.0,3/15,12.86%,NT5C2;BPNT2;NT5C3A
prerank,poly-purine tract binding (GO:0070717),0.3035754805165707,0.6629795194012983,0.8486293206197855,1.0,1.0,7/27,20.20%,EIF4A3;ELAVL4;RBMS2;HNRNPU;DAZAP1;PPIE;PNPT1
prerank,O-methyltransferase activity (GO:0008171),0.35056986268381796,0.6606027619451501,0.844903988183161,1.0,1.0,2/10,16.08%,CMTR2;LRTOMT
prerank,calcium activated cation channel activity (GO:0005227),0.3203994941767233,0.658970403416045,0.8485237483953787,1.0,1.0,2/17,4.89%,ANO10;KCNN4
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.3101954525568719,0.6568667389635319,0.8451380552220888,1.0,1.0,2/22,13.28%,HTR2A;CHRM3
prerank,serotonin receptor activity (GO:0099589),0.3101954525568719,0.6568667389635319,0.8451380552220888,1.0,1.0,2/22,13.28%,HTR2A;CHRM3
prerank,G protein-coupled amine receptor activity (GO:0008227),0.3101954525568719,0.6568667389635319,0.8451380552220888,1.0,1.0,2/22,13.28%,HTR2A;CHRM3
prerank,Notch binding (GO:0005112),-0.20687836037916485,-0.6563198641069005,0.96045197740113,0.9946168399223817,1.0,10/22,30.59%,GALNT11;JAG1;SNED1;MEGF10;AAK1;KCTD10;TCIM;JAG2;DLK2;NOTCH4
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.2723841414022708,0.6529431310445957,0.9186405767250257,1.0,1.0,15/72,21.08%,STXBP6;PHLDA3;CGAS;GSN;FLII;ACTN2;PLCB1;KCNJ2;RAB35;PLCD1;LDLRAP1;AMER2;MAPKAP1;MARK1;SVIL
prerank,phosphoric ester hydrolase activity (GO:0042578),0.28722700778299665,0.6518742631271892,0.8976545842217484,1.0,1.0,16/49,24.31%,PTPN22;PPP1CB;ARMT1;EPHX2;PPP1CC;APEX1;DUSP12;PPP1CA;ENPP6;MPPED2;DUSP16;SACM1L;PGP;SMPD1;PGAM5;SAMHD1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.28135021234641244,0.6507424055763448,0.9046087888531619,1.0,1.0,23/54,28.73%,GLS2;HDAC10;HDAC6;SIRT7;NTAQ1;DARS1;ACER3;SIRT1;HDAC4;HDAC1;HDAC8;NAAA;SIRT4;NADSYN1;HDAC9;NIT2;MIER1;HDAC11;HINT1;ASRGL1;NIT1;ASAH1;PIGL
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.28757496844173636,0.6505481061649725,0.8805460750853242,1.0,1.0,10/38,21.01%,SNX3;PHLDA3;DENND1A;RUBCNL;ZFYVE26;ATG2B;KIF16B;NCF4;WDR45B;SNX13
prerank,Hsp90 protein binding (GO:0051879),0.2913641278826037,0.6492860745697784,0.8688711516533637,1.0,1.0,10/33,25.07%,HDAC6;AHR;UNC45A;AHSA1;RPS3;NPAS2;HDAC8;MAPT;TELO2;STIP1
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.29966786940688445,0.6484616280725971,0.8571428571428571,1.0,1.0,4/24,19.75%,SNX3;OSBPL5;RUBCNL;GOLPH3
prerank,sterol binding (GO:0032934),0.27767884911525553,0.6482014889258626,0.920042643923241,1.0,1.0,7/56,11.42%,VDAC2;OSBP2;CAV1;OSBPL5;TSPO;OSBPL3;STARD5
prerank,ribonuclease P RNA binding (GO:0033204),-0.26251731060253763,-0.6480686156874176,0.9066666666666666,0.9949751396141193,1.0,6/10,35.27%,RPP14;RPP21;RPP38;RPP40;POP5;POP7
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.34226525273975267,0.6475127781838617,0.850415512465374,1.0,1.0,3/10,19.36%,CYBB;CYBA;NCF4
prerank,snoRNA binding (GO:0030515),0.29181077637613007,0.6431945894612763,0.8837209302325582,1.0,1.0,6/30,17.98%,NOP10;NUDT4;UTP6;PRKDC;NOP58;DKC1
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.3259895976789086,0.6428133184889661,0.8518518518518519,1.0,1.0,5/12,20.77%,PNLDC1;CNOT1;CNOT6;CNOT8;CNOT7
prerank,protein tyrosine kinase activator activity (GO:0030296),0.30105877560345995,0.6398239426689376,0.879415347137637,1.0,1.0,4/19,16.33%,ERBB3;EGF;PAK2;CD24
prerank,iron ion binding (GO:0005506),0.2769955781715493,0.6391319141462892,0.9020452099031216,1.0,1.0,5/48,7.94%,HAAO;RIOX1;HEPH;FTO;PHF2
prerank,metal ion:proton antiporter activity (GO:0051139),0.32244285420711816,0.6375735123357742,0.8729508196721312,1.0,1.0,4/13,19.26%,SLC9A8;SLC9A9;SLC9A7;SLC9A6
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.32491758137390403,0.6375160330778334,0.8645690834473324,1.0,1.0,4/12,19.26%,SLC9A8;SLC9A9;SLC9A7;SLC9A6
prerank,estrogen receptor binding (GO:0030331),0.28355333167298313,0.6345219457332317,0.8943181818181818,1.0,1.0,11/32,22.95%,LEF1;STRN;LATS1;CNOT1;MED1;DDX54;NCOA6;MMS19;NRIP1;PHB2;NSD1
prerank,death receptor activity (GO:0005035),0.32355311932847175,0.6298509450419629,0.8826979472140762,1.0,1.0,2/11,15.83%,FAS;TNFRSF11A
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.2935905112550005,0.6279192027610445,0.8850299401197604,1.0,1.0,8/25,26.52%,ART3;PARP14;SIRT1;SIRT4;PARP11;ZC3HAV1;PARP1;PARP9
prerank,anion channel activity (GO:0005253),0.27130324202851547,0.626992737539671,0.914466737064414,1.0,1.0,7/61,10.79%,VDAC2;GABRA4;LRRC8B;CLIC1;LRRC8C;GABRA5;ANO3
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.29289757471367417,0.6234839674486374,0.8883435582822086,1.0,1.0,7/20,21.30%,AK9;MAGI3;AK3;AK6;CMPK2;AK2;CASK
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.30811734767825977,0.620622787001693,0.8917861799217731,1.0,1.0,4/15,14.94%,KMT2C;KMT2A;RBBP5;KMT2B
prerank,histone demethylase activity (GO:0032452),0.2769527741846632,0.6152066829764903,0.9101516919486581,1.0,1.0,7/27,20.42%,RIOX1;KDM3B;PHF2;KDM4C;JARID2;KDM2B;KDM2A
prerank,calcium ion binding (GO:0005509),0.25037920165796196,0.6048237239755223,0.998,1.0,1.0,53/323,20.94%,EFCAB11;SLC25A12;C2CD5;ITPR1;S100A11;PPP3CA;RCN3;S100A9;SYT8;RASGRP1;S100A8;GSN;CIB1;CDH18;CDH24;SMOC2;CAPN1;CEMIP2;MELK;DNER;MICU3;SYT3;SLIT3;SLIT1;CRACR2A;CANX;BAIAP3;TPM4;MICU1;ADGRL3;SLC25A13;TPT1;ANXA11;ADGRV1;GCA;NDUFAB1;CDH4;ACER3;TRPM4;CANT1;HSP90B1;MCTP1;SNCA;IQGAP1;NRXN1;S100A10;MMP12;PKD2;CDH20;CDH19;CDH7;CCDC47;SYT2
prerank,phosphatidylinositol kinase activity (GO:0052742),0.30489034318749825,0.6041815017469176,0.8903394255874674,1.0,1.0,3/15,16.78%,ATM;PI4K2B;PIK3CA
prerank,protein phosphorylated amino acid binding (GO:0045309),0.2662708221212704,0.6036776095186329,0.9143167028199566,1.0,1.0,13/42,23.00%,CRKL;PIN1;GRB2;PLCG2;CRK;IRS1;PTPN5;LDLRAP1;YWHAE;SYK;FGR;PTPN11;NEDD4
prerank,wide pore channel activity (GO:0022829),-0.19212715902171473,-0.6017363092174361,0.9651162790697675,1.0,1.0,11/23,47.25%,GJA1;GJC2;GJB1;GJC1;GJD3;PANX2;PANX1;GJB2;GJD2;PRF1;GJA5
prerank,phosphate ion binding (GO:0042301),0.31725043332818037,0.6009741993086665,0.9118881118881119,1.0,1.0,2/10,19.49%,PDE2A;PNP
prerank,retinoic acid binding (GO:0001972),0.3108187776634604,0.6003511979434785,0.8958904109589041,1.0,1.0,1/12,10.29%,NR2F2
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.31763945877030997,0.5997031387507755,0.9035971223021583,1.0,1.0,4/11,19.40%,CASP2;CFLAR;CASP9;CASP8
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.2979374746658756,0.598892378766819,0.8911022576361222,1.0,1.0,3/13,25.12%,IDI1;SREBF2;MIF
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.20981614894450368,-0.5967581974567341,0.9523809523809523,1.0,1.0,2/15,11.10%,ALDH7A1;ALDH1A1
prerank,SH2 domain binding (GO:0042169),0.26969672112990656,0.5918393256100196,0.9282407407407407,1.0,1.0,6/31,14.53%,CCDC88A;JAK2;CRK;RACK1;DAG1;IRS1
prerank,gap junction channel activity (GO:0005243),-0.18756693042172745,-0.59044457257459,0.9837837837837838,1.0,1.0,9/22,43.34%,GJA1;GJC2;GJB1;GJC1;GJD3;PANX2;PANX1;GJB2;GJD2
prerank,NF-kappaB binding (GO:0051059),0.2781497133933879,0.5885699144767966,0.9212410501193318,1.0,1.0,6/24,18.96%,CDKN2A;FAF1;CDK5RAP3;GSK3B;COMMD6;HDAC1
prerank,voltage-gated calcium channel activity (GO:0005245),0.2644745120352114,0.5884060313919646,0.9248878923766816,1.0,1.0,8/37,21.12%,CACNA1I;CACNG5;ITGAV;CACNA1B;CACNG8;PKD2;CACHD1;CACNG4
prerank,UDP-glycosyltransferase activity (GO:0008194),0.24997443923851326,0.5866342634435951,0.9585921325051759,1.0,1.0,6/70,9.89%,CSGALNACT2;HAS1;EXT1;GXYLT1;MFNG;B3GNT2
prerank,translation initiation factor activity (GO:0003743),0.26060625886673844,0.5848549396817782,0.9456159822419534,1.0,1.0,3/36,5.29%,EIF2S1;EIF2A;EIF3E
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.2643830017026402,0.5775430625819395,0.9352179034157833,1.0,1.0,4/26,18.34%,CSGALNACT2;B3GNT2;CHSY1;GBGT1
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.3080429466650988,0.5757852809012131,0.9097222222222222,1.0,1.0,2/10,16.78%,ATM;PIK3CA
prerank,lysine N-methyltransferase activity (GO:0016278),-0.18996709610269297,-0.5756059890031681,0.9862385321100917,1.0,1.0,7/20,26.18%,SETD3;SETD4;METTL21A;EEF2KMT;EHMT2;ETFBKMT;ANTKMT
prerank,amyloid-beta binding (GO:0001540),0.2434103294896221,0.5754321537581285,0.9642126789366053,1.0,1.0,13/79,17.61%,IAPP;HSPG2;CD74;VBP1;PFDN5;GRIA3;TM2D1;TLR6;TGFB2;GRIA2;CACNA1B;FCGR2B;LDLRAP1
prerank,cell adhesion mediator activity (GO:0098631),0.26173573711862563,0.573183493503197,0.9114832535885168,1.0,1.0,4/24,17.07%,CD47;BSG;PALLD;EMB
prerank,monocarboxylic acid binding (GO:0033293),0.2817985063343689,0.5720401880166266,0.9336734693877551,1.0,1.0,2/18,10.49%,NR2F2;NAPEPLD
prerank,enoyl-CoA hydratase activity (GO:0004300),0.29819251233836197,0.5719343266687722,0.9227467811158798,1.0,1.0,3/10,18.76%,AUH;HADHA;HADHB
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.23771602542503062,0.5715281375195366,0.9776195320447609,1.0,1.0,19/91,21.28%,STXBP6;SNX3;PHLDA3;CGAS;GSN;FLII;ACTN2;PLCB1;KCNJ2;RAB35;PLCD1;LDLRAP1;AMER2;KIF16B;MAPKAP1;MARK1;WDR45B;SVIL;MAPT
prerank,cation channel activity (GO:0005261),0.23851634800542898,0.568610830013787,0.9715157680569685,1.0,1.0,13/94,17.46%,P2RX1;AQP1;ANO10;TRPM7;KCNA1;MCU;PSEN1;SLC24A4;SLC24A2;HVCN1;UNC80;TRPM4;ANO6
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.245410363547004,0.567566491832976,0.9530271398747391,1.0,1.0,11/57,20.69%,NDUFS8;CYBRD1;NDUFB7;COX10;COX4I1;NDUFA1;NDUFA4;NDUFA5;NDUFS1;NDUFS5;UQCRH
prerank,N-acetyltransferase activity (GO:0008080),-0.19049046351261922,-0.567404541632657,0.9769585253456221,1.0,1.0,9/19,32.93%,SAT1;NAT8L;ESCO1;GNPNAT1;NAA10;NAT2;SAT2;NAA80;EP300
prerank,adenylyltransferase activity (GO:0070566),-0.18285072968198848,-0.5662820314932746,0.9735449735449735,1.0,1.0,8/21,27.62%,SELENOO;PAPOLG;NMNAT3;FLAD1;NMNAT1;MTPAP;NMNAT2;OASL
prerank,receptor tyrosine kinase binding (GO:0030971),0.24336425723905428,0.5659874142843678,0.9567053854276664,1.0,1.0,11/56,20.55%,LRP4;PCNA;TRADD;PTPN14;RACK1;IRS1;TP53;ELMO2;MAP3K7;GRB14;FIZ1
prerank,GTPase activity (GO:0003924),0.23556489579181383,0.5655646374202811,0.995,1.0,1.0,35/192,19.06%,RAB33B;GBP4;ATL2;ARHGDIB;RAB1B;RAB22A;RND3;GBP2;GNAI1;RAB8A;MTG2;GNAO1;RIT2;RHOU;GPN2;RAB8B;GFM2;RAB11B;RAB43;RAC2;RAB35;RAB2A;GNG11;EEF2;RAB5A;MMAA;RAC1;SEPTIN9;GSPT1;DRG1;LRRK2;GNB2;RAB6A;NKIRAS1;SAR1B
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.2593306240521907,0.5648523148128041,0.9404052443384983,1.0,1.0,2/25,4.89%,PHLDA3;PLEKHA2
prerank,mechanosensitive ion channel activity (GO:0008381),0.284664520940361,0.5643968596135277,0.9240162822252375,1.0,1.0,1/12,5.24%,TMC4
prerank,dynactin binding (GO:0034452),0.29251955418883313,0.562903031153668,0.916083916083916,1.0,1.0,4/12,21.28%,PAFAH1B1;BBS4;GSK3B;MAPT
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.2652871123544776,0.5627890596463512,0.9388264669163545,1.0,1.0,2/23,4.84%,SNX3;PHLDA3
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.2388854523581389,0.5484620062190478,0.9664138678223185,1.0,1.0,5/46,9.89%,EXT1;PIGA;MGAT2;MFNG;B3GNT2
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.25374360544270874,0.545243453830838,0.9408926417370326,1.0,1.0,5/24,18.99%,AK9;NME4;AK5;AK3;CMPK2
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.20992482599700343,-0.5437849310315579,1.0,1.0,1.0,7/13,42.47%,PYCARD;BMP6;BMP5;BMP2;BMP4;CDH5;BMP7
prerank,myosin binding (GO:0017022),0.23061866088917998,0.5390237266900121,0.9829242262540021,1.0,1.0,16/55,22.98%,GSN;RAB8A;MYBPC1;SHROOM4;HAP1;RAB11B;LMTK2;TRIOBP;CALD1;CXCR4;RAB6A;TRAK2;SHROOM1;RAB27B;NCKIPSD;RAB10
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.2698521507971537,0.5373089369371055,0.9431664411366711,1.0,1.0,5/13,22.45%,EZR;GSK3B;SOX9;PRKAR2A;PKIA
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.22182335724039318,0.535831731134348,0.9837067209775967,1.0,1.0,19/100,21.28%,RACGAP1;SNX3;PHLDA3;OSBPL5;BTK;DENND1B;ARHGAP9;DENND1A;RUBCNL;ZFYVE26;ATG2B;IQGAP1;KIF16B;NCF4;MAPKAP1;GOLPH3;WDR45B;SNX13;MAPT
prerank,FAD binding (GO:0071949),0.24850709512483596,0.5341048007236605,0.9498806682577565,1.0,1.0,2/24,7.18%,KMO;PRODH
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.20021064141192393,-0.5329679847896556,0.9714285714285714,1.0,1.0,2/13,11.10%,ALDH7A1;ALDH1A1
prerank,voltage-gated chloride channel activity (GO:0005247),-0.22238045029978656,-0.5324754795762422,0.9698996655518395,0.99564376166736,1.0,4/10,29.58%,CLCN4;CLCN2;CLCN3;CLCN1
prerank,BMP receptor binding (GO:0070700),-0.20995147832193697,-0.5288341523075765,0.9925650557620818,0.9902212844119012,1.0,7/12,42.47%,PYCARD;BMP6;BMP5;BMP2;BMP4;CDH5;BMP7
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.23439682188174588,0.5230608851856235,0.9743589743589743,1.0,1.0,7/34,19.07%,NDUFS8;NDUFB7;NDUFA1;NDUFA4;NDUFA5;NDUFS1;NDUFS5
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.23439682188174588,0.5230608851856235,0.9743589743589743,1.0,1.0,7/34,19.07%,NDUFS8;NDUFB7;NDUFA1;NDUFA4;NDUFA5;NDUFS1;NDUFS5
prerank,voltage-gated cation channel activity (GO:0022843),0.2154133878801435,0.5159662441592331,0.9908163265306122,1.0,1.0,17/97,21.57%,CACNA1I;HCN3;CACNG5;ITGAV;KCNA1;KCNC2;KCNH7;HVCN1;CACNA1B;KCNQ5;CACNG8;PKD2;KCNC1;CACHD1;CACNG4;KCNH8;GRIN2D
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.2388240373172893,0.5133143686036582,0.9695193434935522,1.0,1.0,3/29,9.07%,HPSE2;GBA2;ENGASE
prerank,N-acyltransferase activity (GO:0016410),0.22634322034754067,0.5108874241156782,0.9701149425287356,1.0,1.0,7/32,20.86%,CERS4;SIRT7;CERS6;SIRT1;NAT10;CERS2;NMT2
prerank,amino acid binding (GO:0016597),0.23219416908626805,0.5108123420078202,0.9668571428571429,1.0,1.0,1/31,2.63%,DDAH2
prerank,kinase inhibitor activity (GO:0019210),0.22209282108542402,0.5001021395810932,0.9779326364692218,1.0,1.0,12/33,28.62%,GMFG;PARVA;HEXIM1;SNCA;CDKN1A;DNAJC3;CDKN1B;NPM1;SH3BP5;SMCR8;MAPK8IP1;GSKIP
prerank,ion gated channel activity (GO:0022839),0.23171493590862763,0.4967156653323605,0.9768009768009768,1.0,1.0,4/24,17.46%,ANO10;ANO3;TRPM4;ANO6
prerank,ion channel inhibitor activity (GO:0008200),0.21942442299368758,0.4943525563790825,0.9820224719101124,1.0,1.0,3/35,13.08%,ITPR1;NEDD4L;RACK1
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.2546204791289862,0.4845474720107955,0.9704697986577181,1.0,1.0,2/12,16.78%,ATM;PIK3CA
prerank,CXCR chemokine receptor binding (GO:0045236),0.25378193459293197,0.4843075369785346,0.9797395079594791,1.0,1.0,11/11,74.64%,ITCH;CXCL5;PPBP;CXCL13;CXCL2;CXCL1;CXCL9;CXCL10;CXCL12;PF4;YARS1
prerank,G protein-coupled receptor binding (GO:0001664),0.20029586553533274,0.48321262352103805,0.9959798994974874,1.0,1.0,10/132,13.02%,FLNA;GPRC5B;CCDC88C;GNAI1;INSL3;PICK1;GNAO1;ARRB2;S1PR2;GRK2
prerank,organic cation transmembrane transporter activity (GO:0015101),0.2410177300291294,0.47898146456085294,0.9696569920844327,1.0,1.0,3/16,20.66%,SLC44A1;SLC22A4;SLC44A2
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.1894182590541592,-0.4741252152056911,1.0,0.9950749161820617,1.0,4/11,34.23%,SLC2A9;SLC5A11;SLC23A1;SLC23A2
prerank,hexosyltransferase activity (GO:0016758),0.19492281449989912,0.46390908627362376,0.9989858012170385,1.0,1.0,25/101,26.70%,CSGALNACT2;HAS1;EXT1;GBA2;MFNG;B3GNT2;TMTC2;GBE1;POMT1;CHSY1;MTAP;PIGM;B3GLCT;POFUT1;GCNT1;MGAT4C;FUT9;TMTC4;POMT2;B3GALNT1;B4GALT3;PIGV;LFNG;B3GALT1;DPY19L1
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.23943499090110398,0.4613538693802718,0.9740437158469946,1.0,1.0,1/12,9.89%,B3GNT2
prerank,potassium channel regulator activity (GO:0015459),0.19465589896129468,0.45886465608907484,0.9967672413793104,1.0,1.0,5/49,17.66%,FLNA;NEDD4L;SUMO1;SGK3;YWHAE
prerank,potassium channel activity (GO:0005267),0.19195162164651874,0.4575361941487695,1.0,1.0,1.0,14/89,21.50%,AQP1;HCN3;KCNN4;KCNA1;KCNC2;KCNH7;KCNK12;KCNK2;KCNQ5;PKD2;KCNC1;GRIK5;GRIK3;KCNH8
prerank,NAD binding (GO:0051287),0.20534074982110306,0.4459608757641836,0.9871043376318874,1.0,1.0,8/26,26.52%,HPGD;UXS1;SIRT1;CRYL1;ZC3HAV1;ALDH2;QDPR;PARP9
prerank,voltage-gated potassium channel activity (GO:0005249),0.18394061194424216,0.44161215218286,0.9989690721649485,1.0,1.0,13/80,22.20%,HCN3;KCNA1;KCNJ3;KCNC2;KCNH7;KCNJ2;KCNK2;KCNQ5;KCNJ10;PKD2;KCNC1;KCNH8;KCNN3
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.21467782371353467,0.4355433419322042,0.982573726541555,1.0,1.0,3/14,20.87%,CAPN1;CAPN10;CAPN15
prerank,phosphatidylglycerol binding (GO:1901611),0.2122448305309963,0.4231506284405427,0.9861495844875346,1.0,1.0,2/13,19.90%,NME4;MME
prerank,ribonuclease P activity (GO:0004526),0.21697142787784007,0.41833801393899606,0.9887640449438202,1.0,1.0,3/11,22.79%,PRORP;POP4;RPP30
prerank,phosphatidic acid binding (GO:0070300),0.17666808798254935,0.37287966862583,0.9987293519695044,1.0,1.0,8/19,29.81%,PACSIN2;MAPKAP1;MARK1;RAPGEF6;RAPGEF2;OPA1;SMPD3;PITPNM1
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.17886255207345927,0.3702070857328393,0.9987357774968394,1.0,1.0,3/17,21.32%,EPHA3;EPHA7;EPHA10
prerank,ephrin receptor activity (GO:0005003),0.17886255207345927,0.3702070857328393,0.9987357774968394,1.0,1.0,3/17,21.32%,EPHA3;EPHA7;EPHA10
prerank,delayed rectifier potassium channel activity (GO:0005251),0.1622403161987156,0.36466817194897866,1.0,1.0,1.0,4/32,19.98%,KCNA1;KCNC2;KCNQ5;KCNC1
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.16187654728284925,0.3253684575533439,0.9986754966887417,1.0,1.0,3/14,22.79%,PRORP;POP4;RPP30
prerank,P-type ion transporter activity (GO:0015662),0.1657636357066164,0.32194748280541163,0.9986263736263736,0.9997354585414481,1.0,4/12,27.96%,ATP7A;ATP2B4;ATP2A2;ATP6V1E1
